Page Summary Flashcards

1
Q

Which nerve is responsible for the larynx?

A

Vagus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2 nerves for motor of larynx?

A

External superior laryngeal and recurrent laryngeal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where is external superior laryngeal nerve responsible for with motor?

A

Cricothyroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Stimulation of which nerve causes laryngospasm?

A

Superior laryngeal nerve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which 2 nerves are responsible for sensory of larynx?

A

Internal superior laryngeal and recurrent laryngeal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where is internal superior laryngeal nerve responsible for with sensory?

A

Above vocal cords and cords

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where is recurrent laryngeal nerve responsible for with sensory?

A

Below vocal cords

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Posterior cricoarytenoid movement?

A

Abduct
“You take it out back”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lateral cricoarytenoid movement?

A

Adduct
“You bring it in from the side”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cricothyroid does — to vocal cords

A

Tenses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Thyroarytenoid does — to vocal cords.

A

Relaxes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which 2 nerves are responsible for pharynx?

A

Spinal accessory and glossopharyngeal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which nerve controls motor in pharynx?

A

Spinal accessory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which nerve controls sensory in pharynx?

A

Glossopharyngeal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Laryngeal cartilages from superior to inferior (6)

A

Epiglottis
Thyroid
Cuneiform
Corniculate
Arytenoids
Cricoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Normal P50 value?

A

26-27mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

8 causes of left shift in oxyhemoglobin dissociation curve?

A

Decrease PCO2
Decrease H+
Increase pH
Decrease temp
Increase CO poisoning (carboxyhemoglobin)
Fetal hemoglobin
Methemoglobin (prilocaine, benzocaine, nitroprusside)
Smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

6 causes of right shift in oxyhemoglobin dissociation curve?

A

Increase PCO2
Increase H+
Decrease pH
Increase temp
Increase 2-3 DPG
Sickle cell anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Right shift — O2 from blood

A

Unloads

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Right shift of oxyhemoglobin dissociation curve=

A

Release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Left shift — O2 affinity

A

Increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Left shift of oxyhemoglobin dissociation curve=

A

Locked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

PaCO2 affects oxyhemoglobin dissociation curve

A

Bohr effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

PaO2 affects CO2 dissociation curve

A

Haldane affect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Cl- exchange for HCO3- in RBC’s
Hamburger shift
26
What is the hamburger shift?
HCO3- out, Cl- in ; non pulmonary
27
90% SaO2 =
60mmHg
28
70% SaO2 =
40 mmHg
29
Dissolved O2 =
.003 x PaO2
30
O2 bound to Hb =
1.34 x Hb x SaO2
31
Total O2 Content (CaO2) =
(1.34 x Hb x SaO2) + (.003 x PaO2)
32
O2 consumption ~
3-4 ml/kg/min ; 250ml/min
33
Dissolved CO2 =
.003 x PaCO2
34
CO2 produced and eliminated @
200ml/min ; 2.4-3.2ml/kg/min
35
CO2 is — more soluble than O2
20x
36
Anatomical dead space =
2ml/kg
37
Alveolar ventilation (VA) =
(TV - DS) x RR
38
PaO2 on O2 =
FiO2 x 5
39
PaO2 on RA =
102 - age/3
40
PAO2 on O2 =
FiO2 x 6
41
PAO2 on RA =
100 - (.4 x age)
42
PAO2 proper equation =
[FiO2 x (Patm - PH2O) - (PACO2/RQ)]
43
Pulmonary ventilation (VT) =
RR and TV
44
Net Filtration pressure =
Kf [(Pc-Pi) - (Oc-Oi)] x SA
45
Normal net filtration pressure
+1
46
Ficks law of diffusion proportional to
(Change in P x SA x diff. Coefficient) / membrane thickness
47
Poiseuille’s law =
R = 8nl/pie(r^4)
48
Tidal volume ml
500
49
Inspiratory reserve volume ml
3000
50
Expiratory reserve volume ml
1000
51
Residual volume ml
1200
52
Which PFT cannot be measure by spirometry?
Residual volume
53
Inspiratory capacity equation
TV + IRV
54
Inspiratory capacity ml
3500
55
Vital capacity equation
TV + IRV + ERV
56
Vital capacity ml
4500
57
Functional residual capacity equation
ERV + RV
58
Functional residual volume ml
2200
59
Total lung capacity equation
TV+ IRV + ERV + RV
60
Total lung capacity ml
5700
61
Total CO2 content of arterial blood
48 mlCO2/100ml blood
62
Total CO2 content of venous blood
52 mlCO2/100ml blood
63
Normal CO2 arterial-venous difference
4 mlCO2/100ml blood
64
2 primary respiratory centers
Dorsal respiratory group (DRG) pacemaker and ventral respiratory group
65
Which location of the brainstem can the primary respiratory centers be found?
Medulla
66
Dorsal respiratory group pacemaker is in charge of which muscles?
Phrenic and external intercostals
67
Ventral respiratory group is in charge of which muscles?
Internal intercostal
68
Secondary respiratory centers can be found where in the brainstem?
Pons
69
What 2 things make up the secondary respiratory center?
Apneustic center and pneumotaxic center
70
Apneustic center is in charge of what?
Deep and prolonged respiration
71
Pneumotaxic center is in charge of what?
Shuts off respiration (hering-Bering 1.5L)
72
Central chemoreceptors in medulla respond to what?
Increase H+, PCO2 in CSF
73
Peripheral chemoreceptors respond to what?
Decrease O2 <60 mmHg
74
Carotid body response to what?
Increase CO2
75
Aortic arch responds to what?
Increase H+
76
Which nerve is in charge of carotid?
Glossopharyngeal
77
Which nerve is in charge of aortic and stretch receptors?
Vagus
78
—: Partial pressure of CO2 in CSF
LeChatelier’s Principle
79
Vagus nerve, prevents overstretching (TV 1.5L)
Hering-Breuer reflex
80
Inspiration HR and intrathoracic pressure response?
Increase HR Decrease intrathoracic pressure
81
Dead space vent and perfusion
Well vent/poor perfusion
82
Shunt perfusion and vent
Well perfusion/ poor vent
83
4 things to increase dead space?
1. Age 2. PP vent 3. PE 4. Lung disease
84
Compliance equation =
Change V / change P
85
Un-anesthetized V and Q in lateral decubitus?
Non dependent: decrease V and Q Dependent: increase V and Q
86
Anesthetized V and Q in lateral decubitus?
Non dependent: increase V and decrease Q Dependent: decrease V and increase Q
87
Jackson-Reese is which mapleson?
E
88
Jackson-Reese minimum — L/min (2.5-3xMV)
5
89
Bain circuit is which mapleson circuit?
D
90
Bain circuit minimum flow for CV and SV?
CV: 70 ml/kg SV: 100-300 ml/kg
91
Normal A-a gradient on RA
5-15mmHg
92
Normal FEV1
4L
93
Normal FVC
5L
94
Normal FEV1/FVC
.8
95
FEV25-75
4.7 L/sec
96
Asthma, bronchitis, emphysema: FEV1, FVC, and FEV1/FVC
FEV1: decrease (<2.5L) FVC: normal FEV1/FVC: decrease (<.7)
97
What is the best test to access early stages of COPD?
FEV 25-75
98
Obstruction is — to get out
Hard
99
Restrictive is — to get in
Hard
100
Pulmonary fibrosis, pneumothorax, scoliosis FEV1, FVC, and FEV1/FVC?
FEV1: decrease FVC: decrease FEV1/FVC: normal to high
101
Moderate risk FEV1 and FEV1/FVC?
FEV1: <2L FEV1/FVC: <50%
102
High risk FEV1, FVC, and FEV1/FVC?
FEV1: <1L FVC: <1.5L or 20 ml/kg FEV1/FVC: <35%
103
CO has — greater affinity for Hb than O2
200-250x
104
4 ways CO2 is carried in blood:
1. Physically dissolved (5%) 2. Carbonic Acid (<1%) 3. Bicarbonate ion (HCO3-, 90%) 4. Protein bound (5%)
105
Responsible for converting CO2 to HCO3-
Carbonic anhydrase
106
Central chemoreceptors response to —
Systemic CO2 & H+ in the CSF
107
Peripheral chemoreceptors respond mostly to —
Decrease PaO2
108
— is the primary stimulus for ventilatory response
PaCO2
109
Mast cells can cause — through histamine release
Bronchoconstriction
110
6 anatomical characteristics of a difficult intubation?
1. Short,muscular neck 2. Receding mandible 3. Protruding maxillary incisors 4. Unable to visualize uvula 5. Limited TMJ (<40mm) 6. Limited cervical mobility
111
Permanent dilation of a bronchus or group of small bronchi, airway resistance increase, compliance increases
COPD
112
Copious sputum, increase Hct, “blue bloater”
Bronchitis
113
Cough with exertion, scant sputum, “pink puffer”
Emphysema
114
COPD post op FEV1/FVC and preop CO2:
FEV1/FVC: <.5 CO2: >50mmHg
115
#1 symptom to asthma?
Wheezing
116
Asthma acid-base:
Hypoxia and hypocarbia with alkalosis
117
2 most common reasons for pulmonary edema:
Increase pulmonary hydrostatic pressure Increase in permeability of alveolar capillary membrane
118
Pulmonary edema colloid osmotic pressure and hydrostatic pressure:
Colloid osmotic pressure: 28mmHg Hydrostatic pressure: 6-8mmHg
119
What is the #1 manifestation of ARDS?
Hypoxia
120
ARDS causes a which kind of shunt?
Right to left
121
Which syndrome has a increased risk of aspiration?
Mendelson’s syndrome
122
Earliest and most reliable sign of aspiration?
Hypoxemia
123
4 causes of pulmonary restrictive disease?
1. Acute intrinsic (ARDS, aspiration, or CHF) 2. Chronic intrinsic (sarcoidosis, drug induce) 3. Chronic extrinsic (obesity, ascites, pregnant; “big bellies”) 4. Disorders of the pleura or mediastinum
124
Intrinsic restrictive lung disease Restrictive ♥ myopathy ↑ Ca++ Splenomegaly Hepatic granulomas Optic and facial nerve involvement
Sarcoidosis
125
Hypotension, Hypoxemia, Tachycardia, increase CVP, increase PIP, Absence of unilateral breath sounds, Tracheal shift, Asymmetric chest wall movement
S/S of tension pneumothorax
126
Transtracheal Jet Vent location?
Cricothyroid membrane
127
Barotrauma & pneumothorax, Mediastinal air (emphysema), Arterial perforation, DAMAGE TO TRACHEAL MUCOSA, Sub Q emphysema, Exhalation difficulty, Esophageal puncture, THICKENED SECRETIONS
Complications of transtrachael jet ventilation
128
Vent modes for — ventilation: IMV, SIMV, MMV, PSV & HFJV
spontaneous ventilation
129
Vent modes for — ventilation: CMV, AC, and PCV
Not supporting spontaneous
130
— is a phosphodiesterase inhibitor (PDEIII). Phosphodiesterase breaks down cAMP. When phosphodiesterase is inhibited, cAMP accumulates and bronchodilation occurs. It also improves diaphragmatic contractility. — cause release of NE from sym postganglionic neurons – avoid w/ halothane, adenosine receptors
Aminophylline ; Xanthines
131
— and— are both methylated xanthines.
Caffeine and Theophylline
132
— receptor stimulation activates adenylate cyclase which converts ATP to cAMP resulting in bronchodilation
Beta-2
133
— is a mast cell stabilizer that prevents the release of histamine, bradykinin. It prevents bronchospasm in asthmatics, but is not effective once bronchospasm develops. CHRONIC
Cromolyn sodium
134
—, a quaternary ammonium compound, is an antimuscarinic used to augment bronchodilation produced by beta-2 agonists. Blockade of the muscarinic receptor leads to a decrease of IP3 so less calcium is released form intracellular vesicles. Smooth muscle tone is reduced.
Ipratroprium
135
— is a non-xanthine central respiratory stimulant. It increases tidal volume and to a lesser extent respiratory rate. It is not good for newborns because it is dissolved in benzyl alcohol. It acts through peripheral chemoreceptors to stimulate central chemoreceptors.
Doxapram
136
ETT equation
Age/4 + 4 (uncuffed) (-) 0.5 cuffed
137
ETT length equation
12 + age/2
138
<6.5kg LMA
1
139
<20kg LMA
2
140
20-30kg LMA
2.5
141
>30kg LMA
3
142
Normal adult LMA
4
143
Large adult/men LMA
5
144
Crazy large LMA
6
145
Sterilization temperatures:
275F & 135C
146
Aspiration steps:
1. head down (#1) 2. disconnect circuit 3. Suction 4. examine w/ bronchoscope 5. x-ray 6. abx (debatable) 7. physiotherapy
147
What is a cleaner used?
Endozime
148
Differences in Neonatal Respiratory System: — Lung compliance — Chest wall compliance — FRC O2 consumption — ml/kg/min
Decrease, increase, decrease, 7
149
Neonatal decrease lung compliance 2nd to less —
Alveoli
150
Neonatal increase chest wall compliance shows — ribs
Floppy
151
Neonatal has decrease FRC to ~ — ml/kg
30
152
Thyro-mental distance
> 6.5 cm = ~3 fingerbreadths
153
Auto regulation: Cerebral Perfusion Pressure = MAP — mmHg Coronary Perfusion Pressure = MAP — mmHg Renal Perfusion Pressure = MAP — mmHg
50-150 60-160 80-180
154
Four types of abnormal Cardiac wall motion:
1. Hypokinesis (less than normal wall motion) 2. Hyperkinesia (greater than normal wall motion) 3. Akinesis (absence of wall motion) 4. Dyskinesis (paradoxical outward motion)
155
Atrial contraction wave on CVP:
A wave on CVP
156
Ventricular contraction, tricuspid valve elevation wave on CVP:
C wave on CVP
157
Tricuspid closed, systolic atrial filling wave on CVP:
V wave on CVP
158
Ventricular systole, atrial relax, displace tricuspid valve wave on CVP:
X wave on CVP
159
Diastole, early ventricular filling, open tricuspid wave on CVP:
Y wave on CVP
160
RIJ or LIJ preferred and why?
RIJ because LIJ has the thoracic duct
161
CVP waveform: tricuspid stenosis, pulmonary stenosis, pulmonary HTN, ↓ right ventricular compliance
Large A waves
162
CVP waveform: tricuspid regurg, r vent papillary muscle ischemia, pericarditis, cardiac tamponade
Large V waves
163
Multiorifice catheter — below SVC
2cm
164
Single orifice catheter — above SVC
3cm
165
— interspace above level of 3rd rib
T4-T5
166
Right ventricular failure, tamponade, tricuspid stenosis, tricuspid regurgitation, pericarditis, pulmonary hypertension, chronic left ventricular failure, and hypervolemia : — CVP
Increased CVP
167
Increase CVP PEEP
may read high- need to d/c from vent 10-15 seconds
168
Where are the venous baroreceptors located?
RA and great veins
169
—: stretch of RA = increase HR with inspiration via vagus nerve
Bainbridge reflex
170
Where are the arterial baroreceptors located?
Aortic arch and carotid sinus
171
Which arterial barorecpetor: Vagus nerve afferent, stretch
Aortic arch
172
Which arterial barorecpetor: Glossopharyngeal (hering’s) nerve afferent
Carotid sinus
173
Action potentials (efferent) via —and — sympathetic cardio accelerators.
vagus and T1-T4
174
Swan-ganz catheter max ballon air
1.5ml
175
Swan-ganz catheter: RA pressure
1-8
176
Swan-ganz catheter: RV pressure
15-25/1-8
177
Swan-ganz catheter: PA pressure
15-25/8-15
178
Swan-ganz catheter: PCWP pressure
6-12
179
Swan-ganz catheter: LA pressure
2-12
180
Swan-ganz catheter: LV pressure
100-140/0-12
181
Swan-ganz catheter: RA depth
20
182
Swan-ganz catheter: RV depth
30
183
Swan-ganz catheter: PA depth
45
184
Swan-ganz catheter: PCWP depth
45-50
185
— is never higher than PADP
PAWP
186
When can PAWP be higher than PADP (3)
1. MS 2. Increase alveolar pressure 3. Pulmonary venous obstruction
187
CVP and PCWP from pt status: hypovolemia
CVP: low PCWP: low
188
CVP and PCWP from pt status: left ventricular failure
CVP: normal or high PCWP: high
189
CVP and PCWP from pt status: Right ventricular failure
CVP: high PCWP: normal
190
CVP and PCWP from pt status: PE
CVP: high PCWP: normal
191
CVP and PCWP from pt status: chronic pulmonary HTN
CVP: high PCWP: normal
192
CVP and PCWP from pt status: cardiac tamponade
CVP: high PCWP: high
193
— = Pressure problem = same size SV
Concentric Hypertrophy
194
— = Volume problem = Larger SV
Eccentric Hypertrophy
195
Arterial wave number: anacrotic limb: contractility & SVR(ease of LV emptying)
1
196
Arterial wave number: dicrotic limb: blood flow to periphery
2
197
Arterial wave number: dicrotic notch: aortic valve closure, coronary artery perfusion
3
198
Pulse pressure greatest in — d/t ↑SBP & ↓DBP
pediatrics
199
High a line transducer = — BP Low a line transducer = — BP
Low ; high
200
Invasive BP is — mmHg higher than non-invasice
20
201
Sitting position = transducer a line @ —
ear
202
Ventricular action potential: 0= 1= 2= 3= 4=
0= Na influx 1= Cl-in, K+out 2= Ca+ influx 3= K+ EF flux 4= Na-K pump
203
SA node action potential: 0= 3= 4=
0= Ca+ and Na+ influx (mostly Ca+) 3= K+ efflux 4= Na-K pump
204
SV equation
(CO x 1000)/HR
205
CI equation
CO/BSA
206
SI equation
CI/HR
207
SVR equation
(MAP-CVP/CO) 80
208
PVR equation
(MPAP-PCWP/CO) 80
209
CoPP equation
AoDBP-PCWP
210
MAP equation
(DBP x 2 + SBP) / 3
211
SV value
60-90 ml/min
212
CI value
2.5-3.5 L/min
213
SI valve
40-60
214
SVR valve
900-1500 dyn
215
PVR value
50-150 dyn
216
CoPP valve
60-160
217
MAP value
80-120
218
RBBB QRS V1 and V6
MARROW V1: m shape; broad R wave V6: w shape; broad S wave
219
LBBB QRS V1 and V6
WILLIAM V1: W shape; no R wave, wide negative S wave V6: M shape; no Q wave, wide notched R wave
220
II, III, aVF lead location
Inferior, posterior
221
I, aVL, V5-V6 lead location
Lateral
222
V1-V4 lead location
Anterior, septal
223
RCA supples blood to where
Inferior, posterior
224
Left circumflex supples blood where
Lateral
225
LAD supplies blood where
Anterior, septal
226
Obstruction of the — or — = SA & AV nodal dysrhythmias -sinus arrest, sinus pause, type I AV block, nodal rhythms, & complete heart
RCA or circumflex
227
Obstruction of the — = Wide complex rhythms- bundle branch block, complete heart block, mobitz type II block, idioventricular rhythms.
LAD
228
ECG electrodes have what type of voltage
Micro
229
Which lead: anterior axillary line at the level of 5th intercostal space
V5
230
Small positive wave following T wave
U wave
231
Which wave is associated w/ ↓ K, ↑ Ca, quinidine, digitalis, epinephrine, intracranial hemorrhage, or papillary muscle dysfunction
U wave
232
Increase Preload = increase SV, same ED vol =
Give fluids
233
Decrease Preload = decrease SV, same ED vol =
NTG, Lasix, tamponade
234
Increase Afterload = increase SVR, decrease SV, increase BP, increase ED vol =
phenylephrine
235
Decrease Afterload = decrease SVR, increase SV, decrease BP, decrease ED vol =
Sodium nitroprusside (SNP)
236
Increase Contractility = increase SV, decrease ED vol, increase BP =
Digoxin, Ca++
237
Decrease Contractility = decrease SV, increase ED vol, decrease BP =
CHF
238
CO to liver
27%
239
CO to kidney
22%
240
CO to heart
5% (225ml)
241
CO to CNS
15% (750ml)
242
CO to lungs
100%
243
Aortic and mitral stenosis HR and SVR: use what
SSS (slow, sinus, SVR); HR: low; SVR: high Phenylephrine
244
Aortic and mitral regurgitation preload, SVR, and HR: come common cause
FFF (fast, forward, full); increase preload; decrease SVR; increase HR Rheumatic fever
245
IHSS (HOCM) volume and SVR: use what?
Keep full, increase SVR Phenylephrine
246
Tetralogy of Fallot SVR: and use what?
Increase SVR Phenylephrine
247
PVR — with acidosis and hypercarbia
Increases
248
Increase PVR causes what kind of shunt?
Right to left shunt
249
SVR — with acidosis and hypercarbia
Decrease
250
Sepsis: PCWP, CO, and SVR
PCWP decrease, CO increase, SVR decrease
251
What 3 things is with becks triad?
Muffled heart sounds, JVD, hypotension
252
Becks triad is most common with what?
Cardiac tamponade
253
Inhibitors of HMG-CoA recluctase
Statins
254
2 side effects of statins
1. Liver dysfunction 2. Sever myopathy
255
Protamine dose
1 mg/100 U heparin
256
Heparin for bypass
300 U/kg
257
Initial dose of FFP
10-15 ml/kg
258
What to give for an antithrombin III deficiency?
FFP
259
Mnemonic for cranial nerves
Oh Oh Oh To Touch And Feel A Girls Vagina - So Heavenly
260
CN 1: name and function
Olfactory and smell
261
CN 2: name and function
Optic and vision
262
CN 3: name and function
Occulomotor and adduction of eye (medial), pupil size
263
CN 4: name and function
Trochlear and eye movements
264
CN 5: name and function
Trigeminal and chewing, mastication, facial sensory
265
CN 6: name and function
Abducens and abduction of eye (lateral)
266
CN 7: name and function
Facial and facial muscles, taste (anterior 1/3 tongue)
267
CN 8: name and function
Acoustic and balance (vestibular), hearing (cochlear)
268
CN 9: name and function
Glossopharyngeal and taste (posterior 2/3 tongue), carotid & sinus afferent
269
CN 10: name and function
Vagus and parasympathetic efferent, decrease HR
270
CN 11: name and function
Spinal accessory and motor control of larynx & pharynx
271
CN 12: name and function
Hypoglossal and tongue muscles
272
CBF amount
750 ml/min, 50 ml/100g/min, 15% of CO
273
CBF equation
CPP/CVR
274
CPP equation
MAP-ICP
275
Cerebral glucose consumption
5 mg/100g/min
276
Blood flow and vessel diameter to non ischemic and ischemic for cerebral steal:
Non ischemic: BF increase & diameter increase Ischemic: BF decrease & diameter maxed dilate
277
Blood flow and vessel diameter to non ischemic and ischemic for inverse cerebral steal:
Non ischemic: BF decrease & diameter decrease Ischemic: BF increase & diameter max dilated
278
2 things that cause cerebral steal?
Hypoventilation and vasodilators (nitro)
279
What causes inverse cerebral steal?
Hyperventilation
280
CN: Superior rectus- supraaduction “look up”
3
281
CN: Inferior rectus- infradduction “look down”
3
282
CN: Medial rectus- adduction “look in”
3
283
CN: Lateral rectus- abduction “look out”
6
284
CN: Supeiror oblique- look in & down
4
285
CN: Inferior oblique- look out and up
3
286
— pathway = Trigeminal nerve- V
Afferent
287
— pathway = Vagus nerve - X
Efferent
288
Oculocardiac relfex ECG manifestation: 3
↓ HR, Junctional Rhythm, PVC’s
289
Oculocardiac reflex triggered by:
traction on extraocular muscles- MEDIAL RECTUS, ocular manipulation, manual pressure on globe
290
Oculocardiac reflex Tx/Blockade:
antimuscarinic meds, retrobulbar block, IA
291
What 2 nerves are associated with oculocardiac reflex?
Trigeminal (5) and vagus (10)
292
Normal ICP
5-15
293
Focal ischemia ICP
25-55
294
Global ischemia ICP
>55
295
IC volume: Brain matter & intracellular H2O
80%
296
IC volume: blood
12%
297
IC volume: CSF
8%
298
ICP waveforms: plateau waves, found in pts with increase ICP
A waves
299
What 3 s/s of Cushing’s triad ?
Bradycardia Hypertension Irregular respirations
300
8 treatments for increase ICP:
1. Dehydrate brain w/ Mannitol (0.25-1g/kg) or Lasix 2. Give steroids- slowest but may restore BBB 3. Hyperventilate PaCO2 25-30 mmHg (1/2 life 6hr) 4. Restrict fluids 5. Elevate HOB to 30degrees 6. Administer cerebral vasoconstrictor (pentathol, etomidate) 7. Control BP 8.Cool pt to 34C for cerebral protection
301
—: above cerebellum= flexion upper & extension lower
Decordicate
302
—: at brainstem = extension arms & legs, arched body
Decerebrate
303
— = Frontal lobe — = Temporal lobe — = Brainstem & cerebellum
Anterior Middle Posterior
304
Time to Close of Fontanelles: Anterior, Posterior, Anterolateral, Posterolateral
18 mos. 2 mos 2 mos 2 years
305
Specific gravity of CSF =
1.003-1.009
306
Hyperbaric fluid =
D10
307
Isobaric fluid =
CSF
308
Hypobaric fluid =
NS/sterile H2O
309
CSF forms @ — in the choroid plexus
21 ml/hr or 500-700 ml/day
310
— is located specifically in temporal horn of each lateral ventricle, the posterior portion of the third ventricle, and the roof of the fourth ventricle.
Choroid plexus
311
CSF is reabsorbed mostly in the — (4/5), but also in spinal villi & lymphatics.
arachnoid villi
312
Total volume of CSF =
150 ml
313
CSF Pressure: —
10 & 20cm H2O
314
— is the most common site of CSF obstruction
Aqueduct of Sylvius
315
4 factors governing passage across BBB:
Size - smaller crosses easier Charge- (ions do not cross- Na, K, Mag) Lipid solubility- Cross Degree of protein binding
316
Do Water & Gases cross BBB?
Yes
317
Do H2O soluble drugs & Proteins cross BBB?
No
318
What 2 areas have no BBB?
Chemoreceptor trigger zone (CRTZ) and area surrounding the posterior pituitary
319
4 electrolyte disorders that decrease Seizure threshold:↑Sz activity
1. Hypocalcemia 2. Hypomagnesemia 3. Hyponatremia 4. Hypernatremia
320
(2)Conditions & (3)Meds Likely to↓Sz Threshold:
Hypoglycemia Alkalosis Demerol is opioid most likely to cause seizures Aminophylline & ketamine together
321
2 causes of Acute Spinal Shock:
1. Hypotension due to sympathetic blockade 2. bradycardia due to blockade of cardiac accelerators
322
Autonomic Hyperreflexia spinal location =
T5 or T6
323
When do Cerebral Vasospasm occur:
4-12 days post op
324
S/S of cerebral vasospasm: 3
worsening headache, confusion, HTN
325
Triple H Therapy For treatment of cerebral vasospasm and med=
1. Hypervolemia = CVP > 10 mm Hg, PCWP = 12-20 2. Hypertension = SBP 160-200 mm Hg 3. Hemodilution = Hct 33% -Medication - Nimodipine
326
Wake-up test monitors the anterior (ventral) spinal cord, which is supplied by the —. These are — tracts.
anterior spinal arteries ; motor
327
In Parkinson’s avoid: (4)
Reglan Compazine Droperidal All meds that↓Dopamine
328
VAE steps: 9
1. Notify surgeon so they can flood the field or pack 2. Turn off N2O 3. Administer 100% O2 4. Aspirate central venous catheter to remove air 5.↑CVP (Valsalva maneuver) 6. CV drugs to support circulation 7. Bilateral jugular vein compression 8. PEEP 9. Position- left lateral decub w/ 15 degree head down tilt
329
CSF pathway: (10)
1. Choroid plexus 2. Lateral ventricle 3. Foramen Monroe 4. 3rd ventricle 5. Aqueduct of Sylvius 6. 4th ventricle 7. Foramen luschka & foramen magendie 8. Subarachnoid space 9. Brain 10. Arachnoid Villi
330
4 main sources for circle of Willis:
1. R internal carotid 2. L internal carotid 3. Basilar artery 4. Vertebral artery
331
Slack Brain maneuvers= (4)
Mannitol/ Diuretics Hyperventilation PaCO2 = 25-30mmHg Hypertonic Saline Head up position
332
1-4 Hz- greatest amplitude- sleeping adult, abn in wake
Delta
333
4-8 Hz- Amplitude- higher than alpha & beta, but lower than delta
Theta
334
9-14 Hz- higher in amplitude, alert but relaxed- eyes close
Alpha
335
15-40 Hz- low amplitude, frontal head, business activity; Variations seen w/ benzo & propofol – mu wave
Beta
336
Amplitude of EEG:
Delta >Theta >Alpha >Beta
337
Frequency of EEG:
Beta > Alpha > Theta > Delta
338
high-order activity like problem solving (> 25yo)
Gamma
339
beta wave variant- seen over motor areas- amplitude 1⁄2 of beta
Mu
340
awake patient that is staring, reading or looking @ objects
Lambda
341
GA: — high frequency in Beta waves — low frequency in delta & theta waves
↓ ; ↑
342
Surgical stimulation or light anesthesia: — high frequency, low voltage activity
343
Cerebral compromise & deep anesthesia: — frequency, — voltage activity
low ; high
344
Isoelectric at — MAC
1.5-2.0
345
Sevo & Enflurane: can accentuate — activity
epileptic
346
Barbiturates, etomidate, and propofol = — suppression
burst
347
Ketamine, opioids and etomidate- — produce a Δ in latency & amplitude
do not
348
— – Afferent – Dorsal Horn ; S.A.D. Posterior
Sensory
349
— – Efferent – Ventral Horn ; S.A.D. Anterior
Motor
350
MMEP: Peripheral- —, Central- —
popliteal ; anterior
351
Preganglionic SNS – —
Intermediolateral Horn
352
SSEP Monitoring (posterior spinal arteries) -Touch, pressure, vibration -Dorsal (posterior) cord – Cuneatus & Gracilis tracts -Ascend ipsilateral side -Decussate @ brainstem to contralateral thalamus & sensory cortex -Goes to RAS where it percolates to sensory cortex -Somewhat sensitive -Tibial – electrodes midline scalp, Ulnar- electrodes lateral
Dorsal-Lemniscal (sensory)
353
— very sensitive to SSEP monitoring
Visual evoked potential- CN II
354
— barely sensitive (altered most by temp) to SSEP monitoring
BAEP – CN VIII
355
Ketamine, etomidate, & opioids, barbs, propofol = — Δ in latency or amplitude in SSEP
no
356
— – Myelinated, Fast “first” Pain & temp Rexed’s lamina I & V, dorsal horn Neurotransmitter - glutamate
A-sigma Fibers
357
— – Unmyelinated, Slow “dull” Pain & temp Rexed’s lamina II (substantia gelatinosa) & III, dors Neurotransmitter – substance P Interneurons go from II & III to V Epidural steroids
C Fibers
358
Ascending Pain (—): Lateral Spinothalamic Tract (neopalatine)
Anterolateral
359
5 factors that alter the latency and/or amplitude of SSEP:
1. Decrease Cerebral perfusion secondary to hypotension, decrease PaCO2, increase ICP 2. Cerebral hypoxia 3. Hypothermia (MOST) 4. Hyperthermia 5. Hemodilution; Hct < 15%
360
Descending Pain (—): Dorsolateral Funiculus – modulates pain
Dorsolateral
361
Originate in the periventricular and periaqueductal gray areas and terminate on enkephalin-releasing interneurons in Rexed’s lamina II (substantia gelatinosa). This inhibits the release of —. (Presynaptic inhibition)
substance P
362
—: physiologic pain, carried by A-delta-sharp, prickly & C fibers-dull
Nociceptive
363
—-sharp & well localized
Somatic
364
—-diffuse, dull & vague
Visceral
365
—: Caused by abnormal processing of painful stimuli. This pain may occur after injury to neural tissue secondary to systemic disease, infection, trauma, ischemia, deficiencies in metabolism or nutrition, or exposure to environmental toxins or neurotoxin medications.
Neuropathic
366
— tract- most important spinal tract for pain
Lateral spinothalamic (neo)
367
—: perception of an ordinarily non-painful stimulus as pain
Allodynia
368
— is a combined disorder consisting of hyperesthesia, allodynia, and hyperalgesia
Hyperpathia
369
Sub P, Bradykinins & serotonin released → arachononic acid released = —, —, and—
thromboxane, prostaglandins & leukotrines
370
Preganglionic Parasympathetic Nerves originate (craniosacral):
Cranial nerves III, VII, IX, & X (3,7,9,10) Sacral segments S2-S4
371
—: (LA, ketamine, opiods, benzos) [- Charge/ Cl-, SO4-]
Weak Base
372
—: (Thiopental, other barbit, [+ Charge/ Na+, Mg++]
Weak Acids
373
— = H2O soluble
Ionized
374
— – lipid soluble (crosses BBB)
Non-Ionized
375
— = lipid solubility
Potency
376
— = protein binding & solubility
Duration
377
— = pKa
Speed of Onset
378
Fetus pH < maternal pH = —
↑ ion trapping
379
Blood flow highest to lowest- loss of LA d/t vascular reabsorb (9)
Intravenous Tracheal Intercostal Caudal Paracervical Epidural Brachial Plexus Spinal Subcutaneous
380
Mnemonic of LA reabsorption
In Time I Can Please Everyone But Susie & Sally
381
Mnemonic of brachial plexus:
Robert Taylor Drinks Cold Beer
382
Brachial plexus order:
Root, trunk, division, cord, branch
383
— block: -for forearm & wrist, safest, miss the muscultaneous 30-40ml, -musculocutaneous = 3-5 mL of LA into coracobrachialis muscle.
Axillary
384
— block = -greatest risk of pneumo, most compact 40ml -Less likely to miss the peripheral or proximal branches
Supraclavicular
385
— block = -shoulder surgery, miss of ulnar nerve & targets TRUNKS, no hand 40 ml -High incidence of ipsilateral hemidiaphragmatic paresis
Interscalene
386
— and — location = interscalene and Supraclavicular
Shoulder & humerus
387
— Block: -C1 (motor), C2, C3, and C4 = 4ml -some plastic surgery procedures, carotid endarterectomy tracheostomy and thyroidectomy. -Complications: hiccups, Horner’s, hoarse
Cervial Plexus
388
Horners Syndrome= -blockage of stellate ganglion @ — -Least likely w/ — block
C7 ; axillary
389
S/S of —: 1.Ptosis (droopy eye lid) 2. Miosis (pupil constriction) 3. Facial & Arm flushing (d/t vasodilatation) 4. ↑ Skin Tem 5. Anhydrosis (lack of sweating on face) 6. Nasal Congestion
Horners Syndrome
390
— block: -Minimum tourniquet time = 15-20 mins or 20-40 -Lidocaine 0.5% or Prilocaine 0. 5% -40 – 50ml -No bupivacaine- ♥ tox or chloroprocaine- thrombophlebitis -Contraindicated: severe crush injuries, uncontrolled hypertension, Raynaud's disease PVD, Homozygous sickle cell
Bier Block
391
Nerves that Flex the Forearm: — and —
Musculocutaneous & Radial
392
-Extension @ elbow, supination of FA, extension of wrist & fingers -Damage = inability to ABDUCT thumb & wrist drop
Radial Nerve
393
-Pronation of FA, flexion of wrist -To thumb, index finger, middle finger & lateral ring finger -Innervates the medial aspects of FA: Pronator teres, Flexor carpi radialis, Palmaris longus, Flexor digitorum superficialis -Damage = inability to ADDUCT thumb & Ape Hand
median nerve
394
-Flexion of wrist, adduction of all fingers -The little finger & medial ring finger (C8) In the forearm: Flexor carpi ulnaris, Medial 1⁄2 of flexor digitorum profundus -And in the hand: Palmaris brevis muscle, Abductor digiti minimi, Flexor digiti minimi -Damage = Claw hand -Innervates the adductor pollicis of the thumb
ulnar nerve
395
Flexion @ elbow
Musculocutaneous
396
Nerves of Lower extremity:
1. Femoral - saphenous 2. Sciatic - common peroneal to deep peroneal & superficial peroneal & tibial to sural
397
— = anteromedial foot, medial anterior calf and the dorsum of the foot
Saphenous
398
—= toe extension & sensation to medial 1⁄2
Deep peroneal nerve
399
— = sensation superficially to dorsum of foot & all 5 toes
Superficial peronal nerve
400
— – sensation to heel, medial sole & lateral sole
posterior tibial
401
— – sensation to lateral foot
Sural
402
— of foot= medial plantar & lateral plantar - tibial nerve
Flexion
403
— of foot – peroneal nerve
Extension
404
Superficial leg nerves :
saphenous, superficial peroneal, sural “S’s”
405
— Nerve: L2, L3, L4 Anterior thigh & knee Anterior muscles of the thigh
Femoral
406
Femoral nerve location mnemonic:
NAVEL (nerve, artery, vein, empty space, and lymphatics
407
Provides sensation to the medial aspect of the thigh and motor innervation to the adductor muscles located in the medial thigh
Obturator nerve
408
— surgeries: Femoral, Sciatic, Lateral Femoral, cutaneous obturator
On or above knee
409
L4, L5, and S1-S3 -innervates the muscles of the back of the thigh (biceps femoris, semitendinosis, semimembranosus, and adductor magnus). -As it continues, it innervates the muscles of the lower leg and foot
Sciatic nerve
410
Popiteal Block = — nerve
sciatic
411
Nerve injury: Face mask ventilation
CN 5 & 7 (facial & tongue numbness)
412
Nerve injury: LMA
SLN or RLN
413
Nerve injury: Intubation
RLN, SLN, CN 10, CN 12
414
Is the most commonly injured peripheral nerve in patients undergoing anesthesia More common in those with BMI > 38 & men
Ulnar nerve
415
Placement of shoulder braces = acromion
Brachial Plexus
416
Damaged = loss of the ability to supinate the extended forearm, wrist drop, abduct thumb, extend the metacarphophalaneal joints
Radial Nerve
417
Most commonly injured nerve of lower extremity Most common injured nerve during lateral position 3 issues: Loss of dorsiflexion of the foot is consistent with injury to the Foot drop and inability to evert foot
Common Peroneal nerve
418
Protect w/ pillow under knees Injured when patient rotated to semi supine (hips)
Sciatic
419
Inside of knee (litho with strap medially) Numbness & tingling along medial aspect of the calves
Saphenous
420
Femoral Decreased sensation — thigh
LATERAL
421
Complications of — block: Stimulation of the oculocardiac reflex, retrobulbar hemorrhage, circumorbital hematoma, penetration of the globe, optic nerve trauma, optic nerve sheath injection, extraocular muscle injury, intra-arterial injection
retrobulbar
422
— : Blocking of RLN through cricothyroid membrane w/4% lido Absorbed across mucous membranes (sim to sublingual)
Transtracheal
423
Isobaric =
CSF
424
Hyperbaric =
Dextrose solution
425
Hypobaric =
Sterile H2O
426
— in the epidural space communicates with the azygous system- important during times of engorgement which can cause engorgement of the vessels during instances of increased abdominal pressure
Batson's plexus
427
Sacrococcygeal membrane (injected into epidural space)
Caudal
428
Caudal Anatomical landmarks:
2 sacral cornua, the coccyx, and the posterior superior iliac spines
429
Caudal Dose Bupivacaine: — mg/kg Infant test dose = — mcg/kg epinephrine Max dose is — mg/kg
0.5-1.0 ; 0.5 ; 3 mg
430
Cutting needles:
Quinke, Pitkin
431
Non-Cutting needles:
Whitacre, Spotte, Greene
432
SAB needle — ga
27ga (normal), 25ga (used with 18ga introducer), 22ga (elderly & obese)
433
Epidural needle
17ga Toughy
434
Passage of Needle for spinal (8)
Skin Subcutanous tissue Supraspinous ligament Interspinous ligament Ligamentum flavum Epidural Space Dura Subarachnoid
435
What will you not pass through on a para median approach for a spinal?
Supraspinous and interspinous ligament; rather paraspinous muscle
436
Dermatome Landmarks —- Completely Motor —- Clavicle —- Nipples —- Xiphoid —- umbilicus —-Tibia —-Perineium
C1- Completely Motor C4- Clavicle T4- Nipples T6- Xiphoid T10- umbilicus L4-L5-Tibia S2-S5-Perineium
437
The tip of the 12th rib corresponds with —
L1
438
The origin of the scapular spine corresponds with —
T3
439
The most protuberant cervical vertebra is at the level of —
C7
440
The tip of the scapula corresponds with —
T7
441
level of the posterior superior iliac spine —
S2
442
Hydrophilic: — Slow onset & prolonged DOA Intrathecal 0 early respiratory depression + late resp depression d/t rostral spread (6-12 hrs) Epidural + early respiratory depression after 2 hours + late resp depression d/t rostral spread (6-12 hrs)
Morphine
443
Lipophilic: — Fast onset & short DOA Intrathecal + early resp depression (2 hrs) 0 late respiratory depression Epidural + early resp depression (2 hrs) 0 late respiratory depression
Fentanyl, Sufentanil, Alfentanil
444
4 common side effects of intrathecal opiods:
1. Pruritus (most common) 2. Urinary retention 3. N & V 4. Respiratory depression
445
4 common side effects of epidural opioids:
1. urinary retention (bup/morphine) 2. pruritus (morphine) 3. weakness of hands 4. HoTn
446
— = Stellate Ganglion- if blocked = Horner’s syndrome
C8-T1
447
S/S of — include: ipsilateral miosis, ptosis, enopthalamos, flushing,↑skin temp, anhydrosis, nasal congestion
Horner’s syndrome
448
— = numbness @ little & ring finger
C8
449
— = numbness @ middle fingers
C7
450
— = numbness @ thumb & index finger
C6
451
Progression of spinal blockade:
Autonomic>sensory>motor
452
Sensitivity to nerves with spinal block:
large mylenated > smaller mylenated > unmylenated
453
Fibers that are blocked with spinal:
Type B > Type Aδ = Type C > Aβ > Aα C type = more resistant to blockade than A & B fibers
454
SAB additives that prolong the duration w/o resulting significant ♥ changes
Epinephrine 0.2 to 0.3 mg Clonidine 75 to 100 mcg phenylephrine 2 to 5 mg
455
Procedure and level of block: TURP, hip arthroplasty, testicles, hysteroscopy
T10
456
Procedures & Level of Block: ESWL
T4-6
457
Procedures & Level of Block: Urinary bladder
S2-S4
458
Procedures & Level of Block: Lower abdominal
T6
459
Procedures & Level of Block: Kidney
T10-L1
460
Procedures & Level of Block: Uterine and cysto
T8-T10
461
Procedures & Level of Block: C section
T4
462
Procedures & Level of Block: Tourniquet
T8
463
Procedures & Level of Block: Upper abdominal
T4
464
—: transient radicular irritation, pain in the lower back or buttocks that may radiate to one or both legs after a spinal anesthetic
TNS
465
Absolute Contraindications to Regional Anesthesia: (8)
1.Infection @ site 2. Coagulopathy 3. Marked hypovolemia 4. True allergy to LA 5. Pt. refusal/inability to cooperate 6. Severe Stenosis 7. ↑ ICP 8. Abruption placentae
466
Relative contraindications to regional anesthesia (8)
1. Preexisting neurological dz 2. Back disorder (Ankylosis) 3. Heart Disease 4. Surgery above umbilicus 5. Failure to obtain free flow 6. Sepsis 7. Mobitz type I or II 8. 3rd degree w/o paceer
467
IV heparin; –need normal — before regional -Hold —hr after placement -Cathetars removed —/hr AFTER last heparin dose -Heparinization — hr after catheter removal
PTT ; 1 ; 2-4 ; 1
468
LMWH -first dose — hrs post op (2x daily dosing) -—hs post op (daily dose) -First dose — hours after catheter removal
24; 6-8 ; 2
469
Warfin- stop — days before surgery & INR —
4 ; < 1.5
470
Fibrinolytic or thrombolytic – — days
10
471
Ticlodipine – — days
14
472
Clopidorgrel- — days
7
473
GPIIb/IIIA – hold for — weeks post operative
4
474
↑potency of LA =↑—,↑DOA,↑affinity for Na channels,↑tendency of cardiac toxicity
protein binding
475
— local anesthetics are eliminated by plasma pseudocholinesterase except cocaine, which is eliminated by hepatic metabolism.
Ester
476
Metabolism of esters: greatest to least (3)
chloroprocaine > procaine > Tetracaine
477
Ester LA↑likely hood of allergic reactions d/t —
para-aminobenzoic acid
478
— local anesthetics are metabolized by hepatic metabolism.
Amide
479
Metabolism of amide LAs: greatest to least (5)
prilocaine >etidocaine > lido > Mepivicaine >Bup
480
— is the least toxic amide LA.
Prilocaine
481
Prilocaine is metabolized to —. It is an oxidizing agent capable of converting hemoglobin to methemoglobin
orthotoluidine
482
— is highly lipid soluble and dissociation form sodium channels are slow. Cardiac toxicity is high.
Bupivacaine
483
Mepivicaine, etidocaine, & bupivacaine = no enhancement w/ —
epi
484
—: an active metabolite of Lidocaine that contributes to toxicity even when lidocaine plasma levels are low
Monoethylglycinexylidide
485
Volatile anesthetics, propranolol, and cimetidine decrease hepatic clearance of —. (They inhibit Cytochrome P-450)
amides
486
Avoid Beta-blockers with amide LAs: & also…4
Labetalol & Propranolol ; Digitalis & Ca++ channel blockers
487
— is used to treat cardiac toxicity by amides.
Bretyllium
488
Max dose epi Subcutaneous or Submucosal infiltration: — mcg/kg for adults
2-3
489
Max Dose Epinephrine Subcutaneous or Submucosal infiltration: — mcg/kg for children
3
490
Max doses for chloroprocaine, cocaine, procaine, tetracaine:
12, 3, 12, 3
491
Duration for chloroprocaine:
.5-1 hr
492
Duration for tetracaine:
1.5-6hrs
493
Max dose with bupivicaine, lidocaine, mepivicaine, prilocaine, ropivicaine:
3, 4.5 (7 with epi), 4.5 (7 with epi), 8, 3
494
Cardiac Toxicity s/s of LA:
Hypoxia, hypercarbia, and acidosis
495
TNS: Transient Neurological Symptoms -with — LA spinals -Tx: —d/t sensory nature
Lidocaine ; NSAIDs
496
Lipid Rescue for LAST: — — ml/kg and then an infusion — ml/kg/min for 30-60 mins
20% Intralipid ; 1.2 to 2 ; 0.25
497
Benzocaine: Ester, Weak — May cause —
ACID ; methemoglobinia
498
Bld:Gas and Oil:Gas for N2O=
.47 and 1.4
499
Bld:Gas and Oil:Gas for sevo=
.65 and 53.4
500
Bld:Gas and Oil:Gas for iso=
1.4 and 90.8
501
Bld:Gas and Oil:Gas for des=
.42 and 18.7
502
Bld:Gas and Oil:Gas for Halo=
2.3 and 224
503
Vapor pressure for sevo=
170
504
Vapor pressure for iso=
239
505
Vapor pressure for des=
669
506
Vapor pressure for halo=
243
507
MAC for N2O=
104
508
MAC for sevo=
2.1
509
MAC for iso=
1.15
510
MAC for des=
6.3
511
MAC for halo=
.74
512
FA/FI for N2O=
.99
513
FA/FI for sevo=
.85
514
FA/FI for iso=
.73
515
FA/FI for des=
.91
516
FA/FI for halo=
.58
517
Increase potency = increase lipid solubility = — MAC
decrease
518
Oil/gas: measurement of —
solubility
519
Blood Solubility = — of uptake
speed
520
Inhalation agents: Increase solubility = — speed of inhalation induction Decrease solubility = — speed of inhalation induction
decrease ; increase
521
— = increase CBF, decrease CMR — = increase CBF, increase CMR — = decrease CBF, decrease CMR
Volatile ; Ketamine/N2O ; IV anesth
522
Vapor pressure of liquid dependent on SOLEY on —
temperature
523
Percentage of volatiles metabolized: Halothane —% Sevoflurane —% Isoflurane —% Desflurane —%
15-20, 2, .2, .02
524
CV side effects: sux
Decrease HR and histamine
525
CV side effects: mivacurium & atracurium
Histamine
526
CV side effects: d-tubocurarine & metocurine
Histamine, increase HR, decrease BP, ganglionic blockade
527
CV side effects: pancuronium & gallamine
Increase HR and increase BP
528
Sux elimination=
Metabolism
529
Atracurium, mivacurium, cisatracurium elimination:
Hoffman elimination
530
Vec and roc elimination:
Biliary primary, renal and metabolism secondary (vec has 20% in renal)
531
Brain uptake of anesthetics depends on: 4
1. Blood solubility 2. Cardiac output 3. Alveolar ventilation 4. Inspired concentration
532
Three ways to increase speed of equilibrium:
1. Increase Inspired anesthetic concentration 2. Second gas effect 3. Increase Alveolar ventilation
533
Two most important factors for increase alveolar partial pressure:
1. Inspired concentration 2. Blood solubility
534
Partial pressures of gas during induction: 4
Inspired>Alveolar>Arterial blood>Brain Note! This order is reversed during emergence when gas is turned off.
535
The — Theory explains that the anesthetic potency of anesthetic agents directly correlates with their lipid solubilities
Meyer-Overton
536
— of anesthetic at one atmosphere that produces immobility in 50% of patients exposed to a noxious stimulus. It is inversely proportional to potency.
MAC is the “Minimum Alveolar Concentration”
537
MAC ~ ED50 of —.
non-inhalational drugs
538
— MAC ~ ED95
1.3
539
There is approximately 1% — in MAC for every 1% of N2O delivery.
decrease
540
Highest Mac age is —
6mos-12mos
541
Seven factors that decrease MAC:
1. Increasing age 2. Hypothermia 3. CNS depressants 4. Acute ethanol intoxication 5. Alpha-2 agonists (Clonidine) 6. Pregnancy 7. Decrease Levels of CNS neurotransmitters
542
Five factors that increase MAC:
1. Hyperthermia 2. Hypernatremia 3. Increase Levels of CNS neurotransmitters 4. Young 5. Chronic alcohol use
543
Volatile anesthetics are metabolized in the — by — in hepatic microsomes.
liver ; cytochrome P-450
544
An oxidative trifluoroacetyl metabolite of — is thought to be responsible for acute hepatotoxicity in susceptible individuals. Reductive liver metabolism occurs with this volatile agent in the presence of hypoxia.
Halothane
545
— is the preservative in Halothane
Thymol
546
— is the most clinically important metabolite of Enflurane.
Fluoride
547
Inorganic — and — are common metabolites of Halothane and Enflurane.
fluoride and chloride
548
— is the only inhalational agent without a halogen.
N2O
549
Acceptable levels in the OR: N2O & Volatile together: N2O = — ppm Volatile = — ppm
25 ; 0.5
550
Acceptable levels in the OR: Volatile alone: Volatile = — ppm
2
551
N2O is metabolized to N2 in the intestine by — metabolism.
reductive anaerobic
552
Five contraindications to the use of N2O:
1. Venous air embolism 2. Ear surgery (middle ear) 3. Closed pneumothorax 4. Potential pneumocephalus 5. Bowel obstruction
553
Four adverse side-effect of N2O:
1. Aplastic anemia 2. Congenital anomalies 3. Spontaneous abortion 4. CNS toxicity
554
↓ methionine synthetase- — = no N2O
B12 deficiency
555
N2O — BP and CO when added to high dose opioids.
decreases
556
N2O — PVR and PA blood pressure due to mild sympathomimetic effects.
increase
557
— will support fire, but is neither flammable nor explosive.
N2O
558
N2O — CBF and — CMRO2
Increase and increase
559
Three renal changes associated with volatile anesthetics:
1. Decrease RBF 2. Decrease GFR 3. Decrease UO
560
— least potentiates NDMRs.
Halothane
561
— and — most decrease SVR, — has little effect on SVR.
Isoflurane and Desflurane ; Halothane
562
— and — produce the greatest myocardial depression.
Halothane and Enflurane
563
— and — most depress the baroreceptor reflex.
Halothane and Sevoflurane
564
— depresses the temperature-regulating center in the hypothalamus.
Isoflurane
565
Isoflurane, Desflurane, and Sevoflurane — cerebral metabolic rate.
decrease
566
N2O alone — cerebral blood flow & ICP.
increases
567
— and — most depress ventilation. — least depresses ventilation.
Enflurane and Desflurane ; Halothane
568
— is most degraded by soda lime and — least.
Sevoflurane ; Desflurane
569
— facilitates CSF absorption = favorable effect on CSF
Isoflurane
570
Point at which the plasma concentration of a drug is in equilibrium with all other tissues is the body
Steady-state
571
—: affinity and efficacy
Agonist
572
—: affinity for a receptor but lacks efficacy (cannot produce conformation Δ)
Antagonist
573
—: can be overcome by ↑ concentrations of agonist
Competitive
574
—: antagonism can’t be overcome by ↑ concern
Non-Competitive
575
—: bind with the receptor and has some efficacy, but it cannot elicit the maximal tissue response
Partial Agonist
576
—: but results in the opposite reaction of an agonist
Inverse Agonist
577
Constant AMOUNT of drug over a constant time ASA, phenytoin, ASA
Zero Order Kinetics
578
Constant FRACTION eliminated per time
First Order Kinetics
579
Dose response curve: —: determined by the binding affinity of receptors for the drugs as well as the efficiency of coupling of binding to response
Potency
580
Dose response curve: —: relationship between dose and effect
Slope
581
Dose response curve: —: maximum drug effect
Efficacy
582
—: Alter the molecular structure of a drug by modifying an existing functional group of a drug.
Phase I biotransformation
583
Phase I biotransformation: 3 functions
1. Oxidation 2. Reduction 3. Hydrolysis
584
Cytochrome P450 participates in most — and some —
oxidation ; reduction
585
—: Consists of a coupling or conjugation of a variety of endogenous compounds to polar chemical groups of the drug.
Phase II biotransformation
586
Biotransformation often makes drugs more — soluble and — for excretion in the urine or bile.
water ; inactive
587
Six groups of drugs metabolized by Cytochrome P450:
1. Barbiturates 2. Opioids 3. Benzodiazepines 4. Amide LA’s 5. Tricyclic antidepressants 6. Antihistamines
588
— Index = LD50/ED50
Therapeutic
589
— is the dose of drug that is effective in 50% of patients.
ED50
590
— dose that produce toxic effect in 50% of animals
TD50
591
— death to 50%
LD50
592
— = time taken for the plasma concentration to fall by one-half.
Elimination half-time (T 1⁄2)
593
T 1⁄2 is directly related to — and inversely related to —.
Vd ; Clearance (Cl)
594
Elimination half time equation =
Cl = Vd/ T 1⁄2
595
↑ Vd= ↑ T1/2
Fast CL=short T1/2
596
Small Vd=↓ T1/2
Slow CL= Long T1/2
597
—: Molecules that relay signals from receptors on the cell surface to target molecules inside the cell
Second messengers
598
Second messengers: 4
cAMP, cGMP, IP3, Ca++
599
Proteins Albumin = —
acid
600
Proteins Alpha-1 acid glycoprotein & Beta-globulins = —
Base
601
— is the major inhibitory transmitter of the CNS. It opens — ion channels. It hyperpolarizes neurons inhibiting action potential production.
GABA ; Cl-
602
—, —, —, and — work primarily on the GABA receptor.
Barbiturates, benzodiazepines, propofol, and etomidate
603
Opens Cl- channel- hyperpolarization
GABA receptor
604
Current research also indicates that inhaled anesthetics also work on — receptors.
GABA
605
— Prolong the attachment of GABA to its receptor. They work in the reticular activating system (RAS).
Barbiturates
606
— (acid) is 72-86% bound to albumin. It reduces the sensitivity of the central respiratory center to CO2. It’s onset is within 10-15 seconds. It’s elimination half-time is 11.6 hours. Metabolized by redistribution dependent on CO.
Sodium Thiopental
607
Sodium Thiopental: — CMRO2 & — CBF
Decrease and decrease
608
Sodium Thiopental: — steal
Inverse
609
Sodium Thiopental: reconstitute with — (no — bc precipitate)
Sterile saline ; LR
610
Sodium Thiopental: can cause this to pain
Hyperalgesia
611
S/S of intra-arterial Thiopental injection: 3
1. Arterial vasospasm with intense pain down the arm 2. Blanching of the skin with loss of distal pulses 3. Eventual cyanosis and possibly gangrene
612
Intra-arterial Thiopental injection is treated with —.
Phenoxybenzamine (Dibenzyline)
613
pH of Barbiturates is > —, pH of — is often cited.
9.0 ; 10-11
614
— are contraindicated in status asthmaticus and porphyria.
Barbiturates
615
— is associated with a higher incidence of hiccups than other non-opioid induction drugs.
Methohexital
616
Benzos: acid or base
Base
617
Benzos: Sedative: effects: the — amnesia: — and — anxiolytic effects: —, —, & —
cortex ; forebrain and hippocampus ; amygdala, hippocampus, & limbic system.
618
Benzos: — swallowing reflex & upper airway reflexes — CMRO2 & — CBF
↓; ↓; ↓
619
—- competitive antagonist of benzos
Flumazenil
620
Propofol: acid or base
Weak acid
621
Propofol: compound is —
2,6 diisoprorylphenol
622
Propofol: Liver metabolism —% & lung metabolism —%
70 ; 30
623
—: caution with soybean and egg allergy
Propofol
624
Etomidate: acid or base
Base
625
—: Maintains CV stability the best.
Etomidate
626
Etomidate: Directly depresses the —.
adrenal cortex
627
Etomidate: — cerebral blood flow, ICP, & CMRO2
Decrease
628
Venous thrombosis and phlebitis are most likely after —, —, & —.
etomidate, diazepam, & lorazepam
629
4 potential problems during recovery from etomidate:
1. Suppression of adrenocortical response to stress 2. N & V 3. Decrease Plasma cortisol concentration 4. Depressed immune response
630
Ketamine: acid or base
Base
631
Ketamine: Causes dissociation between the — and — systems by antagonistic actions on the — receptors.
thalamocortical and limbic ; NMDA
632
Ketamine: Dysphoria is cause by misperception and/or misinterpretation of auditory and visual stimuli by stimulating the — receptor, antagonizing the — receptor, and stimulating the — receptor.
kappa ; muscarinic ; sigma
633
Ketamine: ♥ Effects: — MAP, CI, PAP, CVP, HR
634
Ketamine produces — airways
Bronchodilitation
635
Ketamine — airway secretions- give glyco
636
Ketamine — emergence delirium in kids & higher bioavailability in kids
637
Ketamine provides — for pain
Analgesia
638
Opioids: acid or base
Base
639
Opioids: shortest elimination 1/2 half (6)
Remi < alfent < morphine
640
Opioids: potency (6)
Sufent > remi > fent > alfent > morphine > meperidine
641
—: Less is protein bound in the neonate secondary to decrease in alpha-1 acid glycoprotein
Morphine
642
— Metabolite: morphine-6-glucuronide- prolonged in RF & crosses BBB by mass action
Morphine
643
Meperidine (Demerol): — myocardial contractility and — HR
decrease ; increase
644
Meperidine (Demerol): — shivering - — receptors
↓ ; Kappa
645
Meperidine (Demerol): — sz threshold (— having a sz) d/t —
↓ ; ↑ ; Normeperidine
646
Meperidine (Demerol): should be avoided with — & —
MAO inhibitors & Imipramine
647
Adverse S/S of — & — combined: 1. Hyperpyrexia 2. HTN 3. Hypotension 4. Respiratory depression 5. Skeletal muscle rigidity 6. Seizures 7. Coma ♥ Effects: ↓ HR,↓SVR,↓ venous return,↓ BP
MAO inhibitors & Demerol
648
Most clinically used opioids are relatively selective for — receptors.
Mu
649
Spinal analgesia is mediated primarily by — receptors, but also by kappa and delta receptors. Besides the substania gelatinosa (Rexed’s lamina II), the periaqueductal and periventricular gray areas are important sites of spinal analgesia.
Mu-2
650
Supraspinal analgesia is primarily mediated by — receptors, but also by kappa and delta receptors.
Mu-1
651
— receptors produce: 1. Euphoria 2. Miosis 3. Bradycardia 4. Hypothermia 5. Urinary retention 6. Pruritus
Mu-1
652
low abuse potential & Supraspinal analgesia common with — receptors.
Mu-1
653
- receptors produce: 1. Respiratory depression 2. Marked constipation 3. Physical dependence
Mu-2
654
high abuse potential & Spinal analgesia common with — receptors.
Mu-2
655
— receptors produce: 1. Sedation 2. Dysphoria
Kappa
656
4 Ventilatory effects of opioids:
1. Decrease Breathing rate 2. Decrease Minute ventilation 3. Decrease Response to CO2, secondary brainstem depression 4. Increase Arterial CO2 tension
657
—, —, & — can reverse opioid-induced sphincter of Oddi spasm.
Naloxone, Nitroglycerine, and Glucagon
658
— is eliminated faster than all other opioids (except Remifentanil) because it has a small —. The elimination 1⁄2 time is 10-30 minutes.
Alfentanil ; Vd
659
— is metabolized by blood and tissue nonspecific esterases.
Remifentanil
660
Can remifentanil be used for neuroaxial? And if not, why?
DO NOT use in neuroaxial - Has glycine buffer
661
Agonist-antagonist opioids —: provide analgesia —: reverse respiratory depression
Kappa ; Mu
662
Agonist-antagonist opioids: 3
Naltrexone, naloxone, nalbuphine
663
Muscle Paralyzation order: 5
Eye muscles → extremities→trunk→abd muscles→ diaphragm. Recovery is restored in reverse order
664
Facial muscle = — paralytic
diaphragm
665
— = readiness for intubation
Abductor pollis
666
Recovery from NMB = — nerve
ulnar nerve
667
MOA NMB:
Site of action is the motor end plate- nicotinic receptors
668
ALL MR resemble —
acetylcholine
669
Four NDMRs that release histamine:
1. d-Tubocurarine 2. Metocurarine 3. Atracurium 4. Mivacurium
670
— is metabolized by plasma cholinesterase. 25% spontaneous recovery is reached in 13 minutes in adults and 7 minutes in children.
Mivacurium
671
Method of anesthetizing a limb by IV injection while blood flow to extremity is occluded by a tourniquet
Bier Block
672
Bier Block: Minimum: — mins (don’t release before- local in systemic) Max: — min (usually d/t tourniquet pain)
15-20 ; 40-65
673
— is eliminated by ester hydrolysis and Hoffman elimination
Atracurium
674
— is only eliminated by Hoffman elimination.
Cisatracurium
675
Hoffman elimination is — & —dependent.
temperature and pH
676
Hoffman elimination: The rate of metabolism is slowed by — & — temperature.
acidosis or decrease temperature
677
— is a lipid-soluble metabolite of atracurium that can cause CNS stimulation in high concentrations.
Laudanosine
678
Four MRs that use renal excretion least:
1. Succinylcholine 2. Atracurium 3. Cisatracurium 4. Mivacurium
679
Three NDMRs not significantly excreted by kidneys:
1. Atracurium 2. Cisatracurium 3. Mivacurium
680
— is primarily eliminated by renal (70%) and secondarily by biliary (20%).
Pipecurium
681
What 5 things can augment NMB:
1. Hypermagnesium 2. Hypocalcemia 3. Hypokalemia 4. VA : des > sevoflurane > iso > N2O/fentanyl 5. Hypothermia
682
Eleven possible complications of Succinylcholine administration:
1. Hyperkalemia 2. Bradycardia (@ ♥ SA Node) 3. Increase HR and/or BP 4. Skeletal muscle myalgia 5. Allergic reaction 6. Triggering of MH 7. Sustained masseter muscle contraction 8. Myoglobinuria 9. Increase IOP (NOT prevented with defasculating dose) 10. Increase Intragastric Pressure (prevented with defasiculating dose) 11. Increase ICP (prevented with defasiculating dose)
683
Increase IOP (— prevented with defasculating dose) Increase Intragastric Pressure (— prevented with defasiculating dose) Increase ICP (— prevented with defasiculating dose)
NOT ; is ; is
684
Nine conditions that accentuate succinylcholine-induced hyperkalemia:
1. Unhealed third-degree burns 2. Denervation of skeletal muscle 3. Severe skeletal muscle trauma 4. Upper motor neuron injury (head injury, Parkinson’s, CVA) 5. Muscular dystrophy 6. Renal Failure w/ hyperkalemia 7. Severe Sepsis 8. Duchennes 9. Guillian Barre
685
11 clinical manifestations of MH:
1. Hypercarbia 2. Tachycardia 3. Tachypnea 4. Hyperthermia 5. Hypertension 6. Cardiac dysrhythmias 7. Acidosis (metabolic) 8. Hyperkalemia 9. Skeletal muscle rigidity 10. Myoglobinuria 11. Hypoxemia
686
The earliest sign of MH is —
increase ETCO2
687
Temperature may increase — C every — minutes
1-2 ; 5
688
— and — agents are triggering agents of MH.
Succinylcholine and volatile
689
— rigidity is an early sign of MH.
Masseter muscle
690
CPK > — confirms the diagnosis after masseter muscle rigidity following halothane and succinylcholine administration.
20,000
691
— contracture test is the standard diagnostic test for MH, but it has too many false positives.
Halothane-caffeine
692
Eight actions for initial management of MH:
1. Discontinue inhaled agents & Sux 2. Hyperventilate with 100% O2 3. Administer Dantrolene 4. Treat acidosis with NaHCO3 (1-2 mmoles/kg) 5. Decrease Body temp to 38C 6. Replace anesthesia circuit and CO2 absorber 7. Monitor ETCO2 & ABGs 8. Treat hyperkalemia and dysrhythmias if necessary
693
—: binds to the ryanodine-1 channel and inhibits the calcium channel in the sarcoplasmic reticulum. Decreasing the release of Ca++ from the sarcoplasmic reticulum in skeletal muscle and causes skeletal muscle to relax.
Dantrolene
694
Dantrolene: The initial dose is — mg/kg followed by — mg/kg boluses to a maximum dose of — mg/kg. The therapeutic blood level is 2.5 mcg/ml.
2.5 ; 1-2 ; 10
695
Vials of Dantrolene contain — mg and each is mixed with — ml of sterile distilled H2O.
20 ; 60
696
How often should dantrolene be repeated?
It should be repeated every 10-15 hours for three days.
697
Five dantrolene complications include:
1. Reoccurrence 2. DIC 3. Myoglobinuric renal failure 4. Skeletal muscle weakness 5. Electrolyte abnormalities
698
— is the best method to decrease Temp with MH.
Gastric lavage
699
—, 15 mg/kg is the best antiarrhythmic for MH.
Procainamide
700
The mortality rate of MH is —%
10
701
—: can mimic MH, but the onset and recovery are different. Patients treated with antipsychotic drugs such as Haldol, prolixin, or thorazine are susceptible to it.
Neuroleptic malignant syndrome
702
— is the cardinal sign for neuroleptic malignant syndrome.
Fever
703
Anticholinergic: —, - most ↑ HR
Atropine
704
Anticholinergic: —- most sedative
Scopolamine
705
Anticholinergic: — - does not cross BBB d/t being a quaternary
Glycopyrrolate
706
—: Combine reversibly w/ muscarinic cholinergic receptors prevent acetylcholine from binding to the receptor.
Anticholinergic
707
Anticholinergic: Sedative effect
Scopolamine > atropine > glycopyrrolate
708
Anticholinergic: Antisialogogues effect:
Scopolamine > glycol > atropine
709
Anticholinergic: HR:
Atropine > glycopyrrolate >scopolamine
710
Do not use scopolamine in —
GLAUCOMA
711
Anticholinergic: Bronchodilatory effects:
Ipratropium
712
Anticholinergics: gastric effects: — gastric secretions, — peristalsis and intestinal motility, — gastric emptying time, & — lower esophageal sphincter tone
↓ ; ↓ ; ↑ ;↓
713
—: Scopolamine & atropine both cross the blood-brain barrier and block muscarinic cholinergic receptors in the CNS, producing restlessness, hallucinations, somnolence, and potentially, unconsciousness.
Central anticholinergic syndrome
714
Central anticholinergic syndrome both caused by — and —.
Scopolamine & atropine
715
Central anticholinergic syndrome: Predisposed patients: —, —, and —
Tricyclic antidepressants (like amitriptyline), antipsychotics, and antihistamines (antimuscarinic characteristics)
716
Central anticholinergic syndrome: treatment:
physostigmine
717
Xanthines: 2
Aminophylline & theophylline
718
—: drug that cause release of norepinephrine from sympathetic postganglionic neurons and should be avoided with Halothane.
Xanthines
719
Halothane should be avoided with patients intoxicated with cocaine or using imipramine, because they both block reuptake of —.
norepinephrine
720
Calcium channel blockers and volatile agents act —
synergistically
721
Chemotherapy Medications and Site of Toxicity: Bleomyocin – —
Lungs
722
Chemotherapy Medications and Site of Toxicity: Cisplatin- —
Kidneys
723
Chemotherapy Medications and Site of Toxicity: doxorubicin -—
Heart
724
Chemotherapy Medications and Site of Toxicity: cyclophophains, streptozocin, Methotrexate-—
Liver
725
Calcium Channel Blockers work: Phase —, plateau phase of ventricular action potential Phase — of the pacemaker action potential
2 ; 4
726
4 Drugs to avoid with MAO inhibitors:
1. Tricyclic antidepressants (imipramine) 2. Opioids (especially Demerol) 3. Indirect acting sympathomimetics (ephedrine) 4. Fluoxetine
727
—: -Enhances myocardial contractility, decrease HR, & slows impulse propagation through the AV node. -Used to treat CHF & SVT
Digoxin: (Digitalis)
728
Digoxin: (Digitalis) MOA & phase
-Inhibits the Na+-K+ pump causing increasing intracellular Ca++ accumulation. -Work by decreasing Phase 4 depolarization of the SA node
729
— should be avoided because it creates a relative hypokalemia. Hypokalemia causes binding of digitalis to myocardial cells, resulting in an excessive drug effect.
Hyperventilation
730
Digoxin (digitalis): Eliminated primarily by the —, 35% daily
kidneys
731
—, —, & — increase the likelihood of digitalis toxicity.
Hypokalemia, hypercalcemia, and hypomagnesemia
732
Three side effects of tricyclic antidepressants: (Amitriptyline)
1. Anticholinergic effects (dry mouth, blurred vision, tachycardia) 2. Orthostatic hypotension 3. Sedation
733
Tricyclic antidepressants interact with: 5
1. Anticholinergics (atropine, scopolamine) 2. Sympathomimetics (ephedrine) 3. Inhaled anesthetics (increase dysrhythmias) 4. Antihypertensives (rebound HTN) 5. Opioids (increase analgesia & respiratory depression)
734
Anaphylactic Reaction: (Type I hypersensitivity reaction) Antibody — is produced in response to an antigen (foreign protein). Upon a second exposure to the antigen, it on the surface of mast cells and basophils triggers the release of mediators including histamine. This causes bronchoconstriction, upper airway edema, vasodilation, increased capillary permeability, and urticaria. Life-threatening.
Ig E (immunoglobulin E)
735
Anaphylactoid Reactions — involve Ig E. Foreign substances (i.e. drugs, hetastarch) directly stimulate the emptying of — & —.
do not ; mast cells and basophils
736
Anaphylactic and Anaphylactoid reaction = — S&S
same
737
Top 5 Causative of Anaphylactic Reactions
NMB 60% Latex 17% Abx 15% Colloids 4% Hypnotics 3-4%
738
Latex Allergy: food allergies: 4
bananas, avocados, chestnuts, stone fruit
739
Intrinsic Path =
XII, XI, IX, VIII (12,11,9,8)
740
Vitamin K Dep:
II, VII, IX, X (2,7,9,10)
741
Extrinsic =
III, VII (3,7)
742
CFs Not in Liver:
III, IV, VIII (3, 4, 8)
743
Final CP =
V, X, I, II, XIII (5,10,1,2,13)
744
Heparin = — pathway = — & — labs
Intrinsic ; aPTT & ACT
745
Coumadin = — pathway = — & — labs
Extrinsic ; PT & INR
746
Bleeding time : — min : — measure
3-10 min ; platelet function
747
PT : —sec : — measure
12-15 sec - extrinsic pathway
748
PTT : — sec : — measure
25-35 sec. – Intrinsic pathway
749
ACT : —sec
80-150 sec.
750
TT : —sec : — measure
9-11 sec. – final common pathway
751
One PRBC = ↑ Hct —% 1g/dl
3-4
752
1cc/kg PRBC= ↑ Hct —%
1
753
1 unit plts = ↑ — mm3
5,000-10,000
754
— = 1 complete blood volume in 24 hours
Massive transfusion
755
PRBC: universal donor and universal recipient
Donor: O & recipient: AB
756
Platelets: universal donor & universal recipient
Donor: AB & recipient: O
757
— drugs competitively inhibit vitamin K so synthesis of Vitamin K-dependent factors (II, VII, IX, and X) is diminished.
Coumadin
758
— is the fraction of plasma that precipitates when FFP is thawed at 40 C. (The drug of choice for — disease)
Cryoprecipitate ; Von Willebrand’s
759
Cryoprecipitate contains factors —
I, VIII, XIII
760
— inhibits plasmin and therefore inhibits the breakdown of fibrin.
Aprotinin
761
—: Contains all clotting factors but plts
FFP
762
FFP uses: 4
1. isolated coagulation factor deficiencies 2. reversal of Coumadin 3. liver dz- reverse coagulation issues 4. after massive transfusion and still bleeding
763
Max allowable EBL = equation
EBV x [(Hbi-Hbf)/Hbi]
764
Hct = — x Hbg
3
765
Hct of PRBC = —
75
766
PRBC replacement= equation
[(blood loss - MABL) x desired Hct]/Hct of PRBC
767
Estimated Blood Volume (EBV): Premie (
95ml/kg
768
Estimated Blood Volume (EBV): term
90ml/kg
769
Estimated Blood Volume (EBV): infant (< 6wks)
80 ml/kg
770
Estimated Blood Volume (EBV): toddler (6wk-2yr)
75
771
Estimated Blood Volume (EBV): child (2yr-12yr)
72 ml/kg
772
Estimated Blood Volume (EBV): men
75 ml/kg
773
Estimated Blood Volume (EBV): women
65 ml/kg
774
Total Body Water (TBW): adult
60% ; 42 L
775
Total Body Water (TBW): neonate
80%
776
Total Body Water (TBW): premie
90%
777
ICF: % and L
60-66% ; 25-28 L
778
ECF: % and L
33-40% and 14-17 L
779
Interstitial fluid %
80%
780
Plasma water %
20%
781
—: pH 6.5 - contains K 4, Na 130,lactate 28– hypo (osm 273)
LR
782
Too much of this fluid = metabolic alkalosis
LR
783
— : Na = 154 meq/L = Isotonic (osmol = 308)
NS
784
Too much of this fluid = hyperchorlemic acidosis
NS
785
—: Hypotonic (osmolality 252 mOsm)
D5
786
—- colloid osmotic pressure of 20mmHg
5% Albumin
787
—- No Ca++ (osmol 294)
Normosol
788
—: 6% hydroxyethyl starch in NS =/> 20ml/kg/day = ↑ serum amalayse levels
Hespan
789
—- 6% hydroxyethy starch in solution w/ electrolytes, glucose and lactate
Hextend
790
Hypotonic ~ <— mOsm/L - — vascular volume
285 ; ↑
791
Hypertonic ~ > — mOsm/L - — cells shrink
305 ; ↓
792
—: Improves blood flow through the microcirculation presumably by decreased blood viscosity. Maximal dose = 20 ml/kg/day or about 58 ml/hr for 70 kg patient. -Side effects: interference with blood typing, prolonged bleeding time, renal failure, and anaphylactoid reactions.
Dextran 40
793
Five adverse effects of Mannitol administration:
1. Pulmonary edema and Cardiac decompensation 2. Rebound increase ICP 3. Hypovolemia 4. Hyperkalemia 5. Hyponatremia
794
Virchow Triangle:
1. endothelial injury 2. stasis or turbulent blood flow 3. hypercoagulability of blood
795
—: A hereditary hemolytic anemia resulting from the formation of an abnormal hemoglobin (Hb S). Red cell survival is reduced to 10-15 days, compared with up to 120 days in normal individuals. It occurs only under extreme hypoxemia or in low-flow states.
Sickle Cell Disease
796
Avoid in Sickle Cell Disease: 6
1. hypo- and hyperthermia 2. acidosis 3. mild degrees of hypoxemia 4. hypotension 5. hypovolemia 6. avoid the use of tourniquets.
797
Sickle Cell Anemia is a mutation of the — globin chains – glutamic acid instead of valine
beta
798
Four diseases associated with thrombocytopenia:
1. Chemotherapy or unrecognized cancer 2. Liver disease and splenomegaly 3. DIC 4. Pre-eclampsia
799
—: Metabolic d/o affecting biosynthesis of heme = thick blood
Porphyria
800
Porphyria Signs & Symptoms: 3
1. Acute abdominal pain, N & V 2. Neurotoxicity: confusion, SIADH, difficulty swallowing, HTN & tachycardia 3. Sensory & motor neuropathies
801
AVOID Triggering Agents for porphyria: “—”
KEPT MAN Barbs, Nifedipine, Phenytoin, Benzos, Ketorolac, Hydralazine, Ketamine, Enflurane, mepivicaine, Etomidate, Sulfamides, lidocaine GA- no regional
802
Hemophilia : x-lined recessive —- Factor VIII Deficiency —- Factor IX Deficiency
A ; B
803
Hemophilia : Prolonged — & normal —
Prolonged PTT & normal PT
804
Heat loss:
Radiation >Convection >Evaporation >Conduction
805
The center for Heat Loss is located in the — hypothalamus
anterior (preoptic)
806
Heat Gain center is located in the — hypothalamus.
posterior
807
Greatest decrease of core temp occurs in — of surgery
1st hour
808
— – from atrial muscle in response to local wall stretch
ANP- atrial
809
—- ventricle muscle when distended
BNP- brain
810
—- endothelial walls natriuretic peptides
CNP
811
Natriuretic Peptides: Induces — of arterial and veins = — RBF & GFR
vasodilatation ; ↑
812
Natriuretic Peptides: -Suppress actions of —, —, — -Inhibit – —, —, —
NE, angiotensin, endothelin ; renin, angiotensin II, aldosterone
813
↑ — & — = mortality predicator in CHF
ANP & BNP
814
4 Reasons for difficulty breathing after Thyroidectomy:
1. Laryngeal edema 2. Bilateral cord paralysis 3. Hematoma formation 4. Hypocalcemia secondary to hypoparathyroidism
815
Six hormones of the Anterior Pituitary: (Adenohypophysis) (Blood flow through Hypothalamic-Hypophyseal Portal System)
1. Adrenocorticotropic hormone (ACTH) 2. Thyroid stimulating hormone (TSH) 3. Growth hormone (GH) 4. Prolactin 5. Leutinizing hormone (LH) 6. Follicle stimulating hormone (FSH)
816
2 hormones of the Posterior Pituitary: (Neurohyphosis)
1.Anti-Diuretic hormone (ADH) 2. Oxytocin
817
Thyroid: Regulated by — release from anterior pituitary
TSH
818
Thyroid: —% Thyroxine (T4) —% Tri-iodothyronine (T3)
93 ; 7
819
About 80% of Tri-iodothyronine (T3) is produced outside the thyroid gland by — of thyroxine.
de-iodinazation
820
Tri-iodothyronine (T3) is —x — potent than thyroxine (T4).
four times more
821
T4 is converted to T3 in the —
tissues
822
Thyroglobulin = —
protein
823
Grave’s Disease: (—)
Hyperthyroidism
824
— is the drug of choice for treating hyperthyroid-related ventricular dysrhythmias.
Beta antagonist
825
S/S of —: 1. Intolerance to heat 2. Increase Sweating 3. Mild to extreme weight loss 4. Varying degrees of diarrhea 5. Muscular weakness 6. Nervousness 7. Extreme fatigue 8. Inability to sleep 9. Tremor of the hand 10. Exothlamous
Grave’s Disease: (Hyperthyroidism)
826
Four causes of Hypothyroidism:
1. Subtotal lobectomy of thyroid 2. Goiter 3. Autoimmune disease (myxedema) 4. Radiation therapy of thyroid (Can cause cretism in infant = large tongue)
827
S/S —: 1. Slow mental function 2. Slow movements (weight gain) 3. Dry skin 4. Cold intolerance 5. Depressed ventilatory responses 6. Abnormal cardiac conductivity (decrease cardiac function) 7. Renal disease
Hypothyroidism
828
—: ↓ Anesthesia requirements – however, no Δ in MAC
Hypothyroidism
829
—: Severe exacerbation of hyperthyroidism
Thyroid Storm
830
Thyroid Storm: S/S - — hrs. post-op
6-8
831
— s/s: 1. Hyperthermia 2. Tachycardia 3.CHF 4. Dehydration 5. Shock 6. Hyperglycemia
Thyroid Storm
832
Thyroid Storm Tx:4
Na Iodide, cortisol, propranolol, Propylthiouracil
833
—: Regulates Ca++ & Phosphate
Parathyroid
834
Parathyroid hormone increase [Ca++] by: 1. Increase Absorption of Ca++ from — 2. Increase Reabsorption of Ca++ from — 3. Increase Resorption of Ca++ from —
intestine ; renal tubule ; bone
835
Complications of —: 1. Hypocalcemia 2. Parasthesias 3. Muscle spasm 4. Tetany 5. Laryngospasm 6. Bronchospasm 7. Apnea 8. Hematoma 9. Airway compromise 10. Pneumothorax
Parathyroidectomy
836
Major postop concern after Parathyroidectomy: 4
1. Airway obstruction 2. Laryngospasm secondary hypocalcemia 3. Bilateral recurrent laryngeal nerve damage 4. Hematoma
837
Ca > — mEq/L Ionized Ca++ >— mEq/L
5.5 ; 2.5
838
— is a bone disease caused by hyperparathyroidism. Leaking of Ca out of bones= broken and brittle bones
Osteitis Fibrosa Cystica
839
— promotes the deposition of calcium in the bones and decreases [Ca++] in the ECF. (opposite of PTH)
Calcitonin
840
Clinically significant hypocalcemia: 2
1. ECG changes (prolonged Q-T interval) 2. decrease Myocardial contractility
841
S/S of — following parathyroidectomy: 1. Perioral parasthesias 2. Restlessness 3. Neuromuscular irritability
hypocalcemia
842
3 Neuromuscular irritability seen from hypocalcemia following parathyroidectomy:
Chvostek’s sign Trousseau’s sign Inspiratory stridor
843
Four effects of acidosis on CNS function:
1. Depressed neuronal activity (coma) 2. Cerebral vasodilation (increase CBF, increase ICP) 3. Decrease Cerebral perfusion pressure (cerebral ischemia) 4. Increase Seizure threshold
844
Anion Gap: = equation
[Na+] – [Cl-] + [HCO3-]
845
Anion Gap: Normal range = — mEq/liter
9-15
846
Anion gap: Used in the differential diagnosis of —
metabolic acidosis
847
Four causes of metabolic acidosis:
1. Ketoacidosis 2. Lactic acidosis 3. Renal failure 4. Toxic dose of salicylates
848
Three causes of Metabolic Alkalosis:
1. Vomiting 2. NG suctioning 3. Hypokalemia secondary diuretics
849
Plasma K+ increase approximately — mEq/L for each 0.1 decrease in pH
0.6
850
The kidneys excrete H+ as titratable acids — & —
H2PO4 & NH4+
851
Six physiologic functions that require Ca++:
1. Action potentials in smooth and cardiac muscle 2. Blood coagulation 3. Bone formation 4. Muscle contraction 5. Membrane excitability (Ca++ controls threshold) 6. Neurotransmitter release- Ca is REQUIRED
852
A rapid decrease in plasma — leads to skeletal muscle spasm (laryngospasm) and tetany.
[Ca++]
853
Nine S/S of —: 1. Numbness 2. Circumoral paresthesia 3. Confusion 4. Seizures 5. Hypotension 6. Increase LV filling pressures (due to decrease contractility) 7. Prolonged QT interval 8. Skeletal muscle weakness 9. Fatigue
Hypocalcemia
854
— (contracture of facial muscle with tapping) monitors hypocalcemia
Chvostek’s sign
855
Three ECG changes with Hypocalcemia:
1. Prolonged QT interval 2. Increase ST segment duration 3. Flat or inverted T-waves
856
7 Functions of Magnesium:
1. Functions as a cofactor in many enzyme pathways 2. Regulates the Na+/K+ pump 3. Regulates adenylate cyclase 4. Regulates slow Ca++ channels 5. It antagonizes Ca++ (an endogenous Ca++ channel blocker) = vasodilatation 6. Controls the threshold potential (membrane stabilizer) 7. Regulation of the release of acetylcholine from nerve terminals
857
—: (It both resembles and antagonizes Ca++)
Magnesium
858
↑ Mg = — excitability
859
— Caused from: excess dietary intake of it, excess ingestion of oral antacids, hypothyroidism, hyperparathyroidism, Addison's disease, & lithium therapy
Hypermagnesemia
860
Tx for hypermagnesemia: 2
forced diuresis with saline and loop diuretics
861
—: Impairs coagulation by causing platelet dysfunction. Impairs ventricular contractility & leukocyte function.
Hyperphosphatemia
862
Causes of —: 1. Ingestion of large # antacids containing aluminum & Mg 2. Severe burns 3. DKA 4. ETOH WD 5. Prolonged respiratory alkalosis
hypophosphatemia
863
hypophosphatemia Tx: 4
aluminum based antacids, Carafate, Ca citrate, dialysis
864
Eight signs of Hyponatremia:
1. Arrhythmias 2. Hypotension 3. Pulmonary edema 4. Mental changes 5. Muscle cramps 6. Weakness 7. Myoclonia 8. Edema
865
Hypernatremia = — is what hydration status?
dehydration
866
Treatment of hyponatremia: 2
diuretics and hypertonic saline
867
S/S develop with [Na ] < — mEq/L
120
868
Three factors that promote Hypokalemia:
1. Alkalosis 2. Insulin 3. Beta-2 adrenergic stimulation
869
Seven ways to treat Hyperkalemia:
1. Give calcium gluconate 2. Give glucose/insulin 3. Give sodium bicarbonate 4. Give diuretics (to increase excretion) 5. Give kayexalate (potassium exchange resins) 6. Use hemodialysis 7. Hyperventilate the patient
870
Plasma [K+] is decrease — mEq/L for each 10 mmHg decrease in PaCO2
0.5
871
Cardioplegia – — mEq/L of K+
15-40
872
— should be given to the hyperkalemic pt. when ventricular dysrhythmias appear. (↑ threshold away from RMP)
Calcium
873
5 Medications that cause an ↑ K:
Triamterene, spironolactone, NSAIDs, ACE inhibitors, BB
874
ECG Δ with Hyperkalemia: 3
Prolongation of P-R interval Widening of QRS Peaked or tented T waves
875
ECG Δ with Hypokalemia 3
Prolongation of P-R & Q-T interval Flattening of T waves Appearance of prominent U wave
876
—: glucocorticoid & mineralocorticoid deficient
Addison’s disease
877
— - autoimmune destruct of the adrenal cortex
Hypoadrenocorticism
878
—: S/S 1. Hypotension 2. Hyponatremia 3. Hyperkalemia 4. Hypoglycemia (secondary decrease cortisol levels) 5. Hemoconcentration (d/t to ↑ H2O excretion 2nd to hyponatremia) 6. Skin pigmentation
Addison’s disease
879
2 electrolytes to indicate decrease in aldosterone:
Hyponatremia and hyperkalemia
880
Give — intraop for Addison’s disease
glucocorticoid
881
—- ↑ cortisol & ↑ ATCH in anterior pituitary
Hyperadrenocorticism
882
— disease: Hypoadrenocorticism
Addison’s disease
883
— disease: Hyperadrenocorticism
Cushing’s disease
884
— S/S: 1. HTN (secondary to Na retention) 2. Hypokalemia 3. Hyperglycemia (20 increase cortisol levels) 4. Moon face & buffalo hump 5. Skeletal muscle weakness 6. Skin pigmentation
Cushing’s disease
885
— Disease: Primary hyperadolteronism
Conn’s Disease
886
Conn’s Disease electrolytes :
↑ Na+ ↓ K+
887
—: Tumor of the adrenal medulla chromaffin tissues which results in an ↑ catecholamine release
Pheochromocytoma
888
— S/S: 1. Paroxysmal HTN 2. Diaphoresis 3. Tachycardia 4. Headache
Pheochromocytoma
889
Pheochromocytoma Tx: 2
α block- phenoxybenzamine 20-30mg/day &↑to 60-250mg/day β block- tx for tachy
890
3 drugs to Avoid in Pheochromocytoma:
Trimethaphan, droperidal, histamine
891
—: A group of syndromes characterized by tumor formation in several endocrine organs.
Multiple Endocrine Neoplasia: (MEN)
892
MEN — = tumors in pancreas, pituitary gland, & parathyroid gland
I
893
MEN — = medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism (type IIa) or multiple mucosal neuromas (type IIb or type III)
II
894
Kidney: —% CO
25-30
895
Kidney: 4 Functions:
1.ECF composition 2. Maintenance of EFV- NA & H2O excretion 3. Endocrine 4. Regulation of arterial BP
896
ECF composition: Osmolality: — mOsm/kg Urine osmolality — mOsm/kg H2O
285-305 ; 50-1200
897
Erythropoietin- CRF = —
anemia
898
— System- BP reg, Na/K excretion
RAA
899
Vitamin D: CRF = —
hypocalcemia
900
RBF = equation
(MAP- Venous Pressure) x Vascular resistance
901
Labs: — is single best indicator of renal status
Creatine Clearance
902
Creatine: — mg/dl BUN: —mg/dl
0.7-1.5 ; 10-20
903
GFR: nml —ml/min, mild dsyfx —, mod dsyfx —, failure — ml/min
95-150 ; 50-80 ; <25 ; <10
904
Glomerulus: freely filters 4
Na, Cl, K & H2O
905
Proximal tubule: —% of glomerular filtrate
67
906
Proximal tubule: reabsorbed —, ONLY place permeable to —
H2O > Cl > Na = K ; glucose
907
Descending LOH: filters 2
Urea & H2O (no Na, Cl or K)
908
Descending LOH: Osmotic gradient via —
countercurrent multiplier
909
Ascending LOH: Filters 3
Na, Cl, K – No H2O in thick branch
910
Loop Diuretics – — inhibit reabsorption
Na+, K+, 2CL-
911
Lasix ↑ —= — = ↓BP
prostaglandins ; venodilitation
912
Loop Diuretics –Side effects: 4
↓ K, fluid volume deficit, orthostatic HoTN, reversible deafness (CNVIII)
913
Distal Tubule: Filters 2
Na & Cl (No K or H2O)
914
Distal Tubule: Early: drug —: — K
Thiazides: ↓ K
915
Distal Tubule: Late & CC: drug —: — K
Potassium Sparing Diuretic: ↑ K
916
5 drugs that affect late distal tubule:
Triamterene, amiloride Spiratalctone ADH & Aldosterone
917
CollectingDuct: filter 4
Na & Cl-out, K-In, Low perm H2O, (no urea)
918
CollectingDuct: Site of Action — & —
ADH & Aldosterone (principle cells)
919
6 Nephron Sections:
1. Glomerulus 2. Proximal tubule 3. Descending LOH 4. Ascending LOH 5. Distal tubule 6. Collecting duct
920
3 nephrons sections in Cortex:
Glomeruli, Proximal Tubules, Distal Tubules
921
2 parts of the nephron in Medulla:
loops of Henle, Collecting Ducts
922
—= most vulnerable to ischemia of nephron
Inner stripe of the outer medulla
923
Carbonic Anhydrase Inhibitor: —
Acetazolamide(Diamox)
924
Carbonic Anhydrase Inhibitor: Acetazolamide(Diamox)-↓ — 2 to ↓ — formation
IOP ; aqueous humor
925
Acetazolamide(Diamox)- Inhibit — in — tubule = — Na reabsorption = diuresis – — Metabolic Acidosis
carbonic anhydrase ; proximal ; ↓ ; Hyperchorlemic
926
Mannitol:— Osmotic pressure in renal tubule= — reabsorption of H2O
↑ ; ↓
927
Mannitol: S/E: —
↓ K +
928
Renal Failure: S/S & lab findings normal until —% ↓ in Fx
40
929
Anuric: UO — Oliguric: UO — NonOliguric: —
<100ml/day or < 0.5ml/kg/hr ; 100-400 ml/day ; UO >400ml/day
930
Renal Failure: Electrolytes: —
↑ K, Mg, Phos, ↓Ca , Na , metabolic acidosis
931
Renal Failure: — is # 1 issue and cause of death
Infection
932
— DA1 agonist
Fenoldapam
933
Fenoldapam DA1 agonist: — RBF (6x more potent than —)
↑ ; dop
934
Renal Failure: Avoid — & —
Meperidine & Morphine (metabolite-6)
935
—: (vasopressin)
ADH
936
ADH: (vasopressin) : — Concentration
NA+
937
ADH: (vasopressin) : Synthesized Periventricular and Supraoptic nuclei of the — , stored in and released from the — (neurohyposis).
hypothalamus ; posterior pituitary
938
ADH: (vasopressin) : where does it work and effect 3
1. Primary on collecting ducts in the nephron = passive water reabsorption 2. Vascular smooth muscle and cardiac myocytes. 3.Dramatic vasoconstriction and has an inotropic effect
939
— Released in response to increase ECF osmolarity, decrease plasma volume, & drugs, stress, HoTN, Pain, CPAP, PEEP, VA, Trauma
ADH (vasopressin)
940
ADH (vasopressin): Works in the — & — to increase H2O reabsorption
distal tubule & collecting duct
941
In the absence of ADH the collecting duct and distal tubule are impermeable to — ie: excretion happens.
H2O
942
ADH = — = — (concentration)
Osmolality ; increase [Na+]
943
Extra Cellular Fluid Volume: — = ECFV
Na+
944
Aldosterone: controls —
VOLUME
945
Aldosterone: It controls — volume and works in the — & — tubule.
intravascular ; collecting duct and the late distal convoluted
946
Aldosterone: — Na+ reabsorption, and K+ —.
Increases/conserved ; secretion/excretion
947
—: Release is triggered by Angiotensin II and increase [K+]; also increase ACTH and low serum Na+. It also regulates the total amount of Na+.
Aldosterone
948
— is secreted by the zona glomerulosa of the adrenal cortex.
Aldosterone
949
— (a mineralocorticoid)
Aldosterone
950
— (a glucocorticoid)
Cortisol
951
— is secreted by the zona fasciculata, the middle zone of the adrenal cortex.
Cortisol
952
—, —, & — are catecholamines released from the adrenal medulla.
Epinephrine (80%), norepinephrine (20%), and dopamine
953
Epinephrine (80%), norepinephrine (20%), and dopamine are catecholamines released from the adrenal medulla. This is controlled by — preganglionic neurons that release — to — receptors.
sympathetic ; acetylcholine ; nicotinic
954
3 Stimuli for the release of Renin:
1. Decrease Renal perfusion pressure 2. Hyponatremia 3. Sympathetic NS stimulation of beta-receptors in JG apparatus
955
Normal GFR = — ml/min
125
956
Clinical features of Diabetes Insipidus: — - HALLMARK
Polyuria, > 2-15 L/day
957
3 Clinical features of Diabetes Insipidus:
1. Polyuria, > 2-15 L/day- HALLMARK 2. Hypernatremia (plasma hyperosmolality) 3. Dilute urine (osmolality < 200 mOsm/kg)
958
S/S of —: 1. Polydipsia (increase thirst) 2. Polyuria – (2-15L/Day) HALLMARK 3. Hypernatremia 4. Hypovolemia 5. Hypotension 6. ↓ Urine osmol (<200 mosm/kg) 7. ↓ specific gravity (1.005 or less)
Diabetes Insipidus
959
3 Diagnosis of SIADH: ↑ ADH
1. Decreased plasma osmolality (< 270 mOsm/kg) 2. Increase urine [Na+] (> 100-150 mOsm/kg) 3. Hyponatremia d/t retention of H2O
960
SIADH: Tx: —4
remove underlying cause, Limit H2O , 3% Saline, demecolcine
961
Liver: —% CO
25
962
Liver: Blood Flow: —% Portal vein - splenic & mesenteric —% Hepatic artery
70 ; 30
963
“—” An increase in hepatic arterial flow in response to a decrease in portal blood flow (1) to maintain hepatic O2 supply, and (2) to maintain total hepatic blood flow, which is essential for clearance of many compounds.
Arterial Buffer Response
964
Hepatic Blood Flow Arteries: —, —, —, & —
α-1, β-2, D1 &cholinergic
965
Hepatic Blood Flow Arteries: Blood flow receptors: —
Ohms
966
Hepatic Blood Flow Veins: — & —
α-1 & D1
967
Hepatic Blood Flow Veins: blood flow depend on — & —
GI & Spleen
968
Hepatic Blood Flow Arteries: — % of Blood flow, —% of oxygen supply
30 ; 50
969
Hepatic Blood Flow Veins: —% of blood flow, —% of oxygen supply
70 ; 50
970
Seven functions of the Liver:
1. Storage and filtration of blood (500ml) 2. Metabolic functions such as carbo, fat, and protein metabolism 3. Secretion of bile 4. Storage of vitamins 5. Blood coagulation 6. Storage of iron 7. Detoxification & excretion of drugs
971
P450’s Inducers: 7
chronic ETOH, barbs, ketamine, benzo’s, phenytoin, cigarette smoke, St. Johns wort
972
P450’s Inhibition: 4
cimetidine, chloramphemocel, fluoxetine, grape fruit Bile vomitus is usually alkaline
973
Puke your acids = —
alkalosis
974
Poop your bases = —
acidosis
975
Alcoholic Hepatic Issues/Liver Disease: 4
Thrombocytopenia, leukopenia, anemia, megoblastic anemia d/t folate deficiency
976
Maintain BP- ETOH depends on — FLOW
ARTERIAL
977
Alcoholic Hepatic Issues/Liver Disease: —- agent of choice
Isoflurane
978
Alcoholic Hepatic Issues/Liver Disease: — Vd= — loading dose, — main = prolonged Vec, Roc, Pan
↑ ; ↑ ; smaller
979
Alcoholic Hepatic Issues/Liver Disease: prolonged —
Vec, Roc, Pan
980
Alcoholic Hepatic Issues/Liver Disease: Labs: — total bilirubin,—AST/ALT (ALT more sensitive), — albumin & PT
↑ ; ↑ ; ↓
981
Alcoholic Hepatic Issues/Liver Disease: Hemodynamics: —SVR, —CO, —circ blood volume, —portal blood flow, — plasma osmotic pressure
↓ ; ↑ ; ↑ ; ↓ ; ↓
982
— Syndrome: (aspiration pneumonitis)
Mendelsons
983
Mendelsons Syndrome: (aspiration pneumonitis) Gastric pH < — Gastric volume < —
2.5 ; 25 ml
984
Seven conditions that delay gastric emptying:
1. Obesity 2. Pregnancy 3. Opiods 4. Diabetes mellitus 5. Trauma 6. Pain 7. Anxiety
985
Drugs that ↓ LES Tone: (↑ risk of aspiration)
1. Anticholinergics 2. Dopamine 3. Thiopental 4. Opioids 5. Propofol 6. Tricyclic antidepressants 7. Sodium nitroprusside
986
5 Patients who benefit from antiemetics:
1. Eye surgery patients 2. Gynecological patients 3. Obese patients 4. History of vomiting 5. ECSW Lithotripsy
987
Antiemetics: Competitive Dopamine Antagonists; 3
Droperidal, Compazine, Metoclopramide
988
Competitive Dopamine Antagonists; Droperidal, Compazine, Metoclopramide: Do not give to — Patients
Parkinson’s
989
Droperidol: 1. An antiemetic (secondary — blockade) 2. Produces extrapyramidal signs (secondary — blockade) 3. May decrease BP (secondary weak — blockade)
dopamine ; dopamine ; alpha
990
Treatment for droperidol-induced extrapyramidal symptoms is an 4
anticholinergic (Benadryl or benztropine, Cogentin).
991
Droperidol: Do not give to: — or —
Pheo or Parkinsons
992
Metoclopramide: (NO Δ in — )
pH
993
Metoclopramide: 1. — pyloric sphincter 2. — gastric motility = ↑ gastric emptying 3. — LES tone = ↓ reflux 4. — the small intestine 5. Has — actions
Relaxes ; Promotes ; Increase ; Relaxes ; antiemetic
994
Metoclopramide: also inhibits —
plasma cholinesterase
995
Metoclopramide: Used to treat: 4
Diabetic gastroparesis Reflux esophagitis Pts. at risk for aspiration pneumonitis (Mendelsons syndrome) Parturients
996
Drugs that — gastric pH and — gastric volume: (H2 blockers)
Increase ; decrease
997
3 H2 blockers:
1. Cimetidine (Tagamet) 2. Ranitidine (Zantac) 3. Famotidine (Pepcid)
998
Which H2 blocker inhibits p-450 the most?
Cimetidine (Tagamet)
999
Which H2 blocker is the most potent?
Ranitidine (Zantac)
1000
Proton pump inhibitors: - inhibits the — pump -—secretion of HCl into the lumen of stomach
hydrogen ; ↓
1001
— : proton pump inhibitor
Omeprazole
1002
most powerful agent for ↓ acid secretion
Proton pump inhibitor (omeprazole)
1003
—: Raise gastric pH by neutralizing HCl also ↑ gastric volume
Antacids
1004
How fast is antacids effect?
Immediate
1005
How long does antacids loose effectiveness?
30-60min
1006
Chemoreceptor Zone: —
4th ventricle (area posterema)
1007
4 Neurotransmitters & Receptors in N/V:
Dopamine & DA-2 Serotonin & 5-HT Acetylcholine & muscarinic Substance P & NK-1
1008
—: S/S caused by vasoactive substances released from enterochromaffin tumors or carcinoid tumors
Carcinoid Syndrome
1009
Carcinoid Syndrome: Most carcinoid tumors are in —
GI tract- especially appendix
1010
Carcinoid Syndrome: Cause overproduction: 5
serotonin-hallmark, bradykinin, histamine, kallikrein, prostaglandins
1011
Carcinoid syndrome hallmark overproduction?
Serotonin
1012
Carcinoid syndrome: Avoid activating tumor causing: 3
HoTN, catecholamine release, histamine releasing medications
1013
Five clinical manifestations of nonintestional tumors:
1. Cutaneous flushing 2. Bronchospasm 3. Diarrhea 4. Large BP swings 5. Supraventricular dysrhythmias
1014
— used to blunt vasoactive and bronchoconstritive effects of carcinoid syndrome
Octreotide (somatostatin)
1015
Pancreas: Beta cells: — Alpha cells: — Delta cells: —
insulin ; glucagon ; somatostatin
1016
Evaluation of pancreatitis: 3
1. Malnutrition 2. Abnormal liver FX 3. ETOH WD (alcoholism frequent cause of pancreatitis)
1017
Symptoms of pancreatitis: 4
1. Dehydration 2. Hypocalcemia 3. Hyperglycemia 4. ARDS Alcoholism is a frequent cause of pancreatitis.
1018
5 “F’s” of Cholelathiasis:
1. Fat 2. Female 3. Fertile 4. Forty 5. Fair
1019
— is not needed by brain or RBC to utilize glucose
Insulin
1020
—: Insulin secreting tumor causing massive insulin release.
Insulinoma
1021
Insulinoma: —- during resection —- after resection Check Blood sugar every — mins
Hypoglycemia ; Hyperglycemia ; 15
1022
Diabetic Neuropathy: Anesthetic considerations: 3
orthostatic Hotn, Silent MI, Gastroparesis
1023
Diabetic Neuropathy: HR response blunted w/ use of —
antimuscurinics - Atropine
1024
Normal A1C = — %
6
1025
DM with autonomic neuropathy: 6 Cardiac Concerns
Orthostatic Hotn, Resting tachycardia, absence of beat to beat variability in HR, dysrhythmias, silent MI, painless myocardial ischemia
1026
DM with autonomic neuropathy: HR response blunted in these medications: 2
Antimuscarinics & Beta-Blockers
1027
MOA of DM neuropathy: High concentrations of glucose are converted to — within nerve via the polyol pathway. The high levels of it (and fructose) that develop — ATP→ — NO levels. Because this acts as a vasodilator, the loss of it leads to unopposed vasoconstriction and ischemia of the nerve
sorbitol ; ↓ ; ↓
1028
—: Where T-Lymphocytes mature
Thymus
1029
— is most commonly removed d/t Thyoma & MG
Thymus
1030
Thymus removal has Pneumo most likely on — side
RIGHT
1031
Scoliosis: — curvature of the spine
Lateral
1032
Scoliosis: — lung dz
Restrictive
1033
Scoliosis: most likely to have this heart issue
Mitral valve prolapse
1034
—: Painless degenerative & atrophy of skeletal muscles
Muscular Dystrophy
1035
Muscular Dystrophy: — (most common & severe)- x-linked, recessive
Duchene’s
1036
Muscular Dystrophy (Duchenne’s): EKG- — PR, QRS, ST abnormalities, BBB, Q waves, R waves (tall), CHF
prolonged
1037
Muscular dystrophy (Duchene’s): Resp: —TLC & RV, recurrent pulm infections
1038
Muscular Dystrophy (Duchene’s): NO — (↑MH)
succs
1039
—: Random & multiple sites of demyelination of corticospinal tracts in brain & SC (NO PERIPHERY)
Multiple Sclerosis- MS
1040
Multiple Sclerosis- MS: No — (may exacerbate)
spinals
1041
Multiple Sclerosis- MS: Avoid – rises in —
temps
1042
Multiple Sclerosis- MS: — in response to Succs
Hyperkalemia
1043
—: Loss of dopanergic fibers basal ganglia (dop is a inhibitory NT)
Parkinson Disease
1044
—: s/s: skeletal muscle rigidity, resting tremor, diaphragmatic spasm
Parkinson Disease
1045
Parkinson Disease tx:
Levodopa
1046
Parkinson Disease: Avoid: 3
droperidal, reglan, Compazine
1047
—: Chronic inflammation disease w/cervical vertebral involvement
Rheumatoid Arthritis
1048
Rheumatoid Arthritis: -—lung disease, pulmonary fibrosis, FOB, pulm fx test -Hoarseness or stridor – — involvement
Restrictive ; Cricoarytenoid
1049
—: Cyanide binds to cytochrome oxidase resulting in inhibition of oxidative phosphorylation causing inhibition of cell respiration.
Cyanide Toxicity:
1050
Cyanide Toxicity: caused by administration of —
Nitroprusside
1051
—: Chronic autoimmune @ NMJ, weakness
Myasthenia Gravis- MG
1052
Myasthenia Gravis- MG: Tx: 3
steroids, anticholinesterase meds, plasma phoresis
1053
Myasthenia Gravis- MG: Avoid —
muscle relaxants
1054
—: A disorder of neuromuscular transmission associated with carcinomas. An autoimmune disease in which immunoglobulin G (IgG) antibodies against voltage-gated sodium channels cross-react with calcium channels at the neuromuscular junction. The result is a decreased release of acetylcholine in response to nerve stimulation.
Lambert-Eaton Syndrome ~ Myasthenic Syndrome
1055
Lambert-Eaton Syndrome (Myasthenic Syndrome): — sensitivity to NDMRs and succinylcholine is seen.
Increased
1056
Lambert-Eaton Syndrome (Myasthenic Syndrome): ↓ Weakness with — activity
1057
—: A familial d/o associated w/ histocompatibilityantigen HLA-B27. Low back pain associated w/ early morning stiffness young men progressively restricted movement of the spine. Some patients develop arthritis of the hips and shoulders.
Ankylosing Spondylitis
1058
Ankylosing Spondylitis: — dose if needed
Stress steroid
1059
—: characteristic manifestations: antinuclear antibodies, nephritis, serositis, thrombocytopenia, or a characteristic rash
Lupus
1060
Drug most likely to cause lupus like symptoms:
Hydralazine
1061
4 Complications of TURB:
1.Blood Loss 3. bactermia 2. Hypothermia 4. Bladder perforation
1062
TURP: Preference for —: ↓ blood loss, ↓ thrombus risk, atonic bladder, prevents postop bladder spasms, awake pt. can assist detecting issues
SAB
1063
Bladder Perforation during TURP –Signs & Symptoms: 2
1.Abdominal pain & spasm 2. HTN & tachy—followed by sudden & severe HoTN
1064
TURP Syndrome: Triad of S/S:
↑ PP, bradycardia, mental status Δ Other symptoms: HTN, CV collapse, ↑ CVP, Dyspnea, N, anxiety
1065
TURP Syndrome: Tx:
Give O2, notifiy surgeon, invasive monitors, blood to lab, 12-lead ECG,
1066
— - complication from TURP syndrome- d/t the rapid tx of hyponatremia
Central Pontine Myelinolysis
1067
TURP Syndrome: Management: stop resection, Labs, fluid restriction, Lasic, NS3% Amount of NS 3% = Dose (mEq) = — Stop NS 3% when NA > —
kg x (140-(Na)mEq/L) ; 120
1068
Na+ levels: — mEq/L = restlessness & confusion, (psbl. wide QRS), N/V
120
1069
Na+ Levels: — mEq/L = nausea, somnolence, ECG (wide QRS, ST elevation)
115
1070
Na+ levels: — mEq/L = seizures & coma with VT, VF
110
1071
Irrigating fluid = — ml/min of surgery time
20
1072
Blood loss is ~ — ml/min of resection time
3-5
1073
Gas Embolism – laparoscopic surgery S/S: HoTN, Tachy, bilateral wheezing & ↓ ETCO2 Halt insufflation, eliminate N2O, release pneumoperitoneum, place in — lateral decub, aspirate gas via central venous cath
LEFT
1074
Fat Emboli Syndrome – — hrs
12-72
1075
Fat Emboli Syndrome 5 major signs:
axillary, subconjuctival petechial, hypoxemia,↓CNS, pulm edema
1076
S/S of Intraop PE: 7
1. Hypotension 2. Tachycardia 3. Hypoxemia, decrease SpO2 4. Bronchospasm 5. Hypocapnia, decrease ETCO2 (1st sign d/t dead space ventilation) 6. PVR > 300 7. +D-dimer
1077
—: Skeletal muscle necrosis d/t tissue injury Myoglobin: oxygen transport protein Common causes: major crush injury, thermal or electrical injury, arterial occlusion, acute muscle injury, prolonged immobility, compartment syndrome, MH, extreme lithotomy, hyperlordotic position
Rhabomylosis
1078
—: To improve blood flow to ischemic areas: causalgia, Raynaud’s, frostbite, gangrene, ischemic ulceration of lower extremities L2-L3
Surgical Lumbar Sympthathectomy
1079
Cyanide Toxicity: Tx:
Na Thiosulfate 150ml/kg over 15 mins
1080
— = muscle cell
Myocyte
1081
—: ECG = peaked P waves in leads II, III, and aVF which are consistent with right atrial hypertrophy & right axis deviation and right bundle branch block which are consistent with right ventricular hypertrophy.
Cor Pulmonale
1082
Surgical Stimulation: 6
Intubation > upper ab surgery > breast surgery = lower ab = skin incision > skin closure
1083
ASA classes: Healthy
1
1084
ASA class: mild systemic disease- HTN, DM, Anemia, age, obesity, chronic bronchitis
2
1085
ASA class: severe systemic disease- Cardiac dz with limiting activity, Uncontrolled HTN, DM w/vascular issues, MI or Angina
3
1086
ASA class: incapacitating systemic dz – CHF, persistent angina, advanced kidney or liver dz
4
1087
ASA class: moribund pt. – Not expected to live 24 hours after surgery- PE, AAA, cerebral trauma
5
1088
ASA class: brain dead- organ procurement
6
1089
ASA class: not elective- i.e appy
E
1090
Mallampati: Pillars, soft palate, fauces, uvula
Class I
1091
Mallampati: Uvula, soft palate, fauces
Class II
1092
Mallampati: Soft palate, uvula
Class III
1093
Mallampati: Hard Palate
Class IV
1094
Mallampati score mnemonic:
PUSH (from I to IV)
1095
ECT: 1st response
parasympathetic- HoTN, ↓HR
1096
ECT: 2nd response
sympathetic- HTN, ↑HR ↑CBF = ↑ICP
1097
ECT: Medication of choice:
Brevital (0.5mg/kg)
1098
ECT: Desired Duration
30-60 seconds, sz sec needed= 400-700
1099
ECT: 6 Absolute contraindications:
1. Pheo 2. Recent MI (4-6 wks) 3. CVA <3mos 4. recent intracranial surgery- <3mos 5. Intracranial mass lesion 6. Unstable C-spine
1100
ECT: 9 Relative contraindications
angina, CHF, Pacer/ICD, pulm dz, major bone fx, glaucoma, retinal detachment, thrombophlebitis, pregnancy
1101
Fetal heart Circulation:
RA to foramen ovale and RV (foramen ovale to LA), RV to PA, PA to patent ductus and lungs (PDA to aorta)
1102
Fetal circulation: — arteries-deoxygenation blood & — vein- oxygenated
2 ; 1
1103
Hemoglobin levels are lowest at — of age —mg/dl
3 months ; 10-11
1104
Basal metabolic rate is highest at — of age
2 years
1105
Oxyhemoglobin curve: Newborn= — shift & — @ —
Left ; Right ; 3-4 mos.
1106
Peds Inspiratory pressure more negative than — to open alveoli
25-40
1107
—: hyaline membrane disease, 50-75% mortality rate d/t result of inadequate surfactant in the alveoli
Respiratory distress syndrome (RSD)
1108
Premie: less than —
37 weeks
1109
Neonate: less than — of age
30 days
1110
Infant: — of age
1-12 mos.
1111
Children: — of age
1-12 years
1112
Post conceptual Age = equation
gestational age + post maternal age
1113
Apgar scores: taken at — min & — min
1 ; 5
1114
Apgar scores: 1 min = — & 5 min = —
survival ; neurologic outcome
1115
Differences in body systems in Pediatrics: Cardiac: -CO is dependent on — -fixed SV & noncompliant & poorly developed — (depends on —)
HR ; L vent ; Ca++
1116
Differences in body systems in Pediatrics: Cardiac: Innervation: — = SPARSE, —-complete
Sympathetic ; parasympathetic
1117
Differences in body systems in Pediatrics: Respiratory:— RR, — Lung compliance + — chest wall compliance = — FRC (↑ IA induction), Deficient in Type — fibers, high closing volumes
↑ ; ↓ ; ↑ ; ↓ ; I
1118
Differences in body systems in Pediatrics: Respiratory: larynx are — & — (@ —), Adult —
Anterior and cephalad ; C3-C4 ; C4-C5
1119
Differences in body systems in Pediatrics: Respiratory: Obligate — breathers
nasal
1120
— airway narrowest point in children less than 5 yrs.
Cricoid cartilage
1121
MAC highest — of age
6 mos.
1122
Differences in body systems in Pediatrics: Kidney: — glomerular development, ↓ size of glomerulus ↓ perfusion pressure, ↓ ability to concentrate urine, obligate — losers
Incomplete ; Na
1123
Differences in body systems in Pediatrics: Hepatic: — hepatic biotransformation, ↓ protein binding, fetal liver = hematopoiesis, — risk of hypoglycemia, — LBF
Immature ; ↑ ; ↓
1124
Peds spinal cord and dural sac end at:
Spinal cord: L2-L3 and dural sac: S3
1125
Adult spinal cord and dural sac end at:
Spinal cord: L1-L2 and dural sac: S2
1126
— cortex- unmylenated and poorly developed until 2 years
Motor
1127
— cortex- mylenated @ birth, nerves poor develop until 3 mos.
Sensory
1128
Peds CBF —ml/100g/min (adults 100/100/g/min)
40
1129
Peds Neuro surgery: PaCO2 → — mmHg
20-25
1130
Peds Non-shivering thermogenesis (inhibited by: 4 )
IA, BB, fent, prop)
1131
Best way to maintain infants body heat = heat up OR to —
26C (78.8)
1132
Peds O2 consumption — an adults
2x
1133
Peds Large volume of distribution 2nd to higher — content
total body water
1134
Peds Higher ratio of body — to body —
surface area ; weight
1135
Hypotension: SBP NB <—
60
1136
Hypotension: SBP 1year <—
70
1137
Hypotension: SBP >1yr —
70+(agex2)
1138
Peds ETT Diameter:
4 + Age /4 (uncuffed) = -.5(cuffed)
1139
Peds ETT Length:
10 + age/2
1140
Wt in kg NN-5: size LMA and ETT
LMA: 1 and ETT: 3.5
1141
Wt in kg 5-10: size LMA and ETT
LMA: 1.5 and ETT: 4.0
1142
Wt in kg 10-20: size LMA and ETT
LMA: 2 and ETT: 4.5
1143
Wt in kg 20-30: size LMA and ETT
LMA: 2.5 and ETT: 5.0
1144
Wt in kg >30: size LMA and ETT
LMA: 3 and ETT: 6
1145
French Suction Catheter: neonate
8 Fr
1146
French Suction Catheter: 2mths - 2yrs
10 fr
1147
French Suction Catheter: 2-12 yrs
14 Fr
1148
Precordial Stethoscope: — intercostal — of sternal border
3rd-4th ; left
1149
Propofol < 2 y.o = IV induction — mg/kg.
3-4
1150
Propofol >2 y.o. = — mg/kg
2.5-3
1151
Peds Propofol — mg/kg/min GA
200-300
1152
Peds Midazolam IV dose = —mg/kg PO dose= — mg/kg
0.05 ; 0.5 to 0.75
1153
Peds Flumazenil IV — mg/kg → — mg total
0.05 ; 1
1154
Peds thiopental —mg/kg
4-6
1155
Peds Succinylcholine = ↑ intubate dose IV —mg/kg IM — mg/kg
2-3 ; 4
1156
Peds NDMR dose —
Same dose as adults
1157
Less than — weeks post conceptual = > risk of post anesthesia comp
60
1158
Elective surgery: at least — weeks post conception
60
1159
—: vasoconstriction of retinal vessels- leading to permanent scarring, blindness and retinal detach
ROP- retinopathy of prematurity
1160
ROP- retinopathy of prematurity: most likely < — (post conception)
44 weeks
1161
ROP- retinopathy of prematurity: Causes: 4
Hyperoxia, hypercarbia, Hotn, Sepsis Maintain PaO2 60-80mmHg O2 sats 89-94%,
1162
—: Recurrent pauses in ventilation no longer 5-10 seconds. During REM sleep not associated with any physiologic disorder.
Periodic breathing
1163
—: Unexplained cessation of breathing > 15 sec or shorter resp pauses w/ HR < 100, cyanosis, pallor or loss of muscle tone.
Central Apnea
1164
Central Apnea has highest risk in premies. Most important risk of —.
Postop apnea
1165
MOA of foramen ovale: 2
1. Decrease PVR and increase pulmonary flow 2. Increase SVR = increase L vent = increase LAP
1166
MOA of ductus arteriosus: 2
1. Increase PaO2 and decrease prostaglandins 2. Increase SVR and decrease PVR
1167
Function foramen ovale closure:
Rapidly after birth
1168
Anatomical closure of foramen ovale:
3-12 mths
1169
Functional closure of PDA:
2-4 days
1170
Anatomical closure of PDA:
1-4 mths
1171
Foramen ovale problem:
Cyanosis
1172
Ductus arteriosus problem:
Increase work of L side of heart - L ventricular hypertrophy
1173
Foramen ovale: IV induction time
Faster
1174
Foramen ovale: inhalational induction time
Slower
1175
Ductus arteriosus: IV induction time
Slower
1176
Ductus arteriosus: inhalational induction time
Faster
1177
RAP — LAP (causes of return or continuation of fetal circulation)
>
1178
RAP > LAP: 5 problems
1. Hypoxia 2. Hypercarbia 3. Acidosis 4. Hypothermic 5. Coughing, bucking & Valsalva
1179
RAP>LAP: — underestimates AaCO2
ETCO2
1180
RAP > LAP: Preductal Monitoring :
Right Hand or Finger
1181
RAP > LAP: Postductal monitoring:
Left foot or toe
1182
RAP > LAP: ABG’s best obtained from —
Right Artery
1183
—: Narrowing of the descending aorta.
Neonatal Coarctation of the Aorta
1184
Neonatal Coarctation of the Aorta: If severe – perfusion is dependent on open — shunt. — use to maintain patency
PDA; PGE1
1185
Neonatal Coarctation of the Aorta: BP monitoring in —
Right Radial artery
1186
—: Foramen of Bochdaleck or anterior foreman of Morgagni Larger on left & 90% of diaphragmatic hernias on left.
Congenital Diaphragmatic Hernia (CDH)
1187
Congenital Diaphragmatic Hernia (CDH): Larger on — & 90% of diaphragmatic hernias on —.
left ; left
1188
Congenital Diaphragmatic Hernia (CDH): Maintain preductal saturation > — w/ PIP < — cm H2O
85 ; 25
1189
Congenital Diaphragmatic Hernia (CDH): Keep them —, — stomach and avoid barotrauma
breathing ; Decompress
1190
Congenital Diaphragmatic Hernia (CDH): — shunt – monitor pre and post ductal perfusion
R to L
1191
Congenital Diaphragmatic Hernia (CDH): problems: 3
Cyanosis, Dyspnea & Dextrocardia
1192
4 issues with Tetralogy of Fallot:
1. Large single ventricular septal defect 2. Aorta that overrides the right & left ventricles 3. Obstruction to right ventricular outflow 4. Right ventricular hypertrophy
1193
Tetralogy of Fallot: — shunt
RIGHT to left
1194
Tetralogy of Fallot Goals: 2
maintain volume status and SVR (need to ↑ = NEO)
1195
—: Most common form ends in blind pouch & lower esophagus that connects to trachea – C (then B & E) Associated with VACERTL syndrome Principle cause of death = pulmonary complications
TEF: Tracheoesophageal Fistula
1196
TEF: Tracheoesophageal Fistula: — secretions and No — prior to intubation
↑ ; PPV
1197
—: Infants: projectile vomiting & visible peristalsis Adults: Peptic ulcer scarring
Pyloric Stenosis
1198
Pyloric Stenosis: problems 3
1. Hyperchorlemic metabolic alkalosis- ↓Cl, K, Na, Ca 2. ↑ Aldosterone secretion 3. Cleft palates & esophageal reflux
1199
Pyloric Stenosis: Anesthetic Considerations: 3
correct electrolytes, rehydration, OG
1200
Is pyloric stenosis a surgical or medical emergency?
Medical
1201
Pyloric stenosis: post op complication
Respiratory depression
1202
Down’s syndrome (trisomy 21) Concerns: 3
1. Difficult intubation: use small than usual ETT (Large tongue Short neck Small mouth) 2. Neck flexion- Cervical spine dislocation- antlanto-occipt (Instability & Weak ligaments) 3. Congenital heart disease (40% incidence)
1203
Which is more common: omphalocele or gastroschisis
Omphalocele
1204
Location of omphalocele:
Base of umbilicus
1205
Location of gastroschisis:
Lateral to umbilicus
1206
Anomalies with omphalocele:
Yes, cardiac
1207
Anomalies seen with gastroschisis:
No
1208
Omphalocele presence of sac:
Yes
1209
Gastroschisis presence of sac:
No
1210
3 concerns with gastroschisis:
Infection, hypothermia, and hydration
1211
Omphalocele and gastroschisis: steps 4
1. Decompress stomach with tube 2. No nitrous 3. Hydrate 8-16ml/kg/hr 4. If PIP >25-30 cmH2O
1212
Which is emergency: epiglottis or croup?
Epiglottis
1213
Onset of epiglottis:
Rapid, 24 hrs
1214
Onset of croup:
Gradual 24-72 hrs
1215
Radiograph sign of epiglottis:
Thumb (swollen)
1216
Radiograph sign of croup:
Steeple (narrow)
1217
Age with epiglottis:
1-7 year old
1218
Age with croup:
Most < 2yrs
1219
Cause of epiglottis:
Haemophilius B-flu
1220
Cause of croup:
Cold (viral)
1221
Fever with epiglottis:
Yes - high
1222
Fever with croup:
Low grade
1223
Respiratory with epiglottis:
Inspiratory stridor
1224
Respiratory with croup:
Croupy cough “bark” with inspiratory stridor
1225
Tube size with epiglottis:
1/2 size small with leak
1226
Tube size with croup:
1/2 size smaller
1227
Tx with epiglottis:
Ampicillin &/or vaccine before 2 yrs
1228
Tx with croup:
Epi neb, O2, cool humid, steroids
1229
Anesthesia with epiglottis: 2
-do not attempt to visualize glottis -sedate while sitting
1230
Anesthesia with croup: 3
-intubate if high PaCO2 -epi neb-2.25% in 3ml -NS @ 0.05ml/kg up to 0.5ml/kg Q 1-4hr
1231
—: Hereditary disease of exocrine glands of resp and GI
Cystic Fibrosis
1232
Cystic fibrosis: Cl- transport — w/ — Na & H2O transport — Thickness of secretions= avoid antisialogogues — RV & airway resistance, — VC & exp flow rate
↓ ; ↓ ; ↑ ; ↑ ; ↓
1233
Cystic fibrosis: No — secondary to increase secretions
ketamine
1234
—: Most common surgical emergency in the neonate. Decreased mesenteric blood flow = ischemia → intestinal mucosal injury
Necrotizing enterocolitis
1235
Necrotizing enterocolitis: — @ > risk for developing
Premature infants
1236
— is most common pediatric surgical emergency
Foreign body aspiration
1237
—- abn fusion of embryologic neural groove
Neural Tube Defect
1238
—: herniation of brain & meninges through defect in skull producing a fluid filled sac
Encephalocele
1239
—: hernia protrusion of a saclike cyst of meninges filled w/ CSF & no neurological deficits
Meningocele
1240
—: (spina bifida) hernial protrusion of saclike cyst containing meninges, CSF & portion of spinal cord
Myelomeningeocele
1241
Encephalocele, Meningocele, Myelomeningocele: — precautions & — is key
LATEX ; Positioning
1242
—: Nerves blocked: ilioinguinal and iliohypogastric
Inguinal hernia
1243
— is neuroprotective for global ischemia in neonates
Hyperglycemia
1244
Tonsillectomy:↑ Blood loss- — ml/kg
4
1245
Tonsillectomy: 3 complications:
bleeding, laryngospasm & emesis
1246
NPO Guidelines: Solid Food
8
1247
NPO Guidelines: Commercial Formula/Milk
6
1248
NPO Guidelines: Breast Milk
4
1249
NPO Guidelines: Clear Liquids
2
1250
Mendelsons Syndrome: Volume > — ml/kg or pH <—
0.4 ; 2.5
1251
Peds Regional Anesthesia: CSF volume — of adults = dilution of LA = — dosing & — DOA
x2 ; ↑ ; ↓
1252
High spinal – decreasing — #1 sign
oxygen saturation
1253
Caudal: tip of — to fix the midline & sacral — on either side of sacral —
coccyx ; cornua ; hiatus
1254
— LA is not metabolize in the NN
Mepivicaine
1255
Peds Regional Anesthesia: — determines height of block
Volume
1256
Regional Anesthesia: Caudal: —ml/kg analgesia T4-T6- concentration no > 2.5 mg/kg
1.2-1.5
1257
Regional Anesthesia: Epidural Blood Patch: —ml/kg
0.3
1258
Laryngospasm: 3 steps in peds
1. CPAP- 10-15cm H2O 2. atropine 0.02mg/kg 3. Succs 1mg/kg IV or 4mg/kg IM
1259
Maternal Physiological & Physical Changes: Cardiac: — CO, SV, HR, LVEDV, EF, Femoral venous pressure — PVR, MAP, SBP, DBP, SVR, PADP, PCWP
↑; ↓
1260
Maternal Physiological & Physical Changes: Cardiac: — ↑ the most immediately post-partum
CO
1261
Maternal Physiological & Physical Changes: Cardiac: ↑ — & — x12
Renin & angiotensin II
1262
Maternal Physiological & Physical Changes: Respiratory: ↑ Alveolar vent & ↓ FRC = — inhalation agent uptake & — MAC
↑ ; ↓
1263
Maternal Physiological & Physical Changes: Respiratory: Respiratory — CO2 = —
Alkalosis ; 30
1264
Maternal Physiological & Physical Changes: GI: Metabolic — – HCO3 = —
Acidosis ; 20
1265
Maternal Physiological & Physical Changes: GI: ↑ Gastric emptying time &↓ LES secondary to ↑ —
progesterone
1266
Maternal Physiological & Physical Changes: Renal: — RBF & GFR (50%) → — BUN & serum creatinine ↑ Kidney size & weight & ureters and renal pelvis dilates — & — common
↑ ; ↓ ; Glucosuria & proteinuria
1267
Relative — maternal anemia
hemodilutional
1268
Maternal Physiological & Physical Changes: Hemostasis: Hgb > — w/PIH or HTN = low volume
14
1269
Maternal Physiological & Physical Changes: Hemostasis: — Blood volume, plasma volume, RBC, Hbg — Hct —, ↑ Factors —, —, —, —, —, —
↑ ; Hbg 11.5 Hct 35.5 , 1, 7, 8, 9, 10,12
1270
Maternal Physiological & Physical Changes: Hemostasis: No change in —, —, —, and —
2 & 5, platelets, bleeding time
1271
Maternal Physiological & Physical Changes: Hemostasis: Shortened or ↓: 4
PT, PTT, AT, Factors 11
1272
Maternal Physiological & Physical Changes: Hemostasis: —, —, and — that are greater than twice the normal value represents a high-risk state that should be corrected prior to initiating a neuraxial anesthetic.
PT, PTT, and bleeding times
1273
Platelet < — too low to perform a neuraxial anesthetic
100,000
1274
Maternal Physiological & Physical Changes: Anesthetic considerations w/ Δ: Do not — = ↓ maternal alkalosis = ↓ — blood flow
hyperventilated ; uterine
1275
Maternal Physiological & Physical Changes: Anesthetic considerations w/ Δ: GA = RSI — gestation to — of postpartum
8 wk. ; 6 week
1276
Most common cause of maternal death during GA =
Hemorrhage
1277
Most common cause of maternal death with anesthesia =
Airway issues
1278
Maternal Physiological & Physical Changes: Anesthetic considerations w/ Δ: — MAC & — sensitivity to LA
↓ ; ↑
1279
DO NOT give — to PIH/HELLP parturient
esmolol
1280
Maternal — & fetal — = ↑ fetal ion trapping
alkalosis ; acidosis
1281
— receptors: relaxes smooth muscles & stops contractions via activation of adenylyl cyclase = ↑ cAMP = myometrial relaxation
β2
1282
Tocolytics 2
Methergine Hemabate
1283
Uterine Blood Flow:
800ml/min (10% maternal CO)
1284
Uterine Blood Flow:↓ Perfusion pressure: 6
supine, hemorrhage/hypovolemia, HoTN, contractions, sz, Valsalva
1285
Uterine Blood Flow:↑ Uterine Vascular resistance: 2
catecholamines, vasopress
1286
Maternal — is only factor influence blood flow through placenta
BP
1287
uterine blood flow is — autoregulated
NOT
1288
— receptors predominate uterine vasculature
α adrenergic
1289
Greatest risk to fetus from Maternal issues: 3
Severe hypoxia, HoTN, acidosis
1290
Three layers in placental membrane:
1. Fetal trophoblasts 2. Cytotrophoblasts 3. Syncytiotrophoblasts
1291
Placental Transfer of Drugs: 4
1. Concentration gradient 2. Molecular weight of drugs – MW < 500 = easier transfer 3. Lipid solubility- lipids soluble drugs = easier crossing 4. Ionization – ions inhibited
1292
—: Compression inferior vena cava = ↓ venous return = ↓ SV & Hotn
Maternal supine hypotensive syndrome
1293
Maternal supine hypotensive syndrome: tx:
LUD (i.e Right hip up) 15degrees
1294
—: Regular uterine contractions until cervix fully dilated.
First stage
1295
—- Cervical effacement 2-3 cm
Latent
1296
— – frequent contractions 3-5 mins & dilatation is 4 cm in a primiparous patient & 3 cm in a multiparous patient.
Active
1297
—: From the end of the first stage until the delivery of the baby is completed.
Second stage
1298
—: From the delivery of the baby until the placenta and the membranes are expelled.
Third stage
1299
—: excessive amniotic fluid around unborn infant
Polyhydramnios
1300
First stage: uterine contractions & cervical dilatation. Pain travels via — fibers accompanying sympathetic nerves.
visceral afferent
1301
Pain Pathways for Stages of Labor: First stage: Enter cord at —&— → —,—,—,— spinal segments. —-Fibers
T11 & T12 ; T10, T11, T12, & L1 ; C
1302
Second stage: Caused by distention of lower vagina, vulva, and perineum. Pain travels via the — nerves
Pudendal
1303
Pain Pathways for Stages of Labor: Second stage: enters the cord at —,—,— sacral segments. (— dermatomes)
S2, S3, & S4 ; T10-S4
1304
NO —: they inhibit uterine contractions & promote closure of the fetal DA.
NSAID
1305
Early Decelerations (Type —)
1
1306
Late Decelerations (Type —)
II
1307
—: Etiology: head compression or stretching of neck during uterine contractions. Start & end w/ contraction & UNIFORM
Early Decelerations (Type 1)
1308
Early Decelerations (Type 1): Mild decrease in FHR < — BPM
20
1309
—: Etiology: uteroplacental insufficiency & fetal compromise w/ ↓ HR Onset: begin or near end of contraction Uniform in appearance + or - variability
Late Decelerations (Type II)
1310
Late Decelerations (Type II): SEVERE: if FHR > — BPM
45
1311
—: Etiology: cord compression Nonuniform with variable waveform Typically associated with fetal asphyxia when: > 60 bpm FRH, duration > 60 seconds or pattern persists > 30 mins
Variable Decelerations
1312
Variable Decelerations: Severe: FHR ↓ — by BPM, FHR < — BPM or decels — secs +
60 ; 60 ; 60
1313
Fetal bradycardia & late decelerations = —
fetal hypoxia (asphyxia)
1314
Obstetrics & Regional Anesthesia: SAB ↓ dose by —% d/t ↓ epidural space secondary to venous congestion &/or progesterone-induced sensitivity
25
1315
Obstetrics & Regional Anesthesia: Most common S/E = —
Hotn
1316
—: used during 1st stage of labor when traditional neuraxial analgesia is contraindicated
Paravertebral lumbar sympathetic block
1317
—: quickly metabolized no opportunity to accumulate in any significant amount.
Chloroprocaine
1318
—: 1/3 less motor block than bupivacaine & causes less CNS & cardiac toxicity, 0.08-0.15% can be administered via an epidural catheter at a rate of 8-12 mL/hour to provide continuous analgesia during labor
Ropivacaine
1319
— level sufficient for caesarean section
T4
1320
Injuries: Dorsiflex to foot= — nerve
common peroneal
1321
Injuries: Loss of sensation to lateral thigh = — nerve
lateral femoral cutaneous
1322
Injuries: Most common nerve injury during ab hyster= — nerve
femoral
1323
Injuries: Nerve injury most common w/ vaginal delivery= —
lumbosacral
1324
Spotty spinal: 5 helpful things
1. 2.5mg diazepam up to 10mg IV 2. Fentanyl 1μg/kg IV 3. 40% N2O 4. 0.25mg/kg ketamine IV 5. 10-20ml 0.5% lidocaine intraperitoneally
1325
Morphine intrathecal and epidural dose:
Intrathecal: 0.5-1mg and epidural: 7.5-10mg
1326
Meperidine intrathecal and epidural dose:
Intrathecal: 10-20mg and epidural: 100mg
1327
Fentanyl intrathecal and epidural dose:
Intrathecal: 10-25 mcg and epidural: 50-100 mcg
1328
Sufentanil intrathecal and epidural dose:
Intrathecal: 3-10mcg and epidural: 10-30mcg
1329
—: Placed through sacrospinous ligament- via Transvaginal approach
Pudendal block
1330
— block: 2nd stage of labor
Pudendal block
1331
Pudendal block risk:
hitting the scalp
1332
—: Anesthetizing nerve fibers innervate uterus, cervix, upper vagina. Submucosally in the vagina @ 3 & 9’oclock
Paracervical block
1333
— block: 1st stage of labor
Paracervical block
1334
Paracervical block risk:
Fetal Brady (33%)
1335
Signs of Fetal distress: 7
1. Repetitive late decelerations 2. Loss of beat to beat variability associate w/ late or deep decels 3. Sustained FHR < 80 BPM 4. Meconium-stained amniotic fluid 5. Oligohydramnois 6. Fetal Scalp pH < 7.2 7. IUGR
1336
—: Inadequate uterine contractions following delivery
Uterine Atony
1337
Uterine Atony risk factors: 7
multiple gestations, fetal marosomia, prolonged/rapid labor, tocyotlitcs, VA, retained placenta, chorioamniotis
1338
—: One of the most common infections during pregnancy
Chorioaminoitis
1339
Chorioaminoitis: Based on S/S: Temp > — = CARDINAL symptom
38
1340
—: May lead to fetal hypoxia
Uterine Cord Prolapse
1341
—: Dx: sudden fetal bradycardia or profound decels w/ physical exam
Uterine Cord Prolapse
1342
Uterine Cord Prolapse: tx:
immediate steep trendelenburg or knee to chest position
1343
Placenta Previa:- is there pain?
No pain
1344
Placental Abruption: is there pain?
Yes, pain
1345
—: The partial or total covering of the cervical os by the placenta
Placenta Previa
1346
Placenta Previa:↑ incidence of asymmetric —
IUGR (intrauterine growth restriction)
1347
—: Separation of the placenta from deciduas basalias before delivery
Placental Abruption
1348
Placental Abruption tx:
Delivery of fetus
1349
—: placenta adheres to the surface of the myometrium w/o invasion or passage through uterine muscle
Placenta accrete
1350
Placenta accrete is the most common indication for — surgery.
Hysterectomy
1351
—: refers to placental implantation within the myometrium (confined to myometrium)
Placenta increta
1352
—: refers to the condition where the placenta completely penetrates the myometrium or other pelvic structures
Placenta percreta
1353
3rd cause of death in pregnant pts?
Amniotic fluid embolism (AFE)
1354
—: Amniotic fluids into maternal circulation
Amniotic fluid embolism (AFE)
1355
— S/S: tachypnea, cyanosis, shock, generalized bleeding, ↓ CO, acute PE, uterine atony, ARDS, arrhythmias, bleeding, SZ
Amniotic fluid embolism (AFE)
1356
Amniotic fluid embolism (AFE) Tx: 3
aggressive cardioplulamony resuscitation, stabilization, fast delivery
1357
—: Uterine wall defect resulting in fetal distress or maternal hemorrhage
Uterine Rupture
1358
Uterine Rupture Risk Factors: 5
prior C-section, uterine scar, trauma, forces, hard labor
1359
Most diagnostic sign for Uterine Rupture =
fetal distress- loss of fetal heart tones
1360
Uterine Rupture s/s:
Continuous abdominal pain & Hotn (↑ in VBAC)
1361
Uterine Rupture tx:
volume resuscitation & immediate laparotomy & hyster poss
1362
Pregnancy Induced Hypertension: (↑ —)
thromboxane A2
1363
Pregnancy Induced Hypertension: — = ↓ CI & ↓ blood volume
HTN
1364
Pregnancy Induced Hypertension: —= HTN w/o edema or proteinuria
Gestational hypertension
1365
Pregnancy Induced Hypertension: —= HTN w/proteinuria and edema during pregnancy
Preeclampsia
1366
Pregnancy Induced Hypertension: —= preeclamptic patient w/ sz
Eclampsia
1367
Pregnancy Induced Hypertension: —= form of preeclampsia characterized by hemolysis, elevated liver enzymes, and a low platelet count.
HELLP
1368
S/S Severe pregnancy induced HTN:
1. BP 160/110 2. Proteinuria increase 5 g/day 3. Oliguria, < 500 ml/day 4. Pulmonary edema 5. Hepatic tenderness or HELLP syndrome 6. CNS: HA, visual disturbances, or seizures
1369
Complications that necessitate pregnancy induced HTN delivery: SBP >/= — or DBP >/= — – 24-48 hrs
160 ; 110
1370
Complications of pregnancy induced HTN: 1. —- #1 death 2. Renal failure 3. DIC 4. —- #2 death 5. Cerebral edema 6. Airway obstruction
Cerebral hemorrhage ; Pulmonary edema
1371
—: MOA: ↓ presynaptic release of AcH & ↓ post synaptic sensitivity preeclamptic patients & works @ NMDA → ↓ SVR & ↑ CI
Magnesium
1372
—: Beneficial: Anticonvulsant, vasodilatation, ↑ UBF, ↑ RBF, ↑ prostacyclin, ↓ ACE, ↓ renin activity, tocolytic & bronchodilitation
Magnesium
1373
Magnesium IV load = — over 15-20 mins → —g/hr IV gtt
4g ; 1-4
1374
—: drug of choice sz prophylaxis in PIH
Magnesium
1375
Tx for Mg overdose : —
Calcium Gluconate
1376
—: useful in pregnancy—mainstay, decrease BP increase Uteroplacental BF
Hydralazine
1377
Heart Disease in the Parturient: —: -mitral valve dz, aortic insufficiency, L to R shunt -Regional Anesthesia: especially continuous epidural -NEO
Group One
1378
Heart Disease in the Parturient: —: AS, R to L shunt, primary pulm HTN, Regional anesthesia CONTRAINDICATED
Group Two
1379
Four findings that suggest DIC:
1. Thrombocytopenia 2. Prolonged PT 3. Prolonged PTT products 4. Decrease Serum fibrinogen, increase Fibrin split
1380
DIC is associate with 3 OB problems:
1. retention of dead fetus 2. Placental abruption 3. AFE
1381
Lab Tests for —: Plasma fibrinogen <150 mg/dL Plasma fibrinogen <50,000/mm3 Thrombin time >100 sec Prothrombin time >100 sec Partial thromboplastin >100 sec Fibrin split products >200 mcg/ml Red blood cell fragment Yes
DIC
1382
Geriatrics: Progressive loss of functional reserve in ALL organ systems 1 % decline each year after — years old
30
1383
Geriatrics: A-A gradient: >/= —
20 (normal 8)
1384
Geriatric System Changes Cardiac: fx declines —% (20-80 y.o)
50
1385
Geriatric System Changes Cardiac: increase, decrease, or no change : left ventricular wall thickness, LVH d/t chronic ↑ afterload, left ventricular wall tension (law of Laplace), afterload, cardiac workload 2nd to ↓ aortic compliance - AC, SBP, PVR, Circulation time, conduction fibrosis, dysrhythmias, SA node cell loss, Vagal tone – d/t ↓ sensitivity of adrenergic receptors, systolic
Increase
1386
Geriatric System Changes Cardiac: increase, decrease, or no change: cardiac reserve, CO –d/t ↑ in AL, CI, HR, left ventricular compliance, chronotropic & inotropic responses, baroreceptor fx, adrenergic sensitivity
Decrease
1387
Geriatric System Changes Cardiac: increase, decrease, or no change: DBP, resting systolic fx, excitation-contraction coupling, ionized Ca levels, contractile proteins, SV
No change
1388
Geriatric System Changes: Respiratory: Obstructive or Restrictive
Restrictive
1389
Geriatric System Changes: Respiratory: increase, decrease, or no change : vocal cord stimulation for closure, airway obstruction, risk of aspiration, pulmonary complications, physiologic dead space, WOB, potential for hypoxia, FRB, Closing volume and Closing capacity, alveolar compliance, resp depression w/opioids, collagen PaCO2-PACO2 gradient d/t V/Q mismatch, VD/VT
Increase
1390
Geriatric System Changes: Respiratory: increase, decrease, or no change: elastin fibers, tissue elasticity, lung recoil, ability to cough, chest wall compliance – kyphosis, VC, ERV, IRV, response to hypoxia & hypercarbia, protective reflexed, cervical spine & TMJ mobility, ease of mask ventilation, PaO2 (0.4mmHg/yr. after 20)
Decrease
1391
Geriatric System Changes: Respiratory: increase, decrease, or no change : PaCO2, PAO2
No change
1392
Geriatric System Changes: Respiratory: CC—FRC @ 44 y.o CC — FRC @ 66yo
= ; >
1393
Geriatric System Changes: Respiratory: Closing volume is —% of VC in the young & —% in the elderly
10 ; 40
1394
Geriatric System Changes: Respiratory: PAO2-PaO2 gradient = equation
0.21 (age +2.5)
1395
Geriatric System Changes: Respiratory: PaO2 = equation
102-Age/3
1396
Geriatric System Changes: Endocrine: increase or decrease : Insulin resistance, heat loss
Increase
1397
Geriatric System Changes: Endocrine: increase or decrease : heat production, hypothalamic temp regulation
Decrease
1398
Geriatric System Changes: GI/Hepatobiliary: increase, decrease, or no change : gastric pH, AAG-1 (↑ binding of basic-LA, opioids)
Increase
1399
Geriatric System Changes: GI/Hepatobiliary: increase, decrease, or no change : liver mass, HBF, liver fx, biotransformation, albumin production, PCHE – MEN, gastric emptying, plasma clearance
Decrease
1400
Geriatric System Changes: GI/Hepatobiliary: increase, decrease, or no change : Hepatocellular fx
No change
1401
Geriatric System Changes: Nervous System: increase, decrease, or no change : skeletal muscle atrophy, degeneration of peripheral nerve cells, Threshold –proprioceptor, hearing, temp thresh, touch thresh, vision thresh, CSF, cerebral cortex neuron loss, SNS
Increase
1402
Geriatric System Changes: Nervous System: increase, decrease, or no change : CBF, intracranial volume, gray matter, brain mass, skeletal muscle steadiness-strength-control, conduction velocity, response to β
Decrease
1403
Geriatric System Changes: Nervous System: increase, decrease, or no change : Auto regulation
No change
1404
Geriatric System Changes: Renal: increase, decrease, or no change: BUN, ADH response to hypertonic saline load (caution w/fluids), ability to develop hyper/hypo kalemia
Increase
1405
Geriatric System Changes: Renal: increase, decrease, or no change: kidney mass, RBF d/t ↓CO (50%), renal plasma flow, GFR, renal fx, muscle mass, creatinine production, fluid handling (prone to fluid overload), Na handling, concentrating ability, response to ADH, response to aldosterone
Decrease
1406
Geriatric System Changes: Renal: increase, decrease, or no change: serum creatinine
No change
1407
Geriatric System Changes: Pharmacology: increase, decrease, or no change: circulation time, body fat, Vd for lipids, recovery of VA
Increase
1408
Geriatric System Changes: Pharmacology: increase, decrease, or no change: muscle mass, body head production, core body temp, basal metabolic requirements, MAC, Total body water, Vd for water soluble drugs, dosing for barbs-- opioid antagonists-- benzos
Decrease
1409
— is most sensitive indicator of renal fx in elderly
Creatine Clearance
1410
Creatine Clearance fx in elderly —ml/min @ y.o
70
1411
Geriatric System Changes: Thermoregulation: > 80 shivering @ — vs. younger pt. at —
35 degrees ; 36.1 degrees
1412
Geriatric System Changes: Pharmacology: increase, decrease, or no change Atropine, Isoproterenol & other Beta agonists
Increase
1413
Geriatric System Changes: Pharmacology: increase, decrease, or no change Thiopental, Propofol, Etomidate, Midazolam, Opioids, remifentanil, pan, vec, roc, succ
Decrease
1414
Decrease opioids and midazolam by —% in elderly pts.
50
1415
Geriatric System Changes: Pharmacology: increase, decrease, or no change: atracurium, neostigmine, Edrophonium
No change
1416
Geriatric System Changes: Pharmacology: — responsiveness secondary to↓receptor affinity & alterations in signal conduction -↓cAMP
Beta receptor
1417
Geriatric System Changes: Preoperative concern: 5
Heart> renal> hepatic > pulm > multi- DM
1418
Geriatric System Changes: postop concern: 2
Heart and lungs
1419
Geriatric System Changes: IV induction = —
SLOWER
1420
Geriatric System Changes: Inhalation Induction= —
FASTER
1421
Geriatric System Changes: Postop Delierum: @ risk: > — yrs, hx of delirium, etoh abuse, narcotic
70
1422
Geriatric System Changes: Postop Delierum: greatest with — procedures.
Orthopedic
1423
Geriatric System Changes: Geriatric & Regional: — Cmin for LA
1424
Geriatric System Changes: Geriatric & Regional: SAB —DOA —Sensory block — Dose
↑ ; ↑ ; ↓
1425
Geriatric System Changes: Geriatric & Regional: Epidural — DOA, — Motor Block, — segment dose, — volume cephalad spread
↓ ; ↓ ; ↓; ↑
1426
Geriatric System Changes: Geriatric & Regional: — for TURPS
T8
1427
Geriatric System Changes: Geriatric & Regional: cysto SAB @ —
T10
1428
Similarities of Neonates to Geriatrics:
1.↓ ability to ↑ HR 2nd to hypovolemia 2.↓ arterial O2 tension 3. impaired ability to cough 4.↓ renal tubular function 5.↑ susceptibility to hypothermia
1429
— (Aka: —): premature aging
Progeria ; Hutchinson-Gilford Syndrome
1430
Progeria (Hutchinson-Gilford Syndrome): average death is — y.o.
13
1431
Progeria (Hutchinson-Gilford Syndrome): Airway effects: 3
mandibular hypoplasia, micrognathia, glottis opening is narrow
1432
Progeria (Hutchinson-Gilford Syndrome): Anesthesia concerns: 2
organ systems fx, positioning
1433
—: Deposition of amyloid beta peptides produces neuritic plaques & neurofibrillary tangles= ↓ NT fx & death of neurons.
Alzheimer’s
1434
Alzheimer’s: The — system and — are most affected.
limbic ; cortex
1435
Alzheimer’s: Tx:
Cholinesterase inhibitors: rivastigmine, donepazil, & Galantamine
1436
Alzheimer’s: Anesthesia/Pharm: -Acetylcholinesterase inhibitors may have a ↑ DOA w/ — -Anticholinergic – Use — is blood brain -May be resistance to — d/t use of acetylcholinesterase inhibiting drugs
succs; glycopyrrolate ; NDMR
1437
Obesity Values: BMI < 18.5 = —
Underweight
1438
Obesity Values: BMI 18.5 -24.9 = —
Normal
1439
Obesity Values: BMI 25-29.9 = —
Overweight
1440
Obesity Values: BMI 40-49.9 = —
Extreme obesity
1441
Obesity Values: BMI 30-39.9 = —
Obesity
1442
Obesity Values: BMI 50-59.9 = —
Superobesity
1443
Obesity Values: BMI 60+ = —
Super super obesity
1444
IBW = equation
ht in cm – 100 (m) or 105 (f)
1445
1 in = — cm
2.54
1446
BMI = equation
kg/m2
1447
BMI > — is cut off for ambulatory surgery center
35- 40
1448
Obesity: cardiac: increase, decrease, or no change: CO, Blood Volume (50ml/kg), incidence of HTN
Increase
1449
Obesity: cardiac: — ♥ effects: polycythemia, pulmonary & systemic vasoconstriction, ↑ risk for ischemic heart dz & cerebrovascular dz, & RHF, cardiomegaly, CHF
OSA
1450
Obesity: cardiac: EKG changes: — ventricular hypertrophy and — atrial enlargement
Left ; left
1451
Obesity: Extra — L/min of CO for each additional kilogram of fat.
0.1
1452
Obesity: Respiratory: increase, decrease, or no change: Diaphragm, O2 consumption, CO2 production, WOB, RR, Hypoxemia
Increase
1453
Obesity: Respiratory: increase, decrease, or no change: ERV, IC, FRC, VC, PaO2, chest wall compliance
Decrease
1454
Obesity: Respiratory: increase, decrease, or no change: PFT’s, lung compliance
No change
1455
Obesity: obstructive or restrictive respiratory?
Restrictive
1456
Obesity: renal: increase, decrease, or no change: GFR renal tubular resorption, impaired Na+ excretion = worse HTN
Increase
1457
Obesity: renal: increase, decrease, or no change: RBF
No change
1458
Obesity: Endocrine: —- activates SNS = Na retention = ↑ HTN
Hyperinsulinemia
1459
Obesity: — single best predictor of difficult airway
Neck circumference
1460
Obesity: ↑ — nerve injury
Brachial plexus
1461
Obesity: Appetite suppressant – — = catecholamine depletion
SSRI’s
1462
Obesity: Regional:— LA dose by 20% secondary to vascular engorgement of the epidural space, the level and onset of an epidural block can be —
↓; unpredictable
1463
Obesity: Pharmacology: — Vd for meds
1464
Obesity: Drugs distributed mainly to lean tissue dosed on — & include: Thiopental, propofol, rocuronium, vecuronium, atracurium, midazolam cisatracurium, fentanyl, sufentanil, & remifentanil
LBW
1465
Obesity: Drugs distributed to lean & adipose dosed on — & include: Succinylcholine and Dexmedetomidine
TBW
1466
Obesity: Hetastarch- 20ml/kg – based on —
IBW
1467
—= males & females, awake PaCO2 > 45 mmHg, doesn't exhibit nocturnal airway obstruction unless concomitant OSA, pulmonary HTN, somnolence, sleep apnea, hypercapnia, & hypoxemia,↓ alveolar ventilation, cyanosis Polycythemia, enlarged heart, hypoxemia – PaO2 < 65mmHg Rales
OSH (pickwickian): Obesity hypoventilation syndrome
1468
—: males > females, normal awake PaCO2 ,sleep induced obstruction, normal paCO2, pH, pulm compliance
OSA: obstructive sleep apnea
1469
—: 1ml of wetting solution per 1ml of fat. >5000 ml – fluid overload concern may promote- hypoxemia, HTN, & pulm edema
Liposuction
1470
—: used to emulsify fat, provide anesthesia, create hemostasis – solution is dilute epi 1:100,000 & lidocaine 0.05- 0.1%
Wetting solution
1471
— is # 1 concern = 25% of liposuction deaths
PE
1472
Positioning: Lateral Position: ↑ risk of —
rhabdo
1473
Ax roll/chest roll – to protect — = relief of pressure from axillary neurovascular bundle & prevent ↓ blood flow to hand
brachial plexus
1474
lithotomy: 5 nerves that may be injured:
Common peroneal (most common), saphenous, sciatic, femoral, obturator
1475
lithotomy: decrease —
FRC
1476
Upright to prone = ↓3
SV, CO, FRC
1477
Supine to prone = ↑ —
FRC
1478
Trendelenberg position — MAP, PCWP, SVR, venous return, CVP, ICP — CI, oxygen delivery, O2 consumption, CO — TLC, VC, FRC
↑ ; ↓ ; ↓
1479
Sitting 90 degrees = — 45 degrees = —
sitting ; beach chair
1480
Lawn chair ↓ — nerve injuries
sciatic
1481
Prone: Large breast = positioning —and —
medial and cephalad
1482
vision loss during prone procedures in — optic neuropathy and central retinal artery occlusion account for 89% of cases of postoperative vision loss in prone
Ischemic
1483
—: Caused because air enters the cranium while the pt. is in a head up position at a time when the volume of intracranial contents has been reduced as a result of some combo of ↓ CO2, good venous drainage, osmotic diuresis, CSF loss from field.
Pneumocephalus
1484
Pneumocephalus: Manifests: delayed — from GA, severe —
emergence ; HA
1485
Bladder perforation Awake- — pain
shoulder
1486
Bladder perforation Anesthetized – —, — or —
tachy, htn or hotn
1487
Total parotidectomy: spares the — nerve
facial
1488
Radical parotidectomy removes the — nerve
facial
1489
— of neck = compression of ipsilateral and/or contralateral vertebral arteries
Hyperextension
1490
Bone Cement: Methylmethacrylate toxicity = sudden —
hotn
1491
— = MOA – transient fat/air embolism from bone marrow or causes vasodilatation & ↓ SVR
Methylmethacrylate toxicity
1492
Radial prostectomy - complications: #1 is — and — nerve injury can happen
Hemorrhage ; obturator
1493
8 causes of rhabdomyolysis
1. Major crush injury 2. thermal/electrical injury 3. Acute muscle ischemia d/t arterial occlusion 4. Acute muscle injury 2nd prolonged immobilization 5. Compartment syndromes 6. MH 7. Extreme lithotomy 8. Hyperlordotic position
1494
6 Congenital syndromes associated with difficult intubation:
1.Downs 4. Pierre Robin 2. Goldenhar 5. Treacher Collins 3. klippel-fiel 6. Turner
1495
—: Overwhelming generalization septic cellulites of submandibular region. Usually after dental procedures. S/S: chills, fever, drooling, ability to open mouth, difficulty speaking.
Ludwig’s Angina
1496
Ludwig’s Angina : Caused by hemolytic —.
streptococci
1497
Ludwig’s Angina: Airway management: preliminary — using LA in awake patient = Safest
tracheotomy
1498
Contraindications for Cricothyrotomy: 2
Children < 6 years old Laryngeal fractures
1499
—: Severe jaw limitation
Scleroderma
1500
Scleroderma: Decreased — = difficult ventilation
compliance
1501
Scleroderma: — hypoxia secondary to decreased diffusion of O2 across alveoli
Arterial
1502
Scleroderma: No RSI – — intubation with head up position= safer
awake
1503
Mouth opening – —mm -- — fingerbreadths
40 ; 2
1504
Thyroidmental distance - > — cm normal < —= difficult airway
6.5 ; 6
1505
ETOH – what kinda of 3 electrolytes
Hypomagnesium, hypokalemia, metabolic alkalosis
1506
Medications to Hold before surgery: 2
Oral Glycemic & Diuretics
1507
Postoperative — complications: with thoracic and upper Abdominal surgery = highest risk.
pulmonary
1508
Post op complications: — in the PACU: hypoventilation & ↑ R to L intrapulmonary shunting secondary to ↓ — (#1)
Hypoxia ; FRC
1509
Post op complication: — secondary to #1- Hypovolemia
HoTn
1510
Post op complication: — 2nd #1 Pain
HTN
1511
#1 Postoperative Complication – —
PONV
1512
High risk PONV = 10
children, women, previous hx, hx of motion sickness, anxiety, abd, gyn , laparoscopic, opioids, surgical duration
1513
Carotid Endarterectomy: PaCO2 — mmHg – Avoid ↓ CO2 → —
35-45 ; vasoconstriction
1514
Carotid Endarterectomy: Stump pressure transmitted pressure through the —, < — = shunting
circle of willis ; 50
1515
Carotid Endarterectomy: Avoid —
hyperglycemia
1516
Carotid Endarterectomy: Post-operative HTN = bc —
carotid sinus baroreceptors
1517
Carotid Endarterectomy: Causes of morbidity & mortality #1- — & #2-—
MI ; Stroke
1518
Carotid Endarterectomy: Nerves: Smile: — nerve, say "EEE": — & — nerves, shrug shoulders: — nerve, swallow: — nerve, stick his tongue out: — nerve
facial ; superior and recurrent laryngeal ; spinal accessory ; glossopharyngeal ; hypoglossal
1519
6 brainstem reflexes absent in brain death:
1. Pupillary response to light 2. Corneal reflex 3. Oculocephalic reflex (dolls eyes) 4. Oculovestibular reflex (caloric response) 5. Gag & cough reflex 6. Facial motor response
1520
Goals of anesthetic management of organ donors: *Maintain — 1. SBP > — 2. PO2 > — 3. Urine Output > —ml/hr 4. Hbg concentration —g/L 5. CVP — 6. FiO2 < —% (if tolerated) 7. Glucose < —mg/dl 8. Peak airway pressures < —
euvolemia ; 100mmHg ; 100mmHg ; 100ml/hr ; 100g/L ; 5-10mmHg ; 40% ; 200 ; 30mmHg
1521
Absolute contraindications for transplants: —
active infection
1522
Transplant: Intraoperative renal considerations: 1. SBP > — 2. MAP > — 3. CVP > —
90mmHg ; 60mmHg ; 10mmHg
1523
Liver Transplant Severe — – THAM – trishydroxymethl
acidosis
1524
Pneumoperitoneum: Hemodynamic Δ’s: 3
↑SVR&MAP,↓CI
1525
Eye Surgeries Normal IOP: —mmHg based on rate of aqueous humor formation & rate of aqueous humor outflow
10-22
1526
IOP ↑ with — IOP ↓ with —
hypercarbia ; hypocarbia
1527
—: cardio effects of ocular meds, oculocardiac reflex, MH, PONV
Strabismus
1528
—- the single most effective means to increase PaO2 w/OLV
CPAP
1529
OLV: —- non-dependent lung 5-10cm H2O
CPAP
1530
OLV: —- dependent lung 5-10cm H2O
PEEP
1531
OLV: Other actions: 2
periodically inflate collapsed lung, ligate PA
1532
OLV: Greatest risk = —
hypoxemia
1533
Inhibition of HPV: 6
1. Hypocapnia 2. Vasodilators 3.VA 4. High or low pulmonary artery pressure 5. High or low mixed venous partial pressures 6. Pulmonary infections
1534
TRAM: Avoid —&— during abd closure
vasopressors and N2O
1535
—: Surgical procedure where a mediastinoscope is inserted into the mediastinal space in order to view and biopsy lymph nodes.
Mediastinoscopy
1536
Mediastinoscopy: Monitors: Art-line & pulse ox - — BP cuff – —
Right ; Left
1537
Mediastinoscopy: The most common reason for doing this —
bronchogenic carcinoma
1538
Mediastinoscopy: Compression: innominate or Right —
brachiocephalic
1539
Mediastinoscopy: Complications: #1- — & #2 — tearing of great vessels, chylothorax,bronchospasm from airway manipulation, air embolism, arrhythmias, & esophageal laceration.
hemorrhage ; pneumothorax
1540
—: Hypotension, tachycardia, cutaneous hyperemia, and hypoxia are signs caused by the release of vasoactive amines (principally prostacyclin) from the vascular bed of the mesentery. As a result, serum prostaglandin levels increase substantially
Mesenteric Traction Syndrome
1541
Mesenteric Traction Syndrome: Tx: 4
H1 & H2, Ketorolac, Neo
1542
Tourniquet Inflated: Arm —mmHg > SBP (—) Leg —mmHg > SBP (—)
50 (250mmHg) ; 100 (300mmHg)
1543
Tourniquet: Tourniquet times should not exceed —
1.5 to 2 hours
1544
Tourniquet: —CVP & SBP — HR, ETCO2, PaCO2, serum K, & serum lactate
↓ ; ↑
1545
Restrictive Lung Disease Extrinsic: 7
pectus carinatum, pectus excavatum, kyphosis, scoliosis, and flail chest as well as obesity, neuromuscular disorders
1546
Restrictive Lung Disease Intrinsic: —
Sarcoidosis
1547
Bowel Obstruction: — should never be administered to a patient suffering from a bowel obstruction due to the possibility of perforation from its prokinetic effects
metoclopramide
1548
—: projects to the medial thalamic nuclei - associated with autonomic & emotional responses to pain.
Paleospinothalamic tract (medial spinothalamic tract)
1549
— possesses fibers that ascend to the lateral cervical nucleus and then cross to the contralateral thalamus.
spinocervical tract
1550
— projects to the midbrain reticular formation and may generate nondiscriminatory pain sensations
spinomesencephalic tract
1551
—: and sends fibers to the posterior nuclei of the thalamus- location and intensity of pain.
Neospinothalamic tract (lateral spinothalamic tract)
1552
— burn: consists of erythema w/ only microscopic damage to the superficial epidermis.
First-degree
1553
— burn: (partial thickness), extend through the epidermis into the dermis. Spontaneous regeneration of the skin is possible
Second degree
1554
— burn: total destruction of the skin, dermal appendages, & epithelial elements occurs with no spontaneous regeneration of the skin possible.
Third-degree
1555
— burn: involve muscle, fascia, and bone
Fourth-degree
1556
Burns: Fluids: first 24 hours is = equation
% body surface area X Kg X 2 to 4. (hct)
1557
Rule of Nines: adults:
each arm 9%, each leg 18%, the entire trunk is 36%, head 9%, perineum 1%.
1558
Burns; Hct & viscosity: — significantly
1559
Burns: UO: Adults —ml/kg/hr < 30kg peds —ml/kg/hr
0.5 ; 1
1560
Burns: Anesthesia: OR —C
28-30
1561
Burns: most heat loss from burns = —
evaporation
1562
Burns: Resistant to — d/t ↑ # of cholinergic nicotinic receptors
NDMB
1563
Most common cause of trauma coagulopathy = —
Dilutional thrombocytopenia
1564
Cardiogenic shock: —PAOP >15mmHg, —CI, —SVR
↑ ; ↓ ; ↑
1565
Hypovolemic shock: —PAOP, — CI, — or—SVR
↓ ; nml ; nml/↑
1566
Autonomic Hyperreflexia: 65-80% ↑— (unlikely below —)
T7 ; T10
1567
—: Triggering stimuli: bladder, or bowel distention, heat/cold, uterine contractions, pyelonephritis
Autonomic Hyperreflexia
1568
Autonomic Hyperreflexia: S/S: Hallmark – —&—
HTN & reflex bradycarda
1569
Autonomic Hyperreflexia: — level of injury – SNS activation = vasoconstriction & HTN
Below
1570
Autonomic Hyperreflexia: — level of injury- SNS blockade = vasodilatation
Above
1571
— block for pancreatic cancer = most effective ; Blocked with alcohol or phenol
Celiac plexus block
1572
— nerve block = relief from cluster headaches
Greater occipital
1573
— fibers from the head are carried within the trigeminal, facial, glossopharyngeal, and vagus nerves.
Pain
1574
— are the most common multipurpose coanalgesic used for cancer pain
Corticosteroids
1575
Post-operative shivering medications: 4
1. Clonidine 2. Physostigmine 3. Serotonin antagonists 4. Propofol
1576
— = large voltage applied to skin/tissue
Macroshock
1577
— = small voltage/current directly to the ♥
Microshock
1578
V-fib caused by — microamp-micro or — milliamp- macro
50 ; 100-2500
1579
Grounded in OR: 3
Power supply, Patient, The floor
1580
Units & Measurements PO2 = —
760mmHg
1581
Units & Measurements 1mmHg= —cm H2O
1.36cmH2O
1582
Units & Measurements 1atm = —mmHg=— psi = — kPa = — bar
760 ; 14.7 ; 101 ; 1
1583
CO2 Absorber -Baralyme = 80% Ca(OH)2 + 20% Ba(OH)2 (no silica) -—L of CO2/100g
10.2L
1584
CO2 Absorber -Soda Lime = 94% Ca(OH)2 + 5% NaOH + 1% KOH -—L of CO2/100g
-26L
1585
E cylinder: O2 = — Liters, — psi
660L ; 2200 psi
1586
E cylinder: Air = — Liters, — psi
625L ; 1800 psi
1587
E cylinder: N2O = — Liters, — psi
1590L ; 750 psi
1588
Law of Laplace T=equation
P x r
1589
When N2O < 745 psi= no more — & ~ —L of N2O remains
liquid ; 400L
1590
—- Quick connectors indexed for specific gas- SAFETY & is a check Valve- Wall Hose to machine – pressor of 40-50psig
DISS
1591
— value on back of gas machine at pressure of 1380 kPa (200 psi) or less. Closes if cylinder pressure is on & pipeline pressure is off.
free floating value
1592
O2 pin index — & N2O is —
2,5 ; 3,5
1593
1st stage regulator- —psig (intermediate)
40-50
1594
2nd stage regulator- 40-50 to — psig
16
1595
O2 Flush Valve- —L/min, —psig (intermediate)
35-75 ; 40-50
1596
Pressure Sensor Shut-Off Valve: (only senses PRESSURE) Senses O2@ 50 psig, shuts of N2O if O2 pressure falls O2 pressure @ —psig to keep open
25
1597
Components of the High Pressure system of AM : > 55psig (4)
1.hanger yoke 2. yoke block w/ check valves (free floating) 3. cylinder pressure gauge 4. cylinder pressure regulators
1598
Components of intermediate pressure system of AM: 40-50 psig (6)
1. Ventilator power inlet 2. pipeline inlets, check valves, pressure gauges 3. flow meter valves 4. oxygen pressure- failure devices 5. oxygen second stage regulators 6. flush valve
1599
Components of the low-pressure system of AM: 16 psig (4)
1. flow meter tube 2. vaporizers 3. check valves 4. CGO
1600
—: dual circuit, gas vapor blender, 39C & pressurized to 2 atmospheres (1300mmHg) @ high elevation – need to ↑ concentration to raise PP
Tec 6 vaporizer
1601
Oxygen supply failure alarm: Sets off an alarm if the oxygen pressure falls below a standard set by the manufacturer typically —psig. Must engage within —seconds of the disconnect and cannot be disabled by the anesthetist.
30 ; 5
1602
—: Prevent hypoxia from lack of oxygen flow, but does not prevent the flow of anesthesia gases (still possibly allow a hypoxic mixture of gases to be delivered).
Oxygen supply failure alarm
1603
—: An intermittent back pressure caused by positive pressure ventilation or use of the oxygen flush valve results in ↑ vaporizer output. (not happening on newer machines)
Pumping Effect
1604
Pumping Effect: —: flows, vapor dial settings, levels of anesthetic in vaporizer
Low
1605
Pumping Effect: —: RR & PIP
High
1606
Tipping of the vaporizer = — agent to the patient
most
1607
— System- no mask on the face ie. NC
Open
1608
— system: mask on face- no rebreathing = ↑ FGF
Semi-Open
1609
— system: mask on face- some rebreathing w/ regular flows
Semi-Closed
1610
— system: Mask on Face: - complete rebreathing APL closed & low flows (150-500ml/min physiological requirements)
Closed
1611
Mapleson Systems: Prevention of rebreathing – spont ventilation: —> DFE > —
A ; CB
1612
Mapleson Systems: Prevention of rebreathing Controlled vent: — > BC > —
DFE ; A
1613
All Mapleson can ventilate the — patient
Apneic
1614
Mapleson — modified = Bain → best for controlled vent
D
1615
Mapleson — only one w/o reservoir bag
E
1616
Mapleson — = Jackson Reese - peds d/t ↓ WOB but heat loss
F
1617
Forced Air Warmer: Maximum temp —C Average contact —C
48 C ; 46 C
1618
Blood Salvage Contraindications: 5
1. Infection 2. malignant cells 3. Urine 4. bowel contents 5. Amniotic fluid
1619
Blood Salvage Contraindications: 5
1. Infection 2. malignant cells 3. Urine 4. bowel contents 5. Amniotic fluid
1620
Pacemaker Chamber — A,V,D Chamber — A,V,D — – Inhibit, Trigger, Double, O-none
paced ; sensed ; Response
1621
Pulse Oximetry: — law
Beer Lambert
1622
Pulse Oximetry: Fx w/ 2 wavelengths: Red light —nm – — Hbg Infrared light —nm- — Hbg
660 nm ; Deoxygenated ; 940nm ; Oxygenate
1623
— are one of the last places to showing desat (central first)
Fingers
1624
Changes in Pulse Oximetry False —: Caboxyhemoglobin & methemoglobin, severe anemia, SpO2 < 85%
High
1625
Changes in Pulse Oximetry False —: Methylene blue, prominent venous pulsations, injection (if dyes- indigo carmine, lymphazurin, nitrobenzene, indocyamine green, patent blue)
Low
1626
5 monitors that can detect disconnection:
1.pulse oximetry 2. mass spectrometer 3. capnography 4. stethoscope 5. spirometer
1627
Mass Spectrophy: Gases analyzed: —,—,—&— (Not —)
CO2, O2, N2 & inhaled agents ; PaO2
1628
Mass Spectrophy: — is ionized by an electron beam and passed through a magnetic field.
Gas sampled
1629
Mass Spectrophy: —: measures gas concentrations by analyzing the intensity of light emitted when a gas sample returns to an unexcited state after being energized by a laser beam
Raman
1630
Mass Spectrophy: —: they detect gases based on the amount of this light that is absorbed by the sample- can not detect oxygen content Most popular in the OR & based on beer lambert
Infrared
1631
Mass Spectrophy: — drug= high false measurements
Isoproterenol
1632
TOF – —Hz – — twitches per — second or — every — seconds
2Hz ; 2/1sec ; 1/.5
1633
Tetany- — seconds @ —Hz
5 ; 50Hz
1634
DBS- — trains of — impulses @ —Hz – separated by 750 ms
2 ; 3 ; 50Hz
1635
—- best to determine fade
DBS
1636
Post Tetanic- —Hz x — seconds – — second pause – stim @ —Hz
50Hz ; 5sec ; 3sec ; 1Hz
1637
# of visible post tetanic twitches correlates — to time required for return of single twin or train-of-four responses
inversely
1638
— nerve = adductor pollicis- —
Ulnar ; abdomen
1639
— nerve = orbicularis oculi – —
Facial ; laryngx
1640
Twitches: 1. one visible twitch = —% blockade G 2. two visible twitch= —% blockade 3. three visible twitches= —% 4. four visible twitches = <—%
95 ; 80-85 ; 75-80 ; 75
1641
— – based on HYPNOSIS
BIS
1642
BIS: —- Awake
100
1643
BIS: —- Light/Moderate Sedation
90-70
1644
BIS: —- Deep sedation (low probablility of recall)
70-60
1645
BIS: —- general anesthesia
60-40
1646
BIS: —- deep hypnotic state
40-10
1647
BIS: —- flat line EEG
10-0
1648
BIS: < — reflect burst suppression.
40
1649
BIS: — can be produced by: Output from cardiac pacemakers, muscle activity such as twitching, shivering, or blinking, incorrect electrode placement, & high frequency electrical devices such as IV pumps and warming devices can all produce artifact.
Artifact
1650
BIS: — waves may occasionally be seen during anesthetic maintenance and emergence.
Paradoxical delta waves
1651
Blood Pressure Cuffs: —% of arms circumference
40
1652
Blood Pressure Cuffs: — if cuff: too loose, too small, or positioned below the level of the heart
Overestimation
1653
Pacemakers Most common indications = —&—
SSS & complete ♥ block
1654
Pacemakers: ID codes 1st = chamber — 2nd= chamber — -- eletrocautery affects 3rd= — to sensing 4th= programmability — modulation 5th= fx
paced ; sensed ; response ; rate ; antitachyarrythmic
1655
Pacemakers: ID codes: —= eletrocautery affects
2nd
1656
Pacemakers: ID codes: AICD affects which letters?
4th and 5th
1657
Pacemakers: — can inhibit the pulse generator d/t fasiculations
Succs
1658
Pacemakers: Avoid — if implanted within 1-2 days ago
nitrous
1659
Magnet —- converts to a fixed rate (asynchronous) mode
Pacer
1660
Magnet —- disables it – loud continuous high pitch sound
AICD
1661
—: destroys most microorganisms- except SPORES
Disinfection
1662
—: all viable forms of microbial life – yes to spores
Sterilization
1663
7 —: quaternary ammonium, alcohols, glutaraldehydes (Cidex), hydrogen-peroxide, formaldehyde, phenolic compounds, chlorine ( bleach)
chemical disinfectants
1664
—- for objects that can’t be heated in steam autoclave
Ethylene oxide
1665
Glutaraldehyde (Cidex) & hydrogen peroxide = — destruct
SPORES
1666
Quaternary ammoniums – WILL NOT kill —
tuberculosis
1667
Lasers can be both long (—) and short (—) wavelengths.
CO2laser ; YAG laser
1668
— laser risks: Thermal injury, eye injuries, electrical hazards, fire, transmission of viruses, and contaminants in the smoke plume
Major
1669
Nd-YAG laser – OD(optical density) 5 or > for 1,064 nm/—
Green
1670
—: Laser vaporization of condylomatous lesions d/t release toxic chemicals: benzene & formaldehyde as well as viable viruses capable of transmitting the disease
N-95 respirator mask
1671
Gas Laws mnemonic:
“Can These Girls Possibly Be Virgins”
1672
Boyle = equation
P1V1 = P2V2
1673
Charles = equation
V1/T1 = V2/T2
1674
Gay-Lussac = equation
P1/T1 = P2/T2
1675
— = 1 mole of gas @ STP = 22.4 Liters
Avogadro’s Hypothesis
1676
Avogadro’s Number: — = 1 mole
6.023 X 10^23
1677
1 mole = 00 = 1 atm = 760 mmHg = —L
22.4L
1678
Gases liquefy if: 2
(1) sufficient pressure is applied and (2) temperature is below critical temperature
1679
critical temperature: N2O = —C O2 = —C
39.5C ; -119C
1680
—: (P1 –P2) (Area) (Solubility)/ (Membrane thickness) (square root Molecular Weight)
Fick Diffusion
1681
Fick Diffusion: the — is the most important factor in determining the rate of diffusion of a drug across a membrane
concentration gradient
1682
% Concentration = equation
(Partial Pressure/Atm) X 100
1683
Partial Pressure = equation
(% Concentration X Atm)/100
1684
Partial Pressure H2O @ 370 C = —mm Hg
47
1685
Laminar Flow: —Law
Poiseuilles
1686
Poiseuilles Law = equation
F=πr4ΔP/8nl Flow F= flow, r = radius, n= viscosity, l= length
1687
Poiseuilles : Doubling the radius = — the flow
16x
1688
Tripling the radius = — the flow
81x
1689
Angle < — degrees = laminar flow
25
1690
— #- turbulent flow
Reynolds
1691
— Reynolds # = turbulent flow
>1,500-2000
1692
— determines flow when turbulent flow present
Density (p)
1693
—: Flow through constricted region of the tube = ↑ Flow & corresponding ↓ in pressure in area of narrowing
Venturi/Bernoulli
1694
—: Law of mass action
LeChatelier’s
1695
LeChatelier’s: ↑ concentration of reactant→ reaction to — products
1696
LeChatelier’s: Law of mass action ↑ concentration of reactant→ reaction to — reactant (— products)
↑ ; ↓
1697
—: Calculation of dissolved O2 & CO2 in blood
Henry’s Law
1698
—: Total pressure in a mixture is = to the sum of pressures of each gas
Dalton’s Law of Partial Pressure
1699
Dalton’s Law of Partial Pressure: of O2, N2, and total
O2: 160mmHg (21%) N2: 600mmHg (79%) Total: 760mmHg
1700
—: A cylinder cools and condenses after opening a valve – Joule is cool
Joule-Thompson
1701
—: The intensity of light is altered as transmitted through liquid. The intensity of the light falls exponentially as light passes through the liquid.
Beer Law
1702
Law of Laplace; T= equation
P x r – cylindrically shaped structures thus ↑T = ↑ r
1703
Law of Laplace: Applies to: 2
blood vessels, left ventricle (Frank-Starling)
1704
Law of Laplace: Applies to alveoli – ARDS equation T=
(P x r) /2 -- spherically- shaped structures thus ↑r = ↑ T, ↓r = ↑ P
1705
Humidification Relative Humidity (%) =
(actual vapor pressure/Saturated vapor pressure) x 100
1706
Humidification: ↓ T = — capacity to hold H2O → H2O condenses
1707
— Law: SVR
Ohms
1708
—: Solubility of a gas in a fluid
Ostwald Solubility Coefficient
1709
Ostwald Solubility Coefficient: -Amount of gas in solution is — proportion to temp -—= ↑ solubility of VA in blood & tissue
inversely ; Hypothermia
1710
—: Non-ideal gas behavior
Van Der Wals
1711
—: Distance from source = amount of exposure
Inverse Square Law
1712
Fires in OR: Components needed for Fire: —,—&—
fuel, oxygen & ignition source
1713
Fires in OR: Steps if fire occurs: 6
1. Stop ventilation 2. Stop O2 Flow 3. Extubate patient 4. Extinguish the fire 5. Mask ventilate 6. Reintubate
1714
—→ formed the AANA in 1931
Agatha Hodgins
1715
— → 'Mother of Anesthesia
Alice Magaw
1716
— → first LA
Cocaine
1717
—= an order by a court to force a party to commence some required action.
A writ of mandamus
1718
—= refers to the doctrine of common law in which courts adhere to the prior decisions of other courts.
Stare decisis
1719
—= (the thing speaks for itself) refers to an event that would not have occurred 'but for actions of the defendant'.
Res ipsa loquitor
1720
— = Civil Wrongdoing
Tort
1721
— = Failure to use reasonable care, which is that level of care recognized as acceptable and appropriate given the circumstances.
Negligence
1722
—= is a lawsuit to recover goods improperly taken by another.
Replevin
1723
—= intentionally causing harmful or offensive contact with a person or to something close to them
Battery
1724
—= intentionally causing the apprehension of an immediate and harmful contact
Assault
1725
Four Elements of Malpractice:
1.Duty- prove defendant had a duty to the plaintiff 2.Breach of Duty- prove defendant failed to fulfill duty to defedant 3. Causation - reasonably close relationship proven to exist between breach of duty by defendant and the injury that resulted 4.Damages - prove some injury occurred due to the breach in duty
1726
Informed Consent Includes: 4
1. Risks 2. Benefits 3. Complications 4. Alternatives
1727
—: defines compressed gas standard
Department of Transportation
1728
—: sets specification for compressed gas cylinder construction
Interstate Commerce Commission
1729
—: defines compressed gas standard
Federal Food, Drug & Cosmetic Act
1730
—: develops purity standards for gases
United States Pharmacopeia
1731
—: recommendations for the construction and location of BULK oxygen containers
National Fire Prevention Association
1732
—: sets standards of practice
Compressed Gas Association
1733
—: performance & safety requirements for components of the AM, ETT, connectors,vacuum & gas pressure regulators
American National Standards Institute (ANSI)
1734
—: promulgates standards for medical devices and gases
Food and Drug Administration
1735
—: voluntary accrediting agency
Joint Commission
1736
—: assess technology & revises standards
American Society for Testing Materials (ASTM)
1737
—: standards to protect the health & safety of workers
National Institute of Occupational Safety & Health
1738
—: When researchers, on the basis of a statistical test, erroneously concludethat there is evidence of an association between two variables when, in fact, there is not
Type I error
1739
—: When researchers, on the basis of a statistical test, erroneously conclude that there is evidence of no association between two variables when, in fact there is
Type II error
1740
Acute hypoparathyroidism & hypocalcemia usually presents w/in —hrs following surgery
24-96
1741
Hypoalbuminemia, hypomagnesemia, hyperphosphatemia, vitamin D deficiency, PTH deficiency, pancreatitis, RF, massive blood transfusions, burns, & sepsis are all causes of —.
hypocalcemia
1742
Factor — is the only clotting factor that decreases w/ pregnancy.
XI
1743
— is active myocardial relaxation
Lusitropy
1744
— or contractility
Inotropy
1745
— is a genetic condition affecting a protein in the body called the fibroblast growth factor receptor. This protein begins to function abnormally, slowing down the growth of bone in the cartilage of the growth plate.
Achondroplasia
1746
— syndrome is a disorder of your immune system identified by its two most common symptoms, dry eyes & a dry mouth. The condition often accompanies other immune system disorders, such as rheumatoid arthritis & lupus.
Sjogren's
1747
— are the MOST SENSITIVE to anesthetic technique & are rarely ever used.
Visual evoked potentials (VEP)
1748
The evoked potentials in order from least to most sensitive to anesthetic technique are:
BAEP < SSEP < MEP < VEP. Another way to remember: BAEP=Barely affected, SSEP=Somewhat affected, MEP=Mostly affected, & VEP=Very affected.
1749
ASA —-A normal healthy pt. (Healthy, non-smoker
1
1750
ASA —-A pt w/ mild systemic disease w/o functional limitation. (Smoker, Pregnancy, Controlled Diabetes)
2
1751
ASA —-A pt w/ severe systemic disease. (Morbid obesity, ESRD with regular dialysis)
3
1752
ASA —-A pt w/ severe systemic disease, constant threat to life. (Recent (< 3mths) TIA or MI, ESRD not on regular dialysis)
4
1753
ASA —-A moribund pt who is not expected to survive w/o the operation (Massive trauma, ICH with mass effect)
5
1754
ASA —-A declared brain-dead pt whose organs are being removed for donor purposes.
6
1755
— are associated w/ leukocytosis, increased Hb, hyperglycemia, hypokalemia, mild hypernatremia, alkalosis, increased urinary uric acid, & increased urinary Ca+.
Corticosteroids
1756
— act on the kidney to stimulate reabsorption of Na+ & excretion of K+ & H+ ions resulting in normal/slightly high plasma Na+, hypokalemia, & alkalosis (not causing uric acid & urinary Ca+).
Mineralocorticoids
1757
— can result in decreased O2 delivery to the tissues through an impairment in the production of 2,3-diphosphoglycerate. Decreased ATP production will also tend to cause diaphragmatic weakness &, in severe cases, cardiac failure. Other sequelae include hemolytic anemia, neurologic deficits, seizure, & eventual death.
Hypophosphatemia
1758
— is characterized by adrenal gland dysfunction manifesting as fatigue, weakness, anorexia, N&V, cutaneous mucosal hyperpigmentation, hypovolemia, hyponatremia, hyperkalemia, HoTN, & metabolic acidosis.
Primary adrenal insufficiency (Addison disease)
1759
During prolonged fasting the brain uses — bodies as an alternate source of energy. The other organs use —.
ketone ; fatty acids
1760
— syndrome is due to an excess secretion of serotonin into the systemic circulation. Diagnosis made by measuring 24hr urinary levels of 5-HIAA.
Carcinoid syndrome
1761
The primary pathophysiology of MH is an uncontrolled release of — by the — that causes a profound hypermetabolic state.
Ca+ ; sarcoplasmic reticulum
1762
— may be used as a 1st-line vasopressor for neurogenic diabetes insipidus following TBI.
Vasopressin
1763
W/ morphine 10mg IV as the standard potency of “1”: — 1/8th as potent, — 8-10x as potent, — & — 100x as potent, — 1000x as potent, & — 10x as potent.
meperidine ; hydromorphone ; fentanyl & remi ; sufent ; alfent
1764
Verapamil & diltiazem are the — & watch for —
Ca+ channel blockers ; hyperkalemia
1765
— is a mast cell stabilizer that works to prevent the release of histamine, leukotriens, & other allergic mediators by preventing degranulation of mast cells.
Cromolyn Na+
1766
— is an inhaled steroid useful in the prevention of attacks, & prednisone may be taken orally for the same purpose.
Fluticasone
1767
— is a leukotriene modifier.
Montelukast
1768
— is a long acting beta agonist that should be administered only w/ a rapid acting beta agonist inhaler available, as it has been linked w/ severe asthma attacks.
Salmeterol
1769
Beta blockers that begin w/ letters after “—” are non-selective (— is an exception).
N ; labetalol
1770
— is a degenerative disease caused by a loss of dopaminergic neurons in the substantia nigra along w/ the presence of Lewy bodies.
Parkinson’s disease
1771
— is a drug administered for Parkinson’s instead of dopamine, as dopamine cannot cross the —.
Levodopa ; BBB
1772
— must be avoided as they worsen symptoms of Parkinson’s
Antidopaminergic drugs (metoclopramide & prochlorperazine)
1773
demyelination & axon degeneration is —.
multiple sclerosis
1774
The inherited autosomal dominant neurodegenerative disorder is — disease.
Huntington’s
1775
immune response directed towards myelin or peripheral axons is —.
Guillain Barre
1776
All — can cause spasm of the sphincter of Oddi & can lead to biliary colic when the gallbladder contracts against a closed sphincter
opioids
1777
spasm of the sphincter of Oddi can be treated w/: 4
naloxone/other opioid antagonist, glucagon 1-2mg IV, nitroglycerin or atropine.
1778
Pancuronium & hydralazine both cause an — in HR
increase
1779
— syndrome may be heralded by sudden onset of refractory bradycardia, HLD, metabolic acidosis, hyperkalemia, RF, & rhabdomyolysis. >4 mg/kg/hr or 67 mcg/kg/min, long term propofol therapy, defined as >48hrs
Propofol infusion
1780
— are contraindicated in decompensated HF pts & in the presence of AV conduction blocks greater than 1st degree.
Beta adrenergic antagonists
1781
— is a potent antiHTN that also increases renal perfusion.
Fenoldopam
1782
— is a non-selective beta blocker that is useful to treat HTN, anxiety disorders, & Grave’s disease/hyperthyroidism.
Propranolol
1783
— is a thyroid hormone replacement for pts w/ hypothyroidism.
Levothyroxin
1784
— is used in the treatment of Grave’s disease & hyperthyroidism.
Propylthiouracil (PTU)
1785
Using — can cause suppression of the hypothalamic-pituitary-adrenal axis (HPA).
exogenous glucocorticoids (prednisone)
1786
— is the most likely neuromuscular blockade agent to cause an allergic reaction of muscle relaxants.
Succ
1787
— treatment of SVT & rapid rate a-fib due to its ability to block the Ca+ channels of the AV node.
Diltiazem (benzothiazepine Ca+ channel blocker)
1788
ACE-I typically cause —kalemia
Hyper
1789
— is broken down by Erythrocyte Esterase hence its short DoA. Anemic pts can experience a prolonged effect.
Esmolol
1790
— for the treatment of carcinoid syndrome
octreotide
1791
— is an opioid that blocks the neuronal re-uptake of serotonin in combo w/ MAOIs. This has lead to serotonin syndrome & caused seizures & deaths in pts when these are combined.
Meperidine
1792
Treatment for beta blocker OD: 4
atropine, glucose & insulin, glucagon, Ca+ chloride
1793
Liver failure decreases amount of acetylcholine that is being produced by the liver, thus — NDMB.
prolonging
1794
— should be avoided in pts w/ sepsis. Adverse outcomes have been reported w/ its use in pts likely due to suppression of adrenal cortisol production.
Etomidate
1795
— agonists (Spinal) provide for analgesia & also provide some of the negative side effects of opioids, including ventilatory depression, physical dependence, & constipation.
Mu2
1796
— receptors activated by intrinsic endorphins & exogenous opioids.
Mu
1797
Reversal of GP IIb/IIIa inhibitors (abciximab) can be accomplished w/ — transfusion, but is less effective w/ the smaller molecules of tirofiban.
plt
1798
— is a selective phosphodiesterase inhibitor that decreases hydrolysis of cyclic AMP & cyclic GMP, leading to increased intracellular cAMP & cGMP. This increases inward movement of Ca+ ions, causing positive inotropic effects & relaxation of vascular & airway smooth muscles. It is thus a positive inotrope & preload & afterload reducer.
Amrinone (inamrinone)
1799
— works upon the activation of beta 2 receptors after inhalation of the aerosolized drug. Beta 2 receptor activation causes relaxation of the bronchial smooth muscles through activating adenylate cyclase & thus increasing cAMP.
Albuterol
1800
Drugs that can be administered through the ETT:
NAVEL or ALIEN V: A – atropine, L – lidocaine, I – Isoproteronol, E – epinephirine, N – naloxone, V – Valium (diazepam).
1801
— work to strongly inhibit factor Xa (traditional heparin effects antithrombin III & inhibits Xa).
Enoxaprin & other LMW heparin
1802
— is an alpha 1 agonist only at all doses.
Phenylephrine
1803
Dobutamine has only — effects
beta 1
1804
isoproterenol has — only
beta 1 & beta 2 agonisim
1805
Dopamine: Doses —mcg/kg/min activate dopamine 1 receptors which produces renal dilation (once believed helpful to pts needing renal protection but evidence does not support the usefulness of dopamine for this). Doses —mcg/kg/min beta 1 receptors are activated. Doses —mcg/kg/min to greater concentrations alpha receptors are activated causing vasoconstriction.
1-3 ; 3-10 ; 10
1806
75% of initial dosage of fentanyl is removed from circulation on the first pass through the —, & repeated doses of fentanyl may cause saturation of the pulmonary sites leading to a prolonged DoA.
lungs
1807
Ventilatory depression is not seen with activation of — opioid receptor activation.
Mu1
1808
Remifent has the advantage of providing a rapid & dense analgesic response (w/in —min), w/ an equally quick termination of action in —min.
1-3 ; 3-10
1809
— disease should not receive droperidol as it antagonizes dopamine receptors. Droperidol can cause extrapyramidal symptoms.
Parkinson’s
1810
one of the greatest challenges in treating the pt on tricyclic antidepressants is the unpredictability of the patient’s —.
BP
1811
— blocks ADP receptors on the surface of platelets, inhibiting platelet activation and aggregation.
Clopidogrel
1812
— is a phenylalkylamine Ca+ channel blocker that blocks slow Ca+ channels of vascular smooth muscle & myocardium, greatly slowing conduction through the AV node. It also has negative chronotropic effects on the SA node (decreasing HR) & is a negative inotrope on cardiac muscle. It also relaxes the coronary vasculature & causes coronary vasodilation. used to treat supraventricular dysrhythmias such as SVT but should be avoided in pts with WPW syndrome.
Verapamil
1813
— should be avoided in pts with WPW syndrome.
Verapamil
1814
— should be avoided to decrease the chances of iatrogenic seizures. Morphine-3-glucuronide also has proconvulsant properties as a metabolite of morphine, but is not listed as a choice here. Morphine-6-glucuronide is the active pain relieving molecule derivitive of morphine.
Meperidine (Demerol)
1815
— acts by decreasing hepatic production of glucose by decreasing gluconeogenesis through increasing hepatic sensitivity to insulin–thus it only works in the presence of insulin. It does NOT cause hypoglycemia.
Metformin
1816
— NDMR is known to increase HR, MAP, & CO. SVR is not changed to a great degree. It produces a slight blockade at cardiac muscarinic receptors, inhibiting parasympathetic activity allowing for an increase in HR.
Pancuronium
1817
A — in SVR may be seen w/ giving midazolam
decrease
1818
Alfentanil is — metabolized extensively
heptically
1819
Most anesthesia providers will use — mA as the goal of optimal position for nerve blocks
0.5
1820
—, a derivative of PABA (para-aminobenzoic acid) & a popular preservative used in multi-dose LA, & is most commonly implicated in anaphylactic reactions from LA adminstration.
Methylparaben
1821
LA w/ the highest amount of — binding have the longest anesthetic duration.
protein
1822
—,—,—,— have high levels of protein binding & are long-acting LA.
Bupivicaine, Etidocaine, Ropivcaine & Tetracaine (BERT likes protein)
1823
— fibers are preganglionic sympathetic neurons located at the outer most area of the nerve root. These fibers are small & myelinated.
B
1824
Sympathetic — fibers are attenuated 1st so the sympathectomy is the 1st sign of the LA starting to work.
B
1825
The — fibers are small & unmyelinated while the — fibers are also small but myelinated.
C ; A-delta
1826
— and — fibers are involved in transmitting pain, temp, & touch w/ a subset of the — fibers, the — fibers, transmitting for various autonomic functions since they are postganglionic sympathetic neurons.
C & A-delta ; C ; sC
1827
The large myelinated fibers —,—&—. These fibers are motor efferents involved in muscle movement, propioception, touch & pressure.
A-gamma, A-alpha & A-beta
1828
— are the abnormal sensation of the skin (tingling, prickling, numbness, or burning) that has no objective cause.
Paresthesias
1829
—&— are 2 LA that can cause methemoglobinemia.
Prilocaine & benzocaine
1830
—: These pts are most often middle age females, but people of a broad spectrum of ages & genders have been diagnosed. Pts may complain of “fibro-fog,” a feeling of impaired concentration & memory problems, & to pain sensitivity. Times of emotional stress seem to bring on exacerbations, & exercise & antidepressants have been proven helpful to many pts w/ this condition.
fibromyalgia
1831
— was the 1st FDA approved med for fibromyalgia. Other meds: —,—&—
Pregabalin (Lyrica) ; SSRI (citalopram) & SNRI (duloxetine) are useful, tricyclic antidepressants (amitriptyline).
1832
Absolute contraindications to neuraxial anesthesia: 7
infxn at site of injection, severe mitral or aortic stenosis, severe hypovolemia, increased ICP, bleeding diathesis, coagulopathy, or pt refusal
1833
Relative contraindications: 4
sepsis, severe scoliosis or kyphosis, demyelinating lesions, & valvular heart lesions
1834
— means painful response to a typically non-painful stimulus. Seen in: migraines, cluster headaches, postherpetic neuralgia, complex regional pain syndrome, neuropathies & fibromyalgia.
Allodynia
1835
Morphine is more likely to spread to — than fentanyl.
CNS
1836
Due to its antagonism, — exhibits a “ceiling effect” & doses >30mg don’t produce further respiratory depression if no other depressants are present.
nalbuphine
1837
Unlike atracurium, — doesn’t cause elevations in plasma histamine levels which may lead to urticaria.
cis-atracurium
1838
— is still one of the most common meds to be implicated in OD & death, w/ its main area of destruction being the liver hence the high AST & ALT levels.
Acetaminophen
1839
For elective surgery, warfarin should be discontinued at least —days prior to procedure if normal INR is desired.
5dys
1840
— acts to inhibit the release of acetylcholine, & — decreases the release even more. It also competitively inhibits Ca+ influx into the presynaptic nerve channels at the Ca+ channel. Other drugs such as Ca+ antagonists also can interfere w/ neurotransmitter release.
Mg+ ; hypermagnesemia
1841
4mg of — is equivalent to 20mg of cortisol or 0.75mg of dexamethasone.
methylprednisolone
1842
—&— steroids both have characteristically low Na+ retaining abilities while providing adequate anti-inflammatory potency.
Methylprednisolone & prednisone
1843
— steroid has no Na+ retaining ability & potent anti-inflammatory properties.
Dexamethasone
1844
—&— steroids can be useful for a variety of inflammatory & immune conditions.
Both dexamethasone & methylprednisolone
1845
All — cause an increased incidence of potential dangerous CV incidents which may include HF, MI, & stroke.
steroids
1846
—: the risk of dyskinesia is elevated due to the presence of Parkinson’s disease & is best avoided
Promethazine (Phenergan)
1847
— is a delayed dyskinesia due to prolonged use of drug.
tardive dyskinesia
1848
— (drooping eyes) & — (double vision) are often the earliest & most commonly seen signs in MG
Ptosis ; diplopia
1849
treatment of — is largely supportive, w/ particular attention to respiratory support. Autonomic dysfunction occurs in up to 70%, w/ tachycardia being the most common reported finding. These pts also need to have proper bowel & bladder care taken, & DVT prophylaxis should be undertaken w/ low molecular weight or unfractionated heparin.
Guillain-Barre
1850
CMRO2 averages — mL/100g/min in adults.
3.5
1851
Cerebral blood flow avg — mL/100g/min in peds (avg — mL/min in the adult pt).
50 ; 750
1852
Cerebral blood flow is regulated b/n — mL/100g/min.
10-300
1853
MG commonly affects — gender more.
females
1854
Volatiles should be limited when evoked potentials are being conducted since they affect the amplitude (—) & latency (—) (below 0.5 MAC recommended).
decrease ; increase
1855
Opioids have — on CMR or ICP.
no net effect
1856
Volatiles — CMR & — ICP.
decrease ; increase
1857
Nitrous — CMR & — ICP, but not as much as volatiles do.
decreases ; increases
1858
Barbiturates profoundly — CMR & ICP w/ etomidate closely following suit.
decrease
1859
CSF is produced at around — ml/hr, or approximately 0.3 cc/min.
20
1860
The CSF is produced by the — in the lateral, third, & fourth ventricles. It circulates in the brain in the subarachnoid space.
choroid plexus
1861
The normal CSF volume is — ml.
125 ml
1862
Profound hypoxemia below tensions of 50mmHg will produce a significant — in CBF.
increase
1863
Pts w/ Lambert-Eaton syndrome will have — sensitivity to succ & — sensitivity to NDMB.
increased ; increased
1864
— is a condition resulting in impaired renal Na+ reabsorption in the proximal tubules leading to excessive urinary Na+ excretion. This leads to hyponatremia & a solute mediated diuresis of free water. The result is hyponatremia combined w/ hypovolemia. Can be caused by many CNS conditions & pathology including (Brain tumor, Tertiary syphilis, Meningiococcal Meningitis, Central nervous system surgery).
Cerebral Salt Wasting
1865
— has had positive effects on pts w/ vasospasm after subarachnoid hemorrhage
Nimodipine
1866
—% of CO in adults is taken as cerebral blood flow.
20
1867
Intracranial HTN is defined as a sustained increase in ICP >— mmHg
15
1868
— is an autoimmune disease in which IgG antibodies act against the voltage-gated Ca+ channels to interfere w/ Ca+ influx required to release acetylcholine at the motor end plate.
Myasthenic syndrome (Lambert-Eaton syndrome)
1869
Vasospasm after subarachnoid hemorrhage usually doesn’’t occur for — after the initial bleed
72hrs to upwards of 2wks
1870
Cerebral blood flow — by approximately 3% or 1-2 cc/100g/min for every 1 mmHg decrease in PaCO2.
decreases
1871
CPP is normally between — mmHg.
80-100
1872
At — mL/100g/min an isoelectric wave is produced, & below — mL/100g/min is irreversible brain damage. <—ml/100g/min, there is slowing of the EEG demonstrating cerebral impairment.
15-20 ; 10 ; 25
1873
Anticonvulsants (anti-epileptics) cross placenta & responsible for a — risk of birth defects when taken during pregnancy.
high
1874
CO will eventually increase to —% greater than that of a nonpregnant female.
50
1875
Terbutaline is a — agonist. Terbutaline’s — effects cause increases in cAMP levels leading to decreases in intracellular Ca+, causing the desired uterine smooth muscle relaxation. Side effects: HoTN, tachycardia, anxiety, chest tightening/pain, ECG changes, hyperglycemia, hypokalemia, & pulmonary edema. It is relatively contraindicated in pts w/ CAD & RF.
beta 1 & beta 2 ; beta 2
1876
Infants delivered to mothers on — may develop hypoglycemia secondary to hyperinsulinemia, & infants may also develop tachycardia & MI.
terbutaline
1877
HELLP stands for: —.
Hemolysis, Elevated Liver enzymes, & Low Platelets (less than 100,000/mm3)
1878
—is a prostaglandin E1 analogue that can be useful to decrease uterine hemorrhage by increasing uterine tone.
Misoprostol (Cytotec)
1879
Mg+ — acetylcholine at neuromuscular junction
decreases
1880
indomethacin (NSAIDs) — prostaglandin synthesis.
inhibit
1881
Beta adrenergic blocking drugs have — role in tocolysis
no
1882
Pain in the 1st stage of labor should be relieved by — epidural blockade & is — pain.
T10-L1 ; visceral
1883
The 2nd stage of labor adds — fibers of the birth canal entering at —.
somatic ; S2-S4
1884
in the infants of hyperglycemic/poorly controlled diabetics mothers, -Congenital — lesions are increased (Transient subaortic stenosis due to ventricular septal hypertrophy) -vertebral, skeletal, renal, & CNS anomalies. -—is common & may be related to placental insufficiency & fetal hypoxia common to reduced O2 delivery. -—, a birth weight >4000 gm, increases risk of Erb’s palsy or phrenic nerve palsy due to shoulder dystocia. -—may be seen -—is caused by delay in the normal rise of PTH.
cardiac ; Polycythemia ; Macrosomia ; Jaundice ; Hypocalcemia
1885
—&— are peptides activated in response to increased ventricular volumes & pressures.
BNP & ANP
1886
Increased oxytocin levels causes release of —. -released in increased amounts w/ fluid loading, as done prior to administration of neuraxial anesthesia. -decrease vasospasm seen in uteroplacental circulation & provide benefit in uteroplacental perfusion. -promotes dilation of the vessels & excretion of Na+ by the kidneys.
ANP
1887
— produces selective afferent arteriolar vasodilation & inhibits Na+ reabsorption in proximal convoluted tubule, but is not released by oxytocin–elevated. -seen in pts w/ CHF among other causes. Risk factors associated w/ nausea in spinal anesthesia includes a block height of T5 or greater, omission of neuraxial opioids, & a hx of motion sickness.
BNP
1888
— is seen in infants of poorly controlled diabetic mothers, — is most often seen in macrosomic infants; & respiratory — secondary to immature fetal lungs-fetal lungs are immature as high levels of insulin block lung maturation.
Macrosomia ; hypoglycemia ; distress ;
1889
—,—,&— is considered safe to use during pregnancy to treat BP.
Labetalol, Hydralazine & methyldopa
1890
The period of greatest susceptibility to teratogenic agents is from —wks after conception
2-8wks
1891
— (highest risk of malformations if taken while pregnant) (carbamazepine, phenobarbital, phenytoin, & valproic acid): neural tube defects & dysmorphic facial features, Cleft lip & palate, congenital heart disease.
Anticonvulsants
1892
The grouping of orofacial, CV, & digital malformations is called fetal — syndrome.
anticonvulsant
1893
— causes kid higher chance to have spina bifida at a rate of around 1-2%.
Valproic acid
1894
— may increase the risk of cleft palate in 1st trimester exposure
Benzodiazepines
1895
—&— depressants meds are thought to be safe.
Tricyclic antidepressants & SSRIs
1896
— b/n 6-9wks gestation, can result in fetal — syndrome. It consists of nasal hypoplasia, mental retardation, growth restriction, & a depressed nasal bridge. It is not safe in any trimester, adverse effects in the 2nd & 3rd trimesters can result in microcephaly, deafness, blindness, & growth restrictions.
Warfarin
1897
— doesn’t cross placenta & is the drug of choice for pregnant females requiring anticoagulation.
Heparin
1898
— doesn’t cross placenta, but is cleared more rapidly in pregnancy than in non-gravid patients & dosing may need adjusting. Twice daily dosing should be considered.
Low molecular weight heparin
1899
— antiHTN were shown to cause fetal renal dysplasia & oligohydramnios.
ACE inhibitors
1900
If steroids are to be used, — is the drug of choice as only a small amount cross the placenta. — readily crosses the placenta & may be used as an aid to accelerate fetal lung maturity.
prednisone ; Dexamethasone
1901
For nausea —,—&— are all considered safe during pregnancy.
promethazine, metoclopramide, & ondansetron
1902
—&— Abx are safe for use during pregnancy.
Penicillins & cephalosporins
1903
The — are probably safe the 2nd trimester, but must be avoided the 3rd trimester due to risk of neonatal pulmonary HTN & other negative outcomes, many recommend avoiding all pregnancy.
NSAIDs
1904
During the 2nd stage of labor variable decelerations are the result of —.
compression of the fetal head
1905
In the 1st stage of labor, variable decelerations are caused by —.
umbilical cord occlusion
1906
— can cause fetus HR variability that is minimal (<5 BPM) to marked (>25 BPM). Variable decelerations are considered severe when they last >60sec or drop 60 BPM below the baseline rate. A healthy fetus can tolerate HR drops into the 80s in some cases
Hypoxia
1907
The 1st trimester is considered the most risky due to the — that takes place during this period (3-8wks).
organogenesis
1908
Due to lack of studies, risk can’t be ruled out in category — drugs.
C
1909
Category — drugs are ones that controlled studies have shown no risk.
A
1910
Category — drugs show no evidence of human fetal risks. These are typically animal reproduction studies w/o performing controlled studies in pregnant women.
B
1911
Fetal abnormalities have been clearly demonstrated w/ administration of category — drugs, & these drugs shouldn’t be given in any pregnancy situation.
X
1912
In Category — Evidence of human fetal risk exists, but the benefits may outweigh the risk in the pregnant woman (gentamycin, phenobarbital, ACE inhibitors (ACEIs are category C in 1st trimester only), & thiazide diuretics).
D
1913
Amniotic fluid embolism resembles — shock.
anaphylactic
1914
Amniotic fluid embolism: The — phase is caused an intense but temporary pulmonary vasospasm secondary to vasoactive mediators being released. This causes severe pulmonary HTN & right HF w/ sudden cardiopulmonary collapse. This collapse leads to the hypoxemia, cyanosis, & HoTN seen in these pts. Severe anxiety or a sense of impending doom may be seen early on as well. In some cases, the right HF will resolve & this phase generally lasts <1hr.
1st
1915
Amniotic fluid embolism: The — phase shows a left HF & pulmonary edema. It is a hemorrhagic phase with massive hemorrhage, uterine atony, & coagulopathies or DIC.
2nd
1916
Amniotic fluid embolism is diagnosed based on 4 criteria:
1) acute HoTN or cardiac arrest 2) acute hypoxia 3) coagulopathy or severe hemorrhage in the absence of other explanation 4) occuring during labor, c-section, or w/in 30min postpartum.
1917
Amniotic fluid embolism coagulopathy should be treated w/ 3:
1. FFP for prolonged PTT 2. cryoprecipitate for fibrinogen levels <100 mg/dL 3. plt transfusions certainly for plt counts <20,000/uL
1918
The detrusor muscle is responsible for micturation & urine storage, & is innervated by the sacral roots —.
2-4
1919
Chest compressions are indicated if HR falls <— after 30sec of assisted ventilation, & should be ceased if the HR >—BPM
60 ; 60BPM
1920
—: # of pregnancies a woman has had.
Graviditiy
1921
—: # of pregnancies beyond 20wks gestation.
Parity
1922
Abortions is the # of pregnancies that ended prior to —wks gestation.
20wks
1923
Preterm pregnancies are deliveries between —wks.
20-36
1924
The format used for reporting pregnancies is GPPAL:
G = Gravida P = Para , followed by Preterm pregnancies, Abortions, & # of Living children.
1925
Rh immune globulin (RhoGAM) should be given to Rh negative mothers w/ Rh positive fetuses w/in —hr of delivery or abortion. This only protects for the D antigen of the Rh system & not any other of the possible blood system antigens.
72hr
1926
Chronic untreated hyperglycemia from mom can cause fetal — is frequently due to reduced CO or hypovolemia.
bradycardia
1927
— symptoms are characterized by slight to severe pain in buttocks & legs, & can develop w/in a few hrs up to 24hrs after the spinal anesthetic is administered. It lasts at most 2dys. Lidocaine is more likely to cause this than bupivacaine, prilocaine, & procaine.
TNS
1928
suggested therapy is — ml/kg of 20% intralipid as an initial bolus for any pt suffering from significant LA toxicity, followed by — ml/kg for 30-60min.
1.5 ; 0.25
1929
— cause the relaxation of uterine muscle, & are used to prevent or delay preterm delivery. As the administration of steroids to the mother can decrease the incidence & severity of fetal lung immaturity & respiratory distress, these are frequently used to delay delivery until steroids have had at least some time to work
Tocolytics
1930
— should be avoided in these pts that labor pts who are abusing heroin bc they are relatively contraindicated as they can precipitate a withdrawal syndrome.
Mixed opioid agonist/antagonists (nalbuphine)
1931
4 functional stages of labor.
1st stage occurs b/n the onset of labor & full cervical dilation (10cm). This includes 2 phases, the latent phase (cervical effacement & early dilation) & the active phase (begins around 4cm, more rapid cervical dilation). 2nd stage of labor encompasses complete cervical dilation through delivery of the infant. 3rd stage begins immediately after delivery of the infant & ends with delivery of the placenta. 4th stage is the immediate postpartum period of 2hrs after deliver of the placenta, when the patient undergoes significant physiologic adjustment.
1932
The root cause of increased airway edema is due to an increased level of — & increased circulating —.
estrogen ; blood volume.
1933
A lack of fetal alcohol dehydrogenase prevents alcohol from being properly metabolised in the unborn infant, contributing to the development of —.
fetal alcohol syndrome.
1934
The pregnant female at term requires smaller doses of LA than a nonpregnant female due to —.
venous engorgement.
1935
Normally the fetus has a — pH than the mother.
lower
1936
—: The lower fetal pH allows basic drugs (lidocaine) to cross the placenta in their non-ionized state, mostly by diffusion. Once in the fetal circulation, the non-ionized weakly basic drug (lidocaine or other LA) will become — in the lower pH fetus.
Ion Trapping ; ionized
1937
A normal vaginal delivery & the period immediately afterwards typically sees blood loss of around —ml while a C-section typically results in —ml blood loss.
600mL ; 1000ml
1938
— prevent Ca+ entry into muscle cells by blocking voltage-dependent cell membrane channels that are selective for Ca+, decreasing uterine muscle tone & providing for —.
Ca+ channel blockers (nifedipine) ; tocolysis
1939
—: the most common side effects in pregnancy are HoTN, headache, & flushing. Adverse effects: possible decreases in uteroplacental blood flow, fetal hypoxia, pulmonary edema & MI. Short term use doesn’t seem to cause the decrease in uteroplacental blood flow or negatively effect fetal oxygenation.
Nifedipine
1940
Ca+ channel blockers may also — side effects of Mg+ sulfate.
potentiate
1941
Uterine blood flow increases greatly during pregnancy, from the baseline of 50-100 ml/min before pregnancy to ~700-900 ml/min at term. The increase in uterine blood flow is achieved by a — in uterine vascular resistance.
decrease
1942
Increased circulating — causes up to a 40% decreased MAC requirement during pregnancy as well as a decreased requirement for LA used in neuraxial blockade.
progesterone
1943
Propofol requirements are — during pregnancy.
unchanged
1944
Greater levels of circulating — act as a respiratory stimulant & increases CO2 receptor sensitivity. alveolar dead space is decreased. These factors combined w/ an increase in total body CO2 production cause an increase in resting minute ventilation. This leads to faster uptake of inhaled anesthetics lowering MAC requirements.
progesterone
1945
Increased circulating blood volume will — the duration of other meds (thiopental) as the increased volume lowers clearance of the drug.
increase
1946
Sensitivity to LA is — lowering doses required by about 25% in the term pregnant pt compared to non-pregnant pt.
increased
1947
Mg+ sulfate competes with Ca+ entry into the cells, — intracellular Ca+. It also — release of acetylcholine at the neuromuscular junction, reduces sensitivity of end plate to acetylcholine, & decreases excitability of muscle membrane. Side effects: flushing & headaches, & pts on Mg+ may appear sedate.
decreasing ; decreases
1948
Therapeutic Mg+ levels b/n 6-8 mg/dL, but these levels do not correlate well to adequate — for every pt. Mg+ levels should be titrated to desired results & side effects. At high blood levels Mg+ may cause respiratory depression (12-15 mg/dL) or cardiac depression (> 15 mg/dL).
tocolysis
1949
Mg+ is contraindicated in pts with — or —, & is renally excreted (pts w/ RF should receive very cautiously).
hypocalcemia or MG ;
1950
— presynaptically decrease sympathetic output from the CNS.
Alpha 2 agonists (clonidine)
1951
There is a 40% increase of CO by the end of the — trimester, & CO continues to rise through the 2nd trimester. It will eventually increase to —% greater than that of a nonpregnant female.
1st ; 50
1952
The greatest increase in — is seen just after delivery of the fetus when there is up to an 80% increase in CO.
SV
1953
Terbutaline is a — agonist w/ — effects, being more selective for — effects. This drug works by increasing cAMP, & is not commonly used in modern medicine due to significant side effects. Plus, the use of this adrenergic agents has not been associated w/ a decrease in overall perinatal morbidity & mortality resulting from preterm labor & birth.
beta ; beta 1 & beta 2 ; beta 2
1954
—: main undesired side effects seen are maternal HoTN, tachycardia, pulmonary edema, hyperglycemia, hypokalemia, & other side effects. Glucose levels rise rapidly after start of beta-adrenergic therapy secondary to glycogenolysis, & fall w/in 24hrs of cessation. Hypokalemia is seen as increased levels of insulin causes greater transport of K+ & glucose into the cell, but there is no “loss of K+” & treatment is not necessary. Fetal side effects include increased fetal HR & neonatal hypoglycemia (secondary to maternal hyperinsulinemia secondary to maternal hyperglycemia), but no long-term fetal effects have been noted.
Terbutaline
1955
Apgar scores are taken at —&— & continue every 5min until either 2 scores of 8 are obtained OR 20min time has elapsed.
1min & 5min
1956
Apgar scores of — indicate an infant that requires no active resuscitation, & — show a mildly to mod depressed infant. Scores of — shows a severely depressed infant & requires immediate resuscitation.
7-10 ; 4-7 ; <4
1957
—: a woman who is currently in labor
parturient
1958
—: a woman who has just recently given birth
puerpera
1959
—: a woman who is in or who has just experienced her 1st pregnancy
primagravida
1960
—: a woman who has delivered 1 pregnancy that progressed beyond the gestational age of an abortion.
primapara
1961
An infant who weighs <—g at birth is considered a low birth weight infant regardless of gestational age. An infant who weighs <—g at birth is considered a very low birth weight infant. <—g at birth is an extremely low birth weight infant.
2500g ; 1500g ; 1000g
1962
During pregnancy, — levels & clotting factors (—,—,—,—,—) are all increased leading to a hypercoagulable state.
fibrinogen ; VII, VIII, IX, X, & XII
1963
The axillary roll, placed just —, is designed to take the weight off the upper thorax & place it on the chest rather than the axilla itself. This decreases the likelihood of injury to the —.
caudad to the axilla ; brachial plexus
1964
Pressure alopecia may occur where a pts hair falls out secondary to pressure on the head when a pt is —
supine
1965
Overextension of the neck has not been associated w/ — injuries.
brachial plexus
1966
Most inhalation agents decrease cerebral metabolic O2 requirements, — increases them. Like the other inhaled agents, nitrous oxide also — ICP through increases in cerebral blood flow & cerebral blood volume.
nitrous oxide ; increases
1967
Sevoflurane, isoflurane, & desflurane will — blood flow through the hepatic artery to varying degrees.
increase
1968
Increasing CO would — be of benefit sevo increasing level
not
1969
During pregnancy, —,—,— decrease, while —&— increase.
Plt levels, albumin levels, & Hb levels ; white cell counts & blood volume
1970
Hypothermic pts, on alpha 2 agonists, elderly, acutely alcohol intoxicated, pregnant pts, IV or neuraxial opioids, lidocaine, & pts w/ hyponatremia have — MAC requirements.
decreased
1971
From least to most metabolized of the volatile anesthetic agents is —,—,—,—,—.
nitrous oxide, des, iso, sevo, & halothane
1972
—&— are considered least irritating of inhaled anesthetics making them the recommended choices for inhaled inductions.
Halothane & sevo
1973
Irritating Volatile Anesthetics =
DIE = Desflurane, Iso & Enflurane
1974
— is by far the most potent trigger of MH of the volatile agents.
Halothane
1975
— is a respiratory depressant, decreasing pts hypoxic drive, but its effects are < other volatile anesthetics.
Nitrous oxide
1976
Nitrous oxide causes the — amount of overall CV change in an otherwise healthy, euvolemic pt. As nitrous oxide releases catecholamines to cause sympathetic stimulation, the net result of CO, BP, & HR is a largely — overall cardiac function. This is despite nitrous oxide causing a — in cardiac contraction.
least ; unchanged ; decrease
1977
MAC requirements by age from highest to lowest MAC concentration needs: 5
infant, neonate, children, adults, geriatrics.
1978
All volatile anesthetics produce a dose dependent — in the ventilatory response to hypercarbia & hypoxemia.
depression
1979
Isoflurane will cause an increase in serum fluoride levels but does not lead to — even after prolonged exposure. Halothane does decrease GFR & overall renal blood flow, but not — does not occur due to its use – the decrease is likely due to the myocardial depressant activity of halothane with a fall in CO.
nephrotoxicity ; nephrotoxicity
1980
Nonsmoking pts administered — will not have a great change in airway pressures or resistance. Smoking pts may see a transient increase in airway resistance that is typically mild.
desflurane
1981
—,—,— w/ poor or no vascularization makes up the vessel poor group.
Bones, cartilage, & other connective tissue
1982
The vessel rich group receives —% of the total CO & is the 1st group to take up the most volatile anesthetic agent. This is followed by the muscle group & then the fat group.
75
1983
— is best avoided in pts w/ hepatic pathology. It is the greatest metabolized inhalational agent w/ ~20% being metabolized by the liver. It decreases CO to the greatest degree & causes decreased coronary blood flow as the output falls.
Halothane
1984
Although — is a pungent, irritating agent that is ill-suited for inhalational induction, it is an effective bronchodilator.
isoflurane
1985
— is best avoided due to the possibility of causing or worsening anemia.
Nitrous oxide
1986
The mechanism of anemia & neurological changes is that — converts vitamin B12 (cobalamin) from the active form to the inactive form, leading to a megaloblastic (in this case B12 deficient) anemia. As vitamin B12 is a coenzyme of methionine synthase (& methionine synthase is required to develop DNA and RNA), symptoms such as paresthesias & other neurological findings may occur w/ it. Anemia & neurological symptoms are known to be caused by it when used for long durations or when it is used by pts w/ low amounts of B12 stores (elderly or chronically malnourished). While there are many causes of megaloblastic anemia & neuropathies, it induced causes are of particular concern to anesthesia bc they are causes that we directly affect.
nitrous oxide
1987
— abuse or overuse can also lead to other problems related to low serum B12, including myeloneuropathies causing paresthesias & motor dysfunction. Bone marrow depression & aplastic anemia have also been reported, usually related to long term use at high concentrations. Other related problems :neurological deficits, including dizziness, inability to concentrate, & possible negative reproductive effects.
nitrous oxide
1988
— should be avoided in pts w/ CAD or renal disease, but not necessarily in pts w/ a primary anemia (ie. not caused by RF).
Ketorolac
1989
— should be avoided in diabetics but not in anemics.
Dexamethasone
1990
—&— cause the least decrease in RBF.
Sevoflurane & desflurane
1991
—,—&— cause the greatest degree of RBF reduction.
Halothane, isoflurane, & nitrous oxide
1992
All inhaled agents cause a — in hepatic blood flow as well.
decrease
1993
Young pts, chronic alcohol abusers, & those acutely intoxicated w/ cocaine or methamphetamine have — MAC requirements.
increased
1994
Chronic methamphetamine abusers, people on barbs or benzos, those acutely intoxicated w/ alcohol, & hypothermics all will have — MAC requirements.
decreased
1995
Thyroid disorders — effect MAC requirements.
do not
1996
Nitrous oxide — provide skeletal muscle relaxation.
does not
1997
Nitrous oxide & all volatile anesthetics do — skeletal muscle blockade caused by depolarizing & non-depolarizing drugs.
potentiate
1998
All of the currently used inhaled anesthetic agents — tidal volume & — RR. Cerebral blood flow is also — in all of the inhaled agents & renal blood flow is — in all agents as well.
decrease ; increase ; increase ; decreased
1999
Induction of anesthesia produces 15-20% reduction in —.
FRC
2000
The hyoid bone is felt at level of — & used as attachment muscles of floor of mouth, tongue, larynx, epiglottis, & pharynx.
C3
2001
— inhalational agent should be avoided in pts w/ long QT syndrome. Likely a dose-dependent prolongation of QT interval.
Sevo
2002
—has the least impact on HR of all volatile anesthetics.
Sevo
2003
— is not a very stable chemical compound, & as such it is stored in amber colored bottles & contains a thymol preservative (to prevent degradation by light).
Halothane
2004
—causes least vasodilation. — causes most vasodilation, then —&— vasodilate about same extent.
Halothane ; Iso ; des & sevo
2005
The muscle group receives —% of CO. The vessel rich group receives —% of CO. The fat group receives —% of CO.
20 ; 75 ; 5
2006
— has some sympathomimetic properties & causes a slight increase or no change in CO.
Nitrous oxide
2007
— may cause a decrease in HT along w/ CO as it blunts the normal increased HR response seen with a decrease in SVR.
Halothane
2008
— may increase HR, & — does as well as volatile agent.
Des ; iso
2009
External intercostal muscles can help augment —, & during labored breathing sterncoleidomastoid, pectoralis & scalene muscles also contribute to — effort.
inspiration ; inspiration
2010
— dyspnea is a condition where a pt develops sudden severe shortness of breath & panic, often awakening the pt from sleep. may occur when a failing LV is being supplied by an adequately pumping RV, leading to sudden right sided HF & pulmonary congestion.
Paroxysmal nocturnal
2011
—: where the pt has shortness of breath sitting up which is relieved by lying down.
Platypnea
2012
—: is the term used to describe shortness of breath when laying flat.
Orthopnea
2013
The trachea begins at the — cervical vertebrae in the adult. The level of the cricoid cartilage begins just below — & continues to — level.
6th ; C6 ; C7
2014
During inspiration, unless it is max, the vocal cords will be found in positions in b/n —&—.
paramedian & lateral
2015
Gas exchange begins at generation — (terminal bronchioles).
17
2016
The avg adult minute ventilation in an adult pt is —L/min. Minute ventilation is measured as: Minute ventilation = RR x TV.
5-8
2017
The — muscle is the only laryngeal muscle that is innervated by the external branch of the superior laryngeal nerve. The function of this system is to tense the muscle to control phonation & pitch.
cricothyroid
2018
One of the biggest issues w/ single lung ventilation is the iatrogenic — that occur, meaning that oxygenated blood from the ventilated, dependent lung, mixes w/ blood from the non-dependent, non-ventilated blood causing lowered FiO2 values. Even with 100% Fi02 PaO2 values may be lower than 80% in about 25% of the population, & <60mmHg in about 10% of pts under the best anesthetic management. Although increased FiO2 requirements are problematic, they are expected in nearly all cases due to the complex changes that occur in pulmonary blood flow & ventilation during these procedures. Right ventricular preload is not generally a major issue due directly to the one lung ventilation, & increased peak airway pressures are also expected in these cases by definition.
right to left shunt
2019
A single abnormal pulmonary function test — contraindicate surgery.
does not
2020
The — nerve is responsible for bronchoconstriction & increased bronchial secretions via muscarinic cholinergic receptors. As this nerve is responsible for bronchoconstriction, anticholinergic drugs (inhaled ipratropium bromide) can be used to block cholinergic mediated bronchoconstriction. Other anticholinergics (atropine & glycopyrrolate) are used to block the mediated bronchial secretions.
vagus
2021
The avg adult airway contains ~— alveoli in the adult. This compares to — alveoli in the newborn. The alveoli are the primary units of gas exchange, & mark the very end of the respiratory tree.
300 million ; 20-50 million
2022
Vital capacity is —mL/kg in a healthy adult pt.
60-70
2023
The — nerves supply the cricothyroid muscles, causing tension of the vocal cords.
superior laryngeal
2024
The hypopharynx is innervated by the superior laryngeal nerve, a branch of the — nerve. The hypopharynx includes the area of the pharynx from the hyoid bone down to the cricoid cartilage.
vagus
2025
Pulmonary embolism leads to a — pulmonary edema. This pulmonary edema is seen as fluid in the alveolar sacs that is not caused by a cardiogenic process.
non-cardiogenic
2026
ARDS is a major cause of — pulmonary edema, & has causes including transfusion-related acute lung injury (TRALI), pulmonary embolism, opioid overdose, eclampsia, & sepsis. SARS also causes a — pulmonary edema, as can high altitudes & neurologic injury that causes significant catecholamine release.
noncardiogenic ; noncardiogenic
2027
Alcohol intoxication, cocaine overdose, myocarditis, & mitral & aortic regurgitation can lead to — pulmonary edema.
cardiogenic
2028
—: located in the interstitial alveolar tissue & supplied by the vagus nerve are responsible for responding to edema & swelling of the tissues. Besides responding to pulmonary edema, these receptors also respond to pulmonary microemboli, overinflation of the lungs, & pneumonia & anything else that causes stretching of the alveoli. When these receptors are stimulated, inspiration is prematurely terminated which results in more rapid & shallow breathing & an increase in minute ventilation.
Juxtacapillary receptors (or “stretch receptors”)
2029
— position of vocal cords is found when a pt has received paralytic or during rest. This position is also found during end expiration.
Paramedian or cadaveric
2030
Type — pneumocytes produce surfactant which is required to reduce surface tension in the alveoli & preventing the alveoli from collapsing during expiration. Pulmonary cells are differentiated during development, & by 25wks These are beginning to produce enough surfactant for the fetus to survive outside of the body. This is not enough surfactant however to prevent infant respiratory distress syndrome, & it is not until the mid 30wks that adequate surfactant is produced to provide more ideal pulmonary function after delivery.
2
2031
Type — pneumocytes are tight junction cells that prevent passage of materials into the alveolar sacs.
1
2032
— are glial cells in the brain that help provide support to various brain cells & help control the cerebral physiological environment.
Astrocytes
2033
— cells are found in the dermis & are antigen presenting cells with functions similar to macrophages.
Langerhans
2034
— cells are made up of a variety of subtypes in the pancreas.
Islet
2035
The more commonly referred to cells are — cells which secrete insulin, — cells which secrete glucagon, & — cells which secrete somatostatin.
beta ; alpha ; delta
2036
The avg adult trachea is —cm in length.
10-15
2037
Thoracic roots — provide sympathetic activation which leads to bronchodilation & decreased secretions via beta 2 receptors agonism.
T1-T4
2038
The respiratory bronchioles are where gas exchange starts & corresponds to generation — in the airway.
17
2039
Nitrous oxide is — at room temperature.
liquid
2040
Cirrhotic pts produce increased levels of nitric oxide which cause chronic —, — vascular resistance, & — CO. Bc of this they may be chronically HoTN.
vasodilation ; decreased ; increase
2041
— is the most common sign of pulmonary embolism occurring in up to 70% of affected pts. —&— are the next most commonly found objective signs. Acute onset of — is the most commonly elicited historical component occurring in up to 75% of pts. Keep in mind that the s/s of PE are non-specific & rarely can be diagnosed by history & physical exam alone.
Tachypnea ; Rales & tachycardia ; dyspnea
2042
Remember that —&— are not helpful in excluding or diagnosing PE as they are frequently normal.
ABG readings & pulse ox
2043
— is used in the treatment of hyperkalemia however but it does not directly reduce serum K+ concentrations. It has been shown to stabilize the cardiac membrane to the arrhythmogenic effects of the elevated K+ concentrations allowing more time for treatment prior to arrhythmia development.
Ca+ gluconate
2044
All that reduce K+ serum levels: 4
bicarbonate, Stimulation of sympathetic beta receptors, insulin, kayexalate
2045
Plasma osmolality is a measurement of ions in the blood & is normally — mOsm.
280
2046
Oculocardiac reflex, also known as trigeminocardiac reflex, is a decrease in pulse rate or new onset heart block caused by traction applied to extra-ocular muscles or compression of the eye, secondary to stimulation of the — nerve.
trigeminal
2047
The trigeminal afferent nerves synapse with the vagus nerve of the — nervous system’s motor nucleus. Vagal stimulation then travels to the heart causing bradyarrhythmias & heart blocks.
parasympathetic
2048
— coma is a severe hypothyroidism that presents w/ decreased mental status & hypothermia. A history of hypothyroidism or Iodine 131 therapy to treat hyperthyroidism may be indicators. HoTN, bradycardia, hyponatremia, hypoglycemia, & hypoventilation are often too.
Myxedema
2049
— pts have severe & life-threatening symptoms of hyperthyroidism. HR can exceed 140BPM & CHF may be present. Temp of 104-106 degrees F are common, along w/ agitation, delierium psychosis & coma. Hepatic failure & jaundice can occur.
Thyrotoxicosis
2050
— syndrome is a cause of sudden cardiac arrest & death in pts w/ apparently normal hearts. This syndrome is detected by obtaining an ECG on the effected pt. ECG will show ST segment elevation in leads V1 to V3.
Brugada
2051
— syndrome is a cardiac condition in which a chronic left to right intra-cardiac shunt causes right ventricular (or atrial) hypertrophy eventually reversing the flow of blood through the defect. Due to the higher right side cardiac pressures systemic HoTN would cause an increase in deoxy blood flow through the defect causing hypoxemia. In these pts, conditions causing elevated PAP will increase the abnormal flow as well. Aggressive pulmonary physiotherapy post op to prevent atelectasis or pneumonia is indicated. Due to the dilation & hypertrophy caused by the syndrome these pts are at higher risk than avg for intraop arrhythmia & care should be taken to be prepared should such an event occur. In addition the risk of systemic air embolism is increased in these pts due to the abnormal right to left side blood flow. Air should be removed from all IV lines & air filter should be used.
Eisenmenger
2052
Maintaining strict — is of key importance for MS pts.
temp
2053
Droperidol is contraindicated in — disease, among other disease, due to its antagonism of dopamine receptors.
Parkinson’s
2054
— meds (donepezil) (used commonly in Alzheimer disease) seem to help improve the cognitive function in pts w/ MS.
Anticholinesterase
2055
— has no use in the treatment or management of a typical MS pt, & dehydration can cause stress leading to an exacerbation.
Fluid restriction
2056
— deficiency is a congenital inherited disorder manifesting w/ early onset hepatic disease &/or early onset emphysema depending on the genotypic allele pattern present in the pt.
Alpha-1 Antitrypsin (AAT)
2057
Propofol infusion syndrome are as follows: metabolic —, lipemia, rhabdomyolisis, HF, RF, hepatic dysfunction, elevated LFT, elevated troponins, elevated lactate. Recognize that these lab values represent hepatic, cardiac, renal, & muscular damage w/ lipemia & lactic acidosis. Treatment is w/ —,—,—
acidosis ; charcoal hemoperfusion, cessation of propofol, & supportive measures.
2058
— is a disorder which occurs when a large amount of hypo-osmolar fluids are used in irrigation of the surgical field. Because this syndrome is caused by absorption of hypo-osmolar, non-electrolyte containing solutions, only 1.5% — solution holds a substantial risk of causing it. The reason is that the electrocautery devices used in these procedures are mono-polar. This leads to hyponatremia & serum hypo-osmolarity causing cerebral edema. The symptoms are thus confusion, nausea, & irritability, & in the case of associated glycine toxicity, temporary blindness.
TURP syndrome ; glycine
2059
— occurs during an acidotic state bc the body attempts to normalize pH by exchanging extracellular H+ ions for intracellular K+. Peripheral — occurs because acidemia seems to augment peripheral responses to nitric oxide & other vasodilators & decrease responses to circulating catecholamines.
Hyperkalemia ; vasodilation
2060
Glucose — affect the serum osmolal gap. Osmolal gap is a calculation to estimate excess osmotically active solutes in the blood.
does not
2061
An elevated osmolal gap can be found in: 5
alcohol ingestions, excess glycine (during TURP), severe hyperlipidemia, DKA, severe RF.
2062
Goiter is associated with —.
hypothyroidism
2063
—&— slow the progression of CKD by lowering the glomerular filtration pressure in kidney.
ACE-I & angiotensin receptor blockers
2064
The — # is used to test a pt for pseudocholinesterase deficiency.
Dibucaine
2065
Classic pheochromocytoma triad: 3
1) sustained or paroxysmal HTN 2) headache 3) generalized sweating.
2066
The mild release of K+ (—mEq) from muscle cells that normally accompanies the administration of succ is magnified & can result in life threatening hyperkalemia in pts w/ pre-existing neurologic & muscular disorders (—mEq increase). It has been well documented to happen in Guillain-Barre syndrome as well as chronic immobilization, spinal chord lesions, & other disorder resulting in muscle paralysis, disuse &/or chronic denervation. The phenomenon is likely due to over sensitization of the damaged myocytes to the depolarizing effects of succ.
0.5mEq ; 5-10mEq
2067
3 stages of heat loss & movement during anesthesia:
1st phase (redistribution), 2nd stage (linear stage), 3rd stage (steady state)
2068
— causes a drop of temp in the central core of the body w/in the 1st hr of anesthesia due to redistribution of heat from the core to the peripheral tissues. This is greatest loss of heat.
1st phase (redistribution)
2069
— is that of combo of reduced heat production & increased heat loss to the environment. This 2nd phase starts at the beginning of surgery & lasts from 2-3 hours where there is decreased heat production due to anesthetic agents, decreased heat production due to limited muscle activity, & further loss of heat to the environment due to convection, radiation, evaporation & conduction. Cold IV fluids also contribute to this heat loss stage.
2nd stage (linear stage)
2070
— is that of a thermal steady state where the body’s production of heat equals the loss of heat to the environment & core temp becomes stable. This stage often not reached during most surgeries, & occurs when the temp drops sufficiently to activate peripheral vasoconstriction & reduce loss of peripherally shunted heat.
3rd stage
2071
Administration of excessive concentrations of normal saline (0.9%) can cause a — metabolic acidosis from the excess chloride concentrations administered & dilution of serum bicarbonate levels. Additional causes include disorders which cause a net loss of bicarbonate ions (diarrhea, renal tubular acidosis & early acute RF).
hyperchloremic
2072
Hyperchloremic acidoses are — acidoses as the body is able to compensatory raise serum Cl- concentrations to maintain electrical neutrality in these examples.
non-anion gap
2073
A rough estimate of renal function deterioration can be surmised by the rule that for every doubling of the — about 1/2 of renal function is lost.
creatinine
2074
Severe — causes lab reports to falsely show low Na+ levels.
HLD
2075
— is the greatest cause of heat loss in a pt & is estimated to be —% of heat loss.
Radiation ; 40
2076
— is heat transfer by electromagnetic waves, which carry energy away from the emitting object. Keeping the body covered helps decrease the body’s area exposed to the energy into its environment.
Radiation
2077
— is responsible for around 30% of heat loss.
Convection
2078
— is the form of heat transfer in liquids & gases, caused by fluid flow around the pt. The ambient temp of the room being set below the pt’s temp is a cause of this heat loss.
Convection
2079
— is responsible for an estimated 20% of heat loss.
Evaporation
2080
—: Water takes heat to turn into a vapor, & the heat in our case is provided by the human body. As the pt breathes & sweat evaporates, the energy (heat) from the pt’s body provides the water the ability to take the water from liquid to vapor form. The heat is transferred from the body to the vapor that drifts away. The heat the body uses to warm the gas traveling to the lungs is not a major cause of heat loss in our pts. Once intubated, the ventilator assists w/ helping maintain humidity & temp, decreasing the rate of respiratory heat loss.
Evaporation
2081
— is believed to be responsible for around 10% of heat loss in pts.
Conduction
2082
— heat loss is caused by direct contact to a surface that is colder than the pt; ex.: laying a pt on a cold bed surface.
Conductive
2083
— is generally believed to be the last sense to be lost before the unconscious state is reached, & may be the 1st sense regained upon your pt’s emergence.
Hearing
2084
— interval is a manifestation of a congenital disorder or of Ca+ and Mg+ abnormalities.
Prolonged QT
2085
Midazolam’s quick onset is due to it’s high — solubility.
lipid
2086
— is useful for irregular narrow complex tachycardias at a dose of 0.25mg/kg initially, or 20mg as appropriate in this pt. In common practice for the adult pt, 15-20mg is typically used although it is technically a weight-based med. This initial dose is given over 2min & may be repeated at 0.35mg/kg after 15min.
Diltiazem (Ca Channel blocker)
2087
— is frequently used for a-fib, however other choices such as —or— are also good depending on the clinical situation.
Diltiazem ; beta blockers or verapamil
2088
— antiarrhythmic medications work to alter or block Na+ channels and inhibit Phase 0 of cardiac depolarization. They also have modest K+ channel antagonism.
Class I
2089
Class I drugs are further subdivided into class IA, IB, & IC. Class IA drugs have an — time of onset & termination, class IB drugs have the rapid onset of action & termination, & Class IC drugs have the — onset & termination of action.
intermediate ; rapid ; slowest
2090
The earliest sign of an ST elevation MI is — waves.
peaked (or “hyperacute”) T
2091
pericardial tamponade will lead to:
lowered BP, muffled heart tones, & jugular venous distension (Beck’s triad)
2092
Measurement of ST depression or elevation should occur at 0.08seconds (2 small boxes) past the — point.
J
2093
The — is the point where the end of the QRS occurs, beginning the ST segment. It is where depolarization ends & repolarization begins.
J point
2094
Defibrillation: Dosing for peds should start at —Joules/kg. If this fails to convert the rhythm, the 2nd dose should be at —Joules/kg or higher but not to exceed — Joules/kg or —J (the suggested adult dose).
2 ; 4 ; 10 or 200
2095
— is indicated in the treatment of v-fib or ventricular tachycardia w/o a pulse, working by depolarizing the entire myocardium to allow restoration of normal electrical conduction. When possible, use ped adhesive pads instead of adult pads.
Defibrillation
2096
A pt in pulseless v-tach or v-fib should be administered — at a dose of —mg in a bolus. After defibrillation & continued CPR, its dosing may be repeated at —mg if the 1st dose is unsuccessful.
amiodarone ; 300 ; 150mg
2097
— is by far the drug of choice for ventricular & atrial dysrhythmias for any pt w/ an EF of <40% or CHF is otherwise present –drugs such as verapamil are contraindicated in these pts.
Amiodarone
2098
The PR interval is measured from the beginning of the P wave to the 1st part of the QRS complex (Q wave or R wave). It is normally <— seconds. The PR segment includes the period of atrial depolarization & conduction through the His-Purkinje system. Any prolongation of the PR interval is typically caused by slowed AV node conduction.
0.20
2099
A normal QRS complex lasts <— seconds (<— very small EKG strip boxes).
0.12 ; 3
2100
For peds pt, the 1st cardioversion dose is — Joule/kg w/ the next doses at — J/kg if needed.
0.5-1 ; 2
2101
— is indicated for pts w/ a reentrant electrical dysrhymia. It stops the reentrant electrical conduction, allowing normal depolarization from the SA node through to the Purkinje system to resume. Pts w/ unstable vital signs who are in cardiac rhythms such as SVT, ventricular tachycardia w/ a pulse, a-fib, & a-flutter
Cardioversion
2102
Lidocaine for v-fib or v-tach & pulsatile stable v-tach should be dosed at — mg/kg. Dosing may be repeated every 5-10min as a bolus at a rate of 0.5-1 mg/kg if the rhythm doesn’t convert –the max dose is —mg/kg. After successful resuscitation, a drip of lidocaine should be started at a rate of 1-4 mg/minute (or 20–50 mcg/kg/min).
1-1.5 ; 3
2103
Lidocaine: If there is no IV present, the same dosing schedule may be used through an intraosseous needle. ETT administration should be at — the IV dose diluted in 10mL of — (normal saline is adequate, but this has greater absorption).
2x ; sterile water
2104
— provides K+ channel blocking (primary mechanism), Na+ blocking (class IB), Ca+ blocking, & sympathetic blocking properties. Blocking of K+ channels prolong the time of repolarization & the refractory period.
Amiodarone
2105
Left ventricular hypertrophy causes — axis deviation.
left
2106
Causes of — axis deviation: PE, COPD, cor pulmonale, lateral wall MI, & right ventricular hypertrophy.
right
2107
ECG findings of ST elevation MI most likely seen in order: Peaked — waves, ST segment —, Q wave development, T wave —.
T ; elevation ; inversion
2108
— at 1-2g should be administered to any pt w/ polymorphic v-tach (Torsades de Pointes) even if serum is thought to be normal. After initial dosing, an infusion drip of 0.5-1g/hr should be continued. It is also useful for pts w/ long QT syndrome who are at significant risk for conversion to polymorphic v-tach an excellent candidate for this is a pt w/ a QTc of >450millisecs who has a bradycardic rhythm & frequent PVCs.
Mg+ sulfate
2109
— complicates diagnosis of MI, bc it changes how ventricles depolarize & leads to its own ST segment & T wave changes.
LBBB
2110
— is not associated w/ QT prolongation & is useful to treat Torsades de Pointes & v-fib.
Lidocaine
2111
Meds such as procainamide, amiodarone, methadone, droperidol, & ondansetron are known to — QT intervals. Antipsychotics (haloperidol) & tricyclic antidepressants also do to.
prolong
2112
— is administered at 2.5-5mg IV for the treatment of irregular narrow complex tachycardic rhythms, including a-fib, multifocal a-tach, & a-flutter. Given over 2min & may be repeated in 15-30min at a dose of 5-10mg. It decreases SVR.
Verapamil
2113
—: is absolutely contrainidacted in pts w/ WPW syndrome due to its ability to send the pt into v-fib.
Verapamil
2114
ST-T wave changes seen in left ventricular hypertrophy are typically seen in — leads (—,—,—). These signs can be seen as T wave inversion & ST depression.
anterolateral leads (I, aVL, V4-V6)
2115
Left axis deviation, left atrial hypertrophy, & increased amplitude of the QRS complex R wave in —&—.
aVL & V5-V6
2116
Procainamide is dosed at —mg/min until rate controlled.
20
2117
— is useful to treat hemodynamically stable v-tach & a-fib w/ an uncontrolled ventricular response. The dose is started at 20mg/min & continued until either the QRS widens by >50%, HoTN develops, or a max dose of 17mg/kg is administered. If an emergent situation is present, procainamide can be administered at 50mg/minute. After successful treatment of the dysrhythmia, a continuous infusion of 1-4mg/minute drip is administered.
Procainamide
2118
— is not to be used for unstable v-tach or v-fib.
Procainamide
2119
—&—, both useful for SVTs, should not be used in any pt w/ a QTc interval of >450 milliseconds.
Procainamide & sotalol
2120
V-tach w/ a pulse should have an initial dose of —J, not —J.
100J ; 200J
2121
A-fib dosing for cardioversion may start at —J biphasic, a-flutter —J biphasic, & v-fib or polymorphic v-tach (Torsades de Pointes) at —J.
50-100J ; 50J ; 200J
2122
Use of antiarrhythmic agents can help result in more succesful cardioversion at lower doses. This has been successfully done by combining — or — w/ cardioversion in therapy for a-fib for instance.
amiodarone or sotalol
2123
— drugs are the Ca+ channel blockers such as verapamil & diltiazem. Ca+ channel blockers slow firing of the SA node & slow conduction through AV node through increasing AV refractory period & prolonging AV conduction. On the EKG an increased PR interval may be seen.
Class IV
2124
— rhythm is most often found during myocardial reperfusion. It is seen as a wide complex ventricular rhythm at a rate of 40-100 (typically 40-60). >100BPM it is referred to as v-tach. Reperfusion may occur as a pt comes off of cardiopulmonary bypass or after interventional cardiology procedures such as arterial stenting. In these cases beta blockers may be beneficial, but the rhythm typically should not be treated with anti-arrhythmics as the pt may convert to asystole.
Accelerated idioventricular
2125
A pt w/ WPW syndrome must not be given certain — blocking drugs to control ventricular rate in the event of a-fib w/ a rapid ventricular response. The contraindicated drugs include —,—&—.
AV node ; verapamil, digoxin, & adenosine
2126
Pts w/ — have their AV conduction travel through a path that bypasses the AV node, causing “pre-excitation” which is seen as rapid ventricular firing. Blocking AV nodal conduction further will cause the accessory tract to be favored. These drugs if given will enhance the ventricular rate & can lead to v-fib & death.
WPW
2127
Pts with WPW syndrome, IV — is the most dangerous of these drugs to give. Not only does it block the AV node & increase its refractory period, it also has a direct effect in reducing myocardial contraction & SVR.
verapamil
2128
— has lead to v-fib when given to a pt in a-fib w/ WPW syndrome.
Verapamil
2129
— is contraindicated in a-fib in any situation.
Adenosine
2130
When WPW is mentioned, — is the drug of choice according to current ACLS guidelines. See WPW, think this unless a contraindication to the drug exists.
procainamide
2131
The vertical deflection on the ECG is a display of detected voltage. A 10mm deflection vertically equals — mV on the standard EKG. 10mm equals 10 of the small boxes.
1
2132
Hypokalemia may lead to prominent - waves.
U
2133
Although U waves may be normal in healthy individuals, certain conditions such as —,—, & certain meds such as — can also cause U waves.
hypokalemia, intracranial hemorrhage ; amiodarone
2134
A pt in complete heart block can not be treated w/ —, which only increases the SA rate & is blocked from increasing the ventricular rate. AV dissociation can not be treated by increasing the SA rate due to the antimuscarinic effects of it only increasing the atrial contraction rate, which is not translated to increasing the ventricular rate. Interventions that are beneficial in this rhythm include transcutaneous pacing, epi infusion, & dopamine infusion which all work to increase the ventricular rate. These interventions can be used either until the situation resolves or until a permanent pacemaker is installed.
atropine
2135
Anesthesia services typically use a minimum of —mm of ST segment depression as a sign of ischemia.
1mm
2136
The auscultation of — prolapse is a mid-systolic click followed by a murmur through the remainder of the systolic cycle. The sounds represent the prolapsed valve reaching max prolapse, then, as the valve becomes incompetent, blood flow regurgitates into the left atria causing the murmur. The murmur has characteristics which can be changed by increasing or decreasing ventricular volume. The characteristic “click” of its prolapse will move closer to S1 when left ventricular volume is decreased such as w/ sitting, standing or valsalva. It will move further from S1 when left ventricular end-diastolic volume is increased such as w/ hand grip maneuvers, laying supine, or squatting. This murmur will be loudest heard over the apex.
mitral valve
2137
“—” refers to cardiac contractile rate.
Chronotropy
2138
“—” refers to cardiac muscle fiber relaxation.
Lusitropy
2139
Pure — HF is is a condition in which the S/S of HF are present while there remains a preserved ventricular EF. The problem with this HF is w/ — of the ventricle.
diastolic ; filling
2140
the problem w/ — HF is — which is directly correlated to EF.
systolic ; contraction
2141
A dilated left ventricle w/ minimal EF & elevated end diastolic pressures best describes left ventricular — failure.
systolic
2142
Low CO caused by decreased preload from hypovolemia & low left ventricular diastolic pressures is — shock.
hypovolemic
2143
HoTN from an infectious cause w/ preserved CO & low end diastolic volume describes — shock.
septic
2144
Elevated PAP w/ eventual decreased right ventricular EF describes a condition known as —.
cor pulmonale
2145
— med (“coronary steal syndrome”) is useful for most indications
Nitroprusside
2146
— med for cardiac ischemia or HF
nitroglycerin
2147
— med for aortic dissection
beta blockade (esmolol)
2148
— med for renal insufficiency
fenoldopam
2149
— is a phenomenon w/ parenteral nutrition
Hyperglycemia
2150
The — is the best test to determine the degree of anticoagulation present from heparin therapy.
activated PTT test (aPTT)
2151
The PTT is used to assess the — pathway & the — pathway of clot formation. PTT evaluates factors —,—,—,—,—,—,—&—.
intrinsic ; common ; I (fibrinogen), II (prothrombin), V, VIII, IX, X, XI, & XII
2152
— inactivates factor II (prothrombin) which prevents the formation of thromboplastin. These actions are present for about 4-6hrs after dosing of heparin.
Heparin
2153
Activated PTT has additives to the testing reagents to shorten & narrow the time of results, where normal values should be between —sec. Traditional PTT’s normal range is —sec.
30-40sec ; 60-70sec
2154
LR produces a metabolic — as the lactate is converted to bicarbonate in the liver.
alkalosis
2155
— metabolic — may be seen after large amounts of Na+ Cl- being administered. It produces a non-anion gap metabolic acidosis.
Hyperchloremic ; acidosis
2156
—,—,—&— are all found in cryoprecipitate.
Factor VIII, XIII, fibrinogen, & vWF factor
2157
Administration of plts is not indicated typically unless the plt count is <— cells/mm^3.
50,000
2158
— for plts, cryoprecipitate, & FFP are considered universal donors. This is the exact opposite of blood in which — is the universal donor. Likewise, — plts, cryoprecipitate & FFP are considered universal recipients for these products.
AB+ ; O- ; O-
2159
Cirrhosis, Viral infection, B12 deficiency, Sepsis may cause a — plt count.
decreased
2160
— is also seen in polycythemia vera, rheumatoid arthritis, & postsplenectomy syndrome.
Thrombocytosis
2161
— TSH & — T4/T3 values will be seen w/ secondary hyperthyroidism.
Low TSH & high free T4/T3
2162
Hyperthyroidism is almost always a — endocrine problem meaning that there is an overproduction of thyroid hormone (T4 & T3) from the thyroid gland itself. This will lead to a suppression of TSH from the anterior pituitary gland in a negative feedback loop, to suppress continued CNS signaling for thyroid hormone production.
peripheral
2163
Hyperthyroidism (Graves Disease): —or— should be started 6 weeks prior to the procedure in order to achieve this state. — is very useful for ameliorating the symptoms of hyperthyroidism & the doses are titrated according to HR. — has a slight advantage for induction in hyperthyroid pts as it decreases the peripheral conversion of T4 to T3 (a more active form of the thyroid hormone).
Propylthiouracil or methimazole ; Beta blockade ; Thiopental
2164
Uncontrolled thyroid pts requiring prompt surgery can be quickly controlled by administering methimazole followed by high dose —. It reduces all stages of thyroid hormone production, IF given with a thyroid synthesis blocking agent (methimazole). It w/o premed will INCREASE thyroid hormone stores.
oral iodide
2165
Preop, — 2mg IV Q 6hrs will decrease peripheral conversion of thyroid hormone to T3 (a more active from) allowing for better control.
dexamethasone
2166
The most important step in the correction of DKA is adequate — followed by insulin administration. The insulin must be continued until the metabolic acidosis resolves to prevent further ketogenesis.
volume resuscitation
2167
— anesthesia is preferred whenever possible in pts w/ Duchenne’s Muscular Dystrophy.
Regional
2168
Pts w/ acromegaly suffer from narrowed upper airways and require — ETT.
smaller
2169
Hyperosmolar Hyperglycemic State (HHS) is one of the 2 acute diabetic emergencies. Pts in HHS are usually older than 65 & suffer from —. They present with blood sugars >— & a serum osmolality of >—. Symptoms consist of lethargy, polyuria, & polydipsia, progressing to obtundation or coma over a matter of days (pts w/ DKA by comparison complain of severe abdominal pain & vomiting in the majority of cases that develops over 24-48hrs).
DM2 ; 600 ; 320
2170
HHS pts generally suffer from a greater degree of — depletion than pts in DKA (9L on avg compared to 6L) as well as a greater deficiency in electrolytes such as —&—. Pts w/ HHS should not suffer from a — which can be useful in differentiating from DKA.
volume ; Na+ & K+ ; ketosis
2171
Cricoid pressure must provide —lbs of force upon loss of consciousness (—Newtons) to be effective.
8-10lbs ; 30-40
2172
Acute —, w/ its characteristic “millwheel murmur.
venous air embolism
2173
Correction of severe hyponatremia should be done to cause an increase in serum Na+ of no more than — mEq/hr. Repletion rates too fast can cause shifts in cerebral cellular water concentrations causing cellular swelling leading to seizures & death. More aggressive treatment is required in pts w/ severe symptoms such as seizure, coma, or obtundation regardless of Na+ level due to the risk of brain herniation.
0.5
2174
In pts w/ — as the primary cause of their hyponatremia, hypertonic saline (1ml/kg body wt/hr) must be used to correct the imbalance when these symptoms are present. If these symptoms are absent then more gradual measures may be taken (fluid restriction).
SIADH
2175
Always monitor the serum Na+ every 2-3hrs during correction to avoid — from overly rapid correction.
central pontine myelinolysis
2176
—coagulability is seen with hypothermia
Hypo
2177
Hypothermia — the rate of emergence (both inhalational & TIVA). It can also — the rate of drug metabolism causing prolonged action or decrease blood blow preventing redistribution. Hypothermia also causes post-op shivering, — the risk of infection, & prolongs the total time for recovery.
slows ; slow ; increases ;
2178
helium cylinders are colored —.
brown
2179
Equation = Hourly Insulin infusion rate
Plasma Glucose/150
2180
Administering 75% nitrous oxide will expand closed air spaces to — the original volume. The amount of nitrous oxide that will diffuse into a closed air space will be that which results in an equal concentration of nitrous oxide to the inspired level. To get the concentration in the pneumothorax to be 75% nitrous oxide, the original air would only be 25% of the total air. Thus, 600mL of nitrous oxide added to the 200mL of air would result in the desired concentration. The total amount of gas in the pneumothorax would be —ml.
4x ; 800 mL
2181
The fail-safe device decreases/stops flow of all gases when pressure falls <—psi.
30psi
2182
Soda lime can absorb —L for every 100g of absorbent, & barium hydroxide lime (BaraLyme) can absorb —L of CO2 per 100g of absorbent.
14-23 ; 9-18
2183
— absorbents are designed to remove CO2 to prevent re-breathing of carbon dioxide which may lead to hypercapnia. Initially the pt’s exhaled CO2 combines with water (there is additional water contained w/in the soda lime) to create carbonic acid. This carbonic acid enters the carbon dioxide absorbent canister & interacts w/ the soda lime (or other absorbent) producing —,—,— carbonate.
Carbon dioxide ; water, heat, & Ca+
2184
The actual VO2 is based on the pt’s —&—.
O2 content (CaO2 or CvO2) & CO.
2185
The NMDA antagonism is non-competetive, & is likely the main mediator of the analgesia found in — use.
ketamine
2186
Metformin can accumulate with renal insufficiency. It is believed to cause — by promoting the conversion of glucose to lactate in the splanchnic bed of the small intestine. It also inhibits hepatic gluconeogenesis from lactate & pyruvate, which causes additional amounts of lactate.
lactic acidosis
2187
metformin induced — almost always occurs in pts with renal or hepatic comorbidities or in the presence of sepsis or alcohol abuse. HF & any hypoxic or hypotensive states also increase the risk due to the increase presence of lactic acid.
lactic acidosis
2188
metformin should be discontinued —hrs prior to surgery.
48 hours
2189
— has been implicated in causing right vocal cord paralysis & laryngeal edema in a lupus-like syndrome (also known as drug-induced lupus erythematosus or DILE). Signs of drug-induced lupus erythematosus include arthralgias, fever, & development of rash on sun-exposed areas of skin.
Hydralazine
2190
— is useful as an alkalinizing agent & given to pts at high risk for aspiration to quickly increase stomach pH, but also increases stomach volume.
Sodium citrate (Bicitra)
2191
—or— which take significant time for the stomach pH to rise, sodium citrate provides immediate benefit.
proton pump inhibitors (omeprazole) or H2 blockers (famotidine)
2192
— is a centrally acting alpha 2 agonist that works by presynaptically decreasing sympathetic output from the CNS.
Clonidine
2193
Exaggerated responses to vasoactive medications may be seen in a patient taking — and under GA. Pts on this should not be administered —or—.
MAOIs ; meperidine or ephedrine.
2194
— is an indirect thrombin inhibitor, forming a complex with AT III (antithrombin) causing deactivation of thrombin as well as factor Xa. It is the most efficacious drug to use in the treatment of pulmonary embolism.
Heparin
2195
— mimics natural somatostatin by inhibiting serotonin release (carcinoid tumors release serotonin) along with the inhibition of gastrin, insulin, glucagon, & growth hormone. its actions in decreasing splanchnic BF.
Octreotide
2196
— are rare, but are the most common GI neuroendocrine tumor. The ones that are local can be surgically resected, but others with metastasis require other therapy. Treatment of this syndrome is typically with octreotide, improving the symptoms of diarrhea & flushing in most pts. Extreme swings in BP with significant flushing, bronchoconstriction, dysrhythmias & altered mental status can last for hours or days.
Carcinoid tumors
2197
— has some same side effects seen with all opioids, including causing nausea, vomiting & constipation. It is the opioid with antichoinergic effects. It causes orthostatic hypotension more so than other opioids, possibly due to alpha 2 agonism. Myocardial contractility is decreased by large doses. It causes an increase of HR rather than bradycardia that is typical of opioids. It can cause mydriasis (eye dilation) instead of miosis typically seen with opioids. Drying of secretions is also noted due to its anticholinergic effects.
Meperidine
2198
—, a metabolite of meperidine, causes CNS effects including seizures in delirium – this is particularly seen in renal failure patients.
Normeperidine
2199
The rate of absorption of any LA is dependent on the — of the location.
vascularity
2200
The rate of absorption fastest to slowest w/ mnemonic:
In Time I Can Please Everyone But Susie and Sally Intravenous>Tracheal>Intercostal>Caudal>Paracervical>Epidural>Brachial Plexus>Subarachnoid, Sciatic, Femoral>SubQ
2201
The risk of toxicity with LA is directly related to —.
potency
2202
The max safe dose of lidocaine is —mg/kg when used without epi. Due to the local vasoconstriction caused by epi, with less drug entering the systemic circulation, epi combinations with lidocaine raise the safe threshold of administrable drug to —mg/kg. Risks of toxicity generally are heralded by neurologic symptoms including paresthesias (circumoral numbness), dizziness, blurred vision, & tinnitus, followed by slurred speech, drowsiness, seizures & obtundation. If toxicity is great, cardiac effects may be noted including heart block, bradycardia, ventricular arrhythmias & hypotension. The doses needed for cardiac toxicity are about 3x that needed for neurologic manifestations making them less likely to be noted without a preceding neurologic symptoms.
5 ; 7
2203
The lateral femoral cutaneous nerve leaves the — roots & travels in a lateral/inferior direction anterior to the iliacus muscle.
L2-L3
2204
Metoclopramide (Reglan) is contraindicated in — disease. Metoclopramide long term use is known to rarely cause tardive dyskinesia, which may not be reversable. Reports of tardive dyskinesia, neuroleptic malignant syndrome, hallucinations & harmful psychological effects have been reported in this disease pts who are administered it.
Huntington’s
2205
Upon removal of the pituitary gland (hypophysectomy), the endogenous hormones secreted from it are also removed including —. Therefore, — is most likely condition to ensue. Replacement — will abate the side effects.
antidiuretic hormone (ADH) ; diabetes insipidus ; vasopressin (desmopressin)
2206
— is released by the posterior pituitary along with oxytocin. —,—,—&— are all released from the anterior pituitary.
ADH ; Thyroid stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH), Prolactin, & Growth Hormone (GH)
2207
— is the only cerebral physiology that is increased by lidocaine administration. Lidocaine cerebrally decreases CMR, Cerebral blood flow, Intracranial pressure, & Cerebral blood volume.
Cerebral vascular resistance
2208
A pH of >— is considered a good sign, & fetus with a pH <— is considered an abnormal sign & raises concerns of fetal well-being; fetal delivery should be done in an expedited fashion in this situation.
7.25 ; 7.20
2209
— is added to increase the neutral, un-ionized fraction in order to quicken the onset of anesthesia.
Bicarbonate
2210
— environments worsen the quality & prolong onset time of the anesthetic.
Acidic
2211
All LA except for — are vasodilators, directly relaxing smooth muscle in arterioles.
cocaine
2212
The greatest concern in pts having a vaginal delivery after a previous c-section (VBAC) is the possibility of —.
uterine rupture
2213
— is the best means of detecting uterine rupture.
Nonreassuring fetal HR
2214
Drugs that — variability of fetal HR include atropine, GA, magnesium, opiods, barbs, benzo, & ingested ethanol.
diminish
2215
Terbutaline, a beta agonist tocolytic, — effect fetal HR variability. Other tocolytics such as nifedipine & nitroglycerine — alter fetal HR variability either, but magnesium as a tocolytic —.
does not ; does not ; does
2216
— is the most common cause of bradycardia in the ped population. Other causes of bradycardia in the pediatric population include vagal stimulation, hypothermia, depression from anesthetic agent, and succ administration.
Hypoxia
2217
The time from —mths is termed physiologic anemia of infancy, as it is a normal variant & is generally well tolerated by healthy term infants.
2-3
2218
Soon after birth, erythropoietin synthesis greatly decreases & Hb levels slowly decrease. In 8wks, Hb reaches a low point of ~— mg/dL. In premature infants, this decrease also occurs more rapidly & will possibly fall as low as —mg/dL. Other factors, including frequent phlebotomy in sick neonates & the rapid growth of the infant compared to blood volume increases may also contribute to this anemia.
10 ; 7 or 8
2219
After trachea, carina marks the — generation of the respiratory tree’s divisions. It then splits into bronchus (—) followed by the bronchioles (—).
1st ; 3rd ; 4th
2220
— position is found during phonation or during effort closure, when the vocal cords are in an adducted position.
Midline
2221
Expiration in humans is a — event that doesn’t require muscle effort.
passive
2222
In pts that force expiration, the — muscles including —,—,— assist w/ forced expiration.
abdominal ; external & internal obliques & the rectus abdominis
2223
The alveolar sac is the — generation (division) of the respiratory tree, which marks the end of the respiratory tree. This is the location where the alveoli begin. Actual gas exchange begins at generation — w/ the bronchioles.
23rd ; 17
2224
Thyroid cartilage felt at — level. This cartilage forms the — wall of the larynx & provides anterior wall of the larynx.
C4-C5 ; anterior
2225
— is the most potent coronary vasodilator volatile agent.
Iso
2226
— has been shown to react w/ CO2 absorbents in anesthesia circuits to produce carbon monoxide. Baralyme that is dried (dessicated) is the most commonly implicated absorbent, however it can be seen w/ soda lime as well.
Des
2227
Anesthesia hoses contain —L of gas in the adult circuit, & anesthesia absorbent containers hold —L of gas. An adult anesthesia bag can contain —L of gas, & ped bags can contain either —L of gas. The total wash-in volume of the anesthesia machine is —L.
2L ; 2L ; 3L ; 1 or 2L ; 7L
2228
Cerebral vasodilation begins at >— MAC, at >1 MAC all modern volatile anesthetics actually begin to increase —.
0.6 ; ICP
2229
— antiarrhythmic meds are the beta blockers. These meds work by antagonising sympathetic activity & slowing rate of SA or ectopic atrial discharges. They further slow conduction through primary 7 abberant accessory conduction pathways.
Class II
2230
Lidocaine is a — antiarrhythmic drug
class IB
2231
A QTc interval of >— seconds (— milliseconds) is considered prolonged.
0.45 ; 450
2232
Most pts w/ a dissecting aorta will have a variation in BP of >— mmHg b/n arms. Pts may have a missing carotid pulse, depending on location of dissection.
20
2233
In a pt w/ — syndrome, the incidence of having a dissecting aneurysm is greatly increased compared to the normal population.
Marfan’s
2234
A pt in — is seen as having a progressively prolonged PR interval followed by a non-conducted (blocked) P wave. This condition can be due to a structural or electrical conduction problem, & is typically seen in pts w/ high vagal tone. If asymptomatic, no treatment is needed/indicated & the problem generally resolves itself. In symptomatic bradycardia (seen with a low atrial rate), atropine may be used temporarily & a permanent pacemaker may be indicated.
2nd degree AVB type I (Mobitz I/Wenckebach)
2235
1 plt pheresis should raise plt count by — cells/microliter in a typical adult pt. 1 unit of plt concentrate should increase plt count by — mm3.
30,000-60,000 ; 5,000-10,000
2236
A pheresis contains — the amount of 1 unit of plts.
6x
2237
The — test is the best test to determine renal functioning.
creatinine clearance
2238
>— mL/min is considered normal renal function on lab testing, but true normal is —mL/min so significant renal function decline can occur before a drop in GFR is noted in lab work. Mild renal insufficiency seen at GFR of —mL/min, & mod renal insufficiency is from —mL/min. A GFR of <—mL/min is seen in overt renal failure, while a GFR of <—mL/min is seen in end stage renal disease.
120 ; 180 ; 40-60 ; 25-40 ; 25 ; 10
2239
— disease: avoiding meds that stimulate SNS due to a potential for an exaggerated CV response under increased thyroid activity including HTN & tachycardia. Ketamine is one such agent.
hyperthyroid
2240
— induction may be preferred as it has thyroid hormone blocking activity.
Thiopental
2241
— is the fluid of choice for pts in RF. Giving a pt in RF any K+ containing fluids increases the incidence of hyperkalemia due to their inability to excrete K+. Glucose free fluids should be used when possible due to the glucose intolerance caused by peripheral tissue insensitivity to insulin in uremic pts.
NS .9%
2242
NS .9% is —, — free & doesn’t contain —.
isotonic ; K+ ; glucose
2243
Lithotomy position places the legs into stirrups most often implicated in damage to — nerve.
common peroneal
2244
A minimum of —L/min is required to provide an FiO2 that will approximate a 1.0 FiO2.
10
2245
Alfentanil is a — potent & — acting analogue of fentanyl.
less ; shorter
2246
— failure, but not —, can prolong the action of Alfentanil.
Liver ; RF
2247
—&— have been demonstrated to cause significant drops in BP when given the morning of surgery. These meds should be w/held at least 1 dosing cycle prior to surgery.
ACE-I (lisinopril) & angiotensin receptor blockers
2248
— inhibit the H+/K+ATP-ase pump of the gastric parietal cell. This is the last stage of gastric acid secretion, reducing acid secretion by up to 98%. These meds can decrease the risk of morbidity in the event of aspiration by increasing stomach pH, but must be given time to work prior to induction–they should not be w/held prior to surgery.
Proton pump inhibitors (omeprazole)
2249
— is a antiHTN w/ B1, B2 & A1 antagonism properties that is used frequently in pts w/ HF, HTN, & left ventricular dysfunction after MI. It also decreases HR & improves CO. It also has been shown to slow progression of CHF & decrease risk of death. This med shouldn’t be stopped the morning of surgery, as sudden cessation of this med or any beta blocker can greatly increase the risk of MI & sudden death.
Carvediol (Coreg)
2250
— is commonly used for mod pain on an outpt & inpt basis. Any pt w/ a hx of mod to severe pain shouldn’t have their narcotics withdrawn unless specific indications are present. Pts should also be dosed w/ adequate analgesia prior to emergence from anesthesia & may have increased needs of analgesics due to down regulation of opioid receptors.
Percocet (combo analgesic consisting of oxycodone & acetaminophen)
2251
— (alpha 1 antagonist) was used primarily as an antiHTN. Due to the incidence of side effects (orthostatic HoTN) & the availability of better antiHTNs, it is not used for this purpose as frequently any more. But, it has found popularity as a drug used to treat benign prostatic hyperplasia (BPH) due to the presence of alpha 1 receptors on the prostate gland. Antagonizing alpha 1 receptors on the prostate allows muscular relaxation & eases the symptoms. May be taken on the morning of surgery.
Terazosin
2252
—: drug used to treat benign prostatic hyperplasia (BPH) due to the presence of alpha 1 receptors on the prostate gland. Antagonizing alpha 1 receptors on the prostate allows muscular relaxation & eases the symptoms.
Terazosin (alpha 1 antagonist)
2253
Should Terazosin (alpha 1 antagonist) be taken on the morning of surgery?
Yes
2254
Should ACE-I (lisinopril) & angiotensin receptor blockers be w/ held prior to surgery?
Yes, at least 1 dosing cycle
2255
Should Proton pump inhibitors (omeprazole) be w/held prior to surgery?
No
2256
Should Carvediol (Coreg) be stopped the morning of surgery?
No
2257
Should Percocet (combo analgesic consisting of oxycodone & acetaminophen) be taken prior to surgery?
Yes
2258
drugs that should not be given morning of surgery: 8
1. ACE inhibitors 2. ARBs 3. metformin 4. most insulins (or reduce dose) 5. oral antihyperglycemics 6. niacin 7. diuretics 8. NSAIDs (unless surgeon advises to take)
2259
Drugs to take morning of surgery:10
1. Proton pump inhibitors 2. H2 blockers 3. pain med 4. beta blockers 5. alpha antagonists 6. other antiHTNs that are not ACE/ARBs/diuretics 7. steroids 8. lithium 9. antibiotics 10. anti-depressants including MAOIs and SSRIs.
2260
Triamterene is a — diuretic
K+ sparing
2261
The common peroneal nerve is — anesthetized by the psoas block bc the — nerve is spared.
NOT ; sciatic
2262
The —,—&— of the thigh are anesthetized in a Psoas block.
femoral n., obturator n., & the lateral cutaneous n.
2263
The — block is a useful block for anesthetizing the medial aspect of the leg from groin to ankle via blockade of the femoral nerve & its branches. It also provides anesthesia to the upper lateral aspect of the thigh.
psoas
2264
The — nerve provides motor innervation to the hamstrings & to all muscles distal to the knee.
Sciatic
2265
If you are performing a Sciatic nerve block & produce evoked contractions of the hamstrings then you are at the main trunk of the sciatic nerve & your position is correct. You want distal evoked contractions (Foot & Toes). The reason is that if you only have evoked contractions of the hamstrings you could be stimulating the —or—.
muscle itself or just a branch of the Sciatic nerve
2266
— is the most cardiotoxic
Bupivacaine
2267
— is a racemic LA mixture w/ a high lipid solubility & protein binding profile.
Bupiv
2268
— competitively replaces NorE at the presynaptic terminal & is mostly used in pain management, not in surgical anesthesia.
Guanethedine
2269
Intracranial HTN is defined as a pressure of >— mmHg, & ICP is typically <— mmHg.
15 ; 10
2270
CO returns to the pt’s normal baseline w/in —wks after delivery of the fetus, assuming no cardiac pathology such as HF had developed during pregnancy.
2wks
2271
— is contraindicated in pts w/ hypocalcemia or MG, due to its inhibition of acetylcholine release.
Mg+
2272
— is renally excreted, so pts w/ RF should receive it very cautiously & serum levels should be monitored.
Mg+
2273
Pts with MG should be administered little if any — meds. Certain other drugs also may worsen weakness in pts w/ MG. These drugs are —,—,—,—&—.
neuromuscular blockade ; beta blockers, lidocaine, opioids, aminoglycosides, & phenytoin
2274
— antibiotics in particular, when given during surgery w/ neuromuscular blocking agents, increase the risk of postoperative respiratory depression.
Aminoglycoside
2275
Spinal analgesia is useful in providing optimal conditions for cerclage placement, but must cover levels from — to ensure anesthesia of both the cervix & vagina. GA may be used & may be preferred when membranes are bulging through the cervix. Volatile anesthetics relax uterine smooth muscle which is beneficial during this procedure, however, this must be weighed against the risks of phsyiologic reflexes to intubation. Coughing & vomiting will raise intrauterine pressure & can herniate more of the fetal membranes through the cervix. No matter the method of anesthetic care, ensure abdominal pressure is kept to a minimum.
T8-S4
2276
Pts w/ — may have the following anesthesia relevant abnormalities: endocardial cushion defects, atlanto-axial instability, hypothyroidism, macroglossia, narrow hypopharynx, subglottic stenosis, choanal atresia, obesity. Although hyperthyroidism does occur at a greater rate than the general population, they are far more prevalent to have a hypothyroid function.
Down syndrome
2277
—&— have decreased brown fat stores, & thus have impaired ability to regulate their own temp.
Neonates & premature infants
2278
— is highly vascularized & is innervated w/ beta sympathetic receptors. Stress created by a cold environment increases sympathetic nervous activity & the release of NorE, causing a breakdown of it & release of heat through increased metabolism. One quarter of the CO may be sent to it to directly warm blood. Decreased NorE stores are not the reason for decreased non-shivering thermogenesis.
Brown fat
2279
During normal —, the following occurs: when NorE release is stimulated by sympathetic activity, free fatty acids & glycerol are released from triglycerides. The increase in O2 consumption due to increased metabolism allows an infant to double the normal thermogenic rate. A larger surface to weight ratio will increase radiant heat losses, thus making the choice about a smaller surface area to weight ratio incorrect.
nonshivering thermogenesis
2280
Infants are born w/ low glycogen stores, & thus are more prone to dangerous —.
low blood sugars
2281
Half of all deaths in pregnant pts are related to —. The next most common causes of death are due to —,—or—.
HTN ; infxn, hemorrhage, or “embolic” events
2282
Failure to — is the leading cause of anesthesia related death.
secure an airway
2283
— is a competetive antagonist of Ca+ at the motor endplate, reducing Ca+ influx into the myocyte.
Mg+
2284
— decreases acetylcholine release at the neuromuscular junction & reduces sensitivity of the end plate to acetylcholine. It shares similar side effects to beta adrenergic tocolytic agents such as terbutaline (terbutaline stimulates beta2 adrenergic receptors causing smooth muscle relaxation). It’s side effects include chest pain & tightness, palpitations, HoTN, sedation, diplopia, nausea, flushing, muscle weakness, lethargy, AV conduction blocks & QRS widening can occur as well. Pulmonary edema & cardiac arrest have been reported. Neonatal side effects: lethargy, hypotonia, & respiratory depression.
Mg+
2285
— is another tocolytic that has been compared to Mg+. Compared to it, Mg+ has less incidence of therapy failure than the drug group. In addition the drug group had to have therapy stopped more often than the Mg+ group due to HoTN.
Nitroglycerin
2286
— is associated w/ polymorphic v-tach (Torsades de Pointes), which has been seen even at normal therapeutic levels of the drug.
Procainamide
2287
— has a short DoA & seems to have a very low risk of pro-arrhythmic effects.
Lidocaine
2288
— also has a very low risk of pro-arrhythmic effects –Torsades de Pointes seen with its use is associated with low serum Mg+ levels.
Amiodarone